In total 412 out of top-10 predicted DTIs per drug were validated.
In total, 1367 validated new DTIs are known for ic dataset, however please note that at most 698 DTIs could be predicted (i.e., some drugs have more than 10 validated DTIs).
Rank | Target | Score | Validated | KEGG | DrugBank | Matador |
---|---|---|---|---|---|---|
1 | hsa6530 ( solute carrier family 6 member 2 ) | 0.988934 | 0 | 0 | 0 | 0 |
2 | hsa6532 ( solute carrier family 6 member 4 ) | 0.9847 | 0 | 0 | 0 | 0 |
3 | hsa6531 ( solute carrier family 6 member 3 ) | 0.971736 | 0 | 0 | 0 | 0 |
4 | hsa6529 ( solute carrier family 6 member 1 ) | 0.878262 | 0 | 0 | 0 | 0 |
5 | hsa3359 ( 5-hydroxytryptamine receptor 3A ) | 0.783687 | 0 | 0 | 0 | 0 |
6 | hsa2554 ( gamma-aminobutyric acid type A receptor alpha1 subunit ) | 0.721977 | 0 | 0 | 0 | 0 |
7 | hsa1135 ( cholinergic receptor nicotinic alpha 2 subunit ) | 0.717633 | 0 | 0 | 0 | 0 |
8 | hsa6331 ( sodium voltage-gated channel alpha subunit 5 ) | 0.70735 | 0 | 0 | 0 | 0 |
9 | hsa116443 ( glutamate ionotropic receptor NMDA type subunit 3A ) | 0.68618 | 0 | 0 | 0 | 0 |
10 | hsa3782 ( potassium calcium-activated channel subfamily N member 3 ) | 0.684985 | 0 | 0 | 0 | 0 |
Rank | Target | Score | Validated | KEGG | DrugBank | Matador |
---|---|---|---|---|---|---|
1 | hsa11254 ( solute carrier family 6 member 14 ) | 0.889649 | 0 | 0 | 0 | 0 |
2 | hsa6534 ( solute carrier family 6 member 7 ) | 0.857479 | 0 | 0 | 0 | 0 |
3 | hsa6323 ( sodium voltage-gated channel alpha subunit 1 ) | 0.851284 | 1 | 1 | 0 | 0 |
4 | hsa6328 ( sodium voltage-gated channel alpha subunit 3 ) | 0.826327 | 1 | 1 | 0 | 0 |
5 | hsa6329 ( sodium voltage-gated channel alpha subunit 4 ) | 0.809486 | 1 | 1 | 0 | 0 |
6 | hsa6326 ( sodium voltage-gated channel alpha subunit 2 ) | 0.78321 | 1 | 1 | 0 | 0 |
7 | hsa6334 ( sodium voltage-gated channel alpha subunit 8 ) | 0.771827 | 1 | 1 | 0 | 0 |
8 | hsa3359 ( 5-hydroxytryptamine receptor 3A ) | 0.73585 | 0 | 0 | 0 | 0 |
9 | hsa6335 ( sodium voltage-gated channel alpha subunit 9 ) | 0.735154 | 1 | 1 | 0 | 0 |
10 | hsa116443 ( glutamate ionotropic receptor NMDA type subunit 3A ) | 0.702965 | 0 | 0 | 0 | 0 |
Rank | Target | Score | Validated | KEGG | DrugBank | Matador |
---|---|---|---|---|---|---|
1 | hsa116443 ( glutamate ionotropic receptor NMDA type subunit 3A ) | 0.929124 | 0 | 0 | 0 | 0 |
2 | hsa3757 ( potassium voltage-gated channel subfamily H member 2 ) | 0.859885 | 0 | 0 | 0 | 0 |
3 | hsa2554 ( gamma-aminobutyric acid type A receptor alpha1 subunit ) | 0.826739 | 0 | 0 | 0 | 0 |
4 | hsa3763 ( potassium voltage-gated channel subfamily J member 6 ) | 0.767087 | 0 | 0 | 0 | 0 |
5 | hsa8913 ( calcium voltage-gated channel subunit alpha1 G ) | 0.762838 | 0 | 0 | 0 | 0 |
6 | hsa3767 ( potassium voltage-gated channel subfamily J member 11 ) | 0.75893 | 0 | 0 | 0 | 0 |
7 | hsa8911 ( calcium voltage-gated channel subunit alpha1 I ) | 0.747503 | 0 | 0 | 0 | 0 |
8 | hsa6323 ( sodium voltage-gated channel alpha subunit 1 ) | 0.729317 | 0 | 0 | 0 | 0 |
9 | hsa6331 ( sodium voltage-gated channel alpha subunit 5 ) | 0.722766 | 0 | 0 | 0 | 0 |
10 | hsa1135 ( cholinergic receptor nicotinic alpha 2 subunit ) | 0.708484 | 0 | 0 | 0 | 0 |
Rank | Target | Score | Validated | KEGG | DrugBank | Matador |
---|---|---|---|---|---|---|
1 | hsa1141 ( cholinergic receptor nicotinic beta 2 subunit ) | 0.966487 | 0 | 0 | 0 | 0 |
2 | hsa1145 ( cholinergic receptor nicotinic epsilon subunit ) | 0.885858 | 0 | 0 | 0 | 0 |
3 | hsa3359 ( 5-hydroxytryptamine receptor 3A ) | 0.869743 | 0 | 0 | 0 | 0 |
4 | hsa9312 ( potassium voltage-gated channel subfamily B member 2 ) | 0.781038 | 0 | 0 | 0 | 0 |
5 | hsa1144 ( cholinergic receptor nicotinic delta subunit ) | 0.774668 | 0 | 0 | 0 | 0 |
6 | hsa2554 ( gamma-aminobutyric acid type A receptor alpha1 subunit ) | 0.772475 | 0 | 0 | 0 | 0 |
7 | hsa1140 ( cholinergic receptor nicotinic beta 1 subunit ) | 0.709062 | 0 | 0 | 0 | 0 |
8 | hsa3752 ( potassium voltage-gated channel subfamily D member 3 ) | 0.706774 | 0 | 0 | 0 | 0 |
9 | hsa9177 ( 5-hydroxytryptamine receptor 3B ) | 0.698164 | 0 | 0 | 0 | 0 |
10 | hsa285242 ( 5-hydroxytryptamine receptor 3E ) | 0.689004 | 0 | 0 | 0 | 0 |
Rank | Target | Score | Validated | KEGG | DrugBank | Matador |
---|---|---|---|---|---|---|
1 | hsa3767 ( potassium voltage-gated channel subfamily J member 11 ) | 0.954905 | 0 | 0 | 0 | 0 |
2 | hsa6833 ( ATP binding cassette subfamily C member 8 ) | 0.92004 | 1 | 1 | 0 | 0 |
3 | hsa1080 ( cystic fibrosis transmembrane conductance regulator ) | 0.792878 | 0 | 0 | 0 | 0 |
4 | hsa3757 ( potassium voltage-gated channel subfamily H member 2 ) | 0.743613 | 0 | 0 | 0 | 0 |
5 | hsa3782 ( potassium calcium-activated channel subfamily N member 3 ) | 0.733117 | 0 | 0 | 0 | 0 |
6 | hsa3763 ( potassium voltage-gated channel subfamily J member 6 ) | 0.720722 | 0 | 0 | 0 | 0 |
7 | hsa3781 ( potassium calcium-activated channel subfamily N member 2 ) | 0.679285 | 0 | 0 | 0 | 0 |
8 | hsa3778 ( potassium calcium-activated channel subfamily M alpha 1 ) | 0.660687 | 0 | 0 | 0 | 0 |
9 | hsa6530 ( solute carrier family 6 member 2 ) | 0.657479 | 0 | 0 | 0 | 0 |
10 | hsa6331 ( sodium voltage-gated channel alpha subunit 5 ) | 0.651395 | 0 | 0 | 0 | 0 |
Rank | Target | Score | Validated | KEGG | DrugBank | Matador |
---|---|---|---|---|---|---|
1 | hsa2741 ( glycine receptor alpha 1 ) | 0.882316 | 0 | 0 | 0 | 0 |
2 | hsa2570 ( gamma-aminobutyric acid type A receptor rho2 subunit ) | 0.880492 | 0 | 0 | 0 | 0 |
3 | hsa2743 ( glycine receptor beta ) | 0.836485 | 0 | 0 | 0 | 0 |
4 | hsa2742 ( glycine receptor alpha 2 ) | 0.822204 | 0 | 0 | 0 | 0 |
5 | hsa3736 ( potassium voltage-gated channel subfamily A member 1 ) | 0.72784 | 0 | 0 | 0 | 0 |
6 | hsa2890 ( glutamate ionotropic receptor AMPA type subunit 1 ) | 0.718624 | 0 | 0 | 0 | 0 |
7 | hsa116443 ( glutamate ionotropic receptor NMDA type subunit 3A ) | 0.7054 | 0 | 0 | 0 | 0 |
8 | hsa6530 ( solute carrier family 6 member 2 ) | 0.70079 | 0 | 0 | 0 | 0 |
9 | hsa1135 ( cholinergic receptor nicotinic alpha 2 subunit ) | 0.69807 | 0 | 0 | 0 | 0 |
10 | hsa1141 ( cholinergic receptor nicotinic beta 2 subunit ) | 0.67905 | 0 | 0 | 0 | 0 |
Rank | Target | Score | Validated | KEGG | DrugBank | Matador |
---|---|---|---|---|---|---|
1 | hsa3782 ( potassium calcium-activated channel subfamily N member 3 ) | 0.814937 | 0 | 0 | 0 | 0 |
2 | hsa3781 ( potassium calcium-activated channel subfamily N member 2 ) | 0.788279 | 0 | 0 | 0 | 0 |
3 | hsa3758 ( potassium voltage-gated channel subfamily J member 1 ) | 0.784905 | 0 | 0 | 0 | 0 |
4 | hsa6833 ( ATP binding cassette subfamily C member 8 ) | 0.778113 | 0 | 0 | 0 | 0 |
5 | hsa5026 ( purinergic receptor P2X 5 ) | 0.75007 | 0 | 0 | 0 | 0 |
6 | hsa3757 ( potassium voltage-gated channel subfamily H member 2 ) | 0.704545 | 0 | 0 | 0 | 0 |
7 | hsa5024 ( purinergic receptor P2X 3 ) | 0.698193 | 0 | 0 | 0 | 0 |
8 | hsa5027 ( purinergic receptor P2X 7 ) | 0.695079 | 0 | 0 | 0 | 0 |
9 | hsa5025 ( purinergic receptor P2X 4 ) | 0.693106 | 0 | 0 | 0 | 0 |
10 | hsa9127 ( purinergic receptor P2X 6 ) | 0.686188 | 0 | 0 | 0 | 0 |
Rank | Target | Score | Validated | KEGG | DrugBank | Matador |
---|---|---|---|---|---|---|
1 | hsa6531 ( solute carrier family 6 member 3 ) | 0.947958 | 1 | 0 | 1 | 0 |
2 | hsa11254 ( solute carrier family 6 member 14 ) | 0.85083 | 0 | 0 | 0 | 0 |
3 | hsa6534 ( solute carrier family 6 member 7 ) | 0.828202 | 0 | 0 | 0 | 0 |
4 | hsa6529 ( solute carrier family 6 member 1 ) | 0.800311 | 0 | 0 | 0 | 0 |
5 | hsa3359 ( 5-hydroxytryptamine receptor 3A ) | 0.784005 | 1 | 0 | 1 | 0 |
6 | hsa3782 ( potassium calcium-activated channel subfamily N member 3 ) | 0.766937 | 0 | 0 | 0 | 0 |
7 | hsa3758 ( potassium voltage-gated channel subfamily J member 1 ) | 0.736283 | 0 | 0 | 0 | 0 |
8 | hsa116443 ( glutamate ionotropic receptor NMDA type subunit 3A ) | 0.730352 | 0 | 0 | 0 | 0 |
9 | hsa6331 ( sodium voltage-gated channel alpha subunit 5 ) | 0.709469 | 0 | 0 | 0 | 0 |
10 | hsa285242 ( 5-hydroxytryptamine receptor 3E ) | 0.691462 | 0 | 0 | 0 | 0 |
Rank | Target | Score | Validated | KEGG | DrugBank | Matador |
---|---|---|---|---|---|---|
1 | hsa27133 ( potassium voltage-gated channel subfamily H member 5 ) | 0.822765 | 0 | 0 | 0 | 0 |
2 | hsa3783 ( potassium calcium-activated channel subfamily N member 4 ) | 0.775281 | 0 | 0 | 0 | 0 |
3 | hsa3776 ( potassium two pore domain channel subfamily K member 2 ) | 0.740724 | 0 | 0 | 0 | 0 |
4 | hsa3758 ( potassium voltage-gated channel subfamily J member 1 ) | 0.73115 | 0 | 0 | 0 | 0 |
5 | hsa90134 ( potassium voltage-gated channel subfamily H member 7 ) | 0.719094 | 0 | 0 | 0 | 0 |
6 | hsa3744 ( potassium voltage-gated channel subfamily A member 10 ) | 0.717689 | 0 | 0 | 0 | 0 |
7 | hsa775 ( calcium voltage-gated channel subunit alpha1 C ) | 0.713586 | 0 | 0 | 0 | 0 |
8 | hsa9424 ( potassium two pore domain channel subfamily K member 6 ) | 0.712692 | 0 | 0 | 0 | 0 |
9 | hsa81033 ( potassium voltage-gated channel subfamily H member 6 ) | 0.710219 | 0 | 0 | 0 | 0 |
10 | hsa8913 ( calcium voltage-gated channel subunit alpha1 G ) | 0.707433 | 0 | 0 | 0 | 0 |
Rank | Target | Score | Validated | KEGG | DrugBank | Matador |
---|---|---|---|---|---|---|
1 | hsa6323 ( sodium voltage-gated channel alpha subunit 1 ) | 0.890235 | 1 | 1 | 0 | 0 |
2 | hsa6326 ( sodium voltage-gated channel alpha subunit 2 ) | 0.832212 | 1 | 1 | 0 | 0 |
3 | hsa6334 ( sodium voltage-gated channel alpha subunit 8 ) | 0.831545 | 1 | 1 | 0 | 0 |
4 | hsa6335 ( sodium voltage-gated channel alpha subunit 9 ) | 0.806706 | 1 | 1 | 0 | 0 |
5 | hsa8913 ( calcium voltage-gated channel subunit alpha1 G ) | 0.78525 | 0 | 0 | 0 | 0 |
6 | hsa8911 ( calcium voltage-gated channel subunit alpha1 I ) | 0.741712 | 0 | 0 | 0 | 0 |
7 | hsa8645 ( potassium two pore domain channel subfamily K member 5 ) | 0.731286 | 0 | 0 | 0 | 0 |
8 | hsa8912 ( calcium voltage-gated channel subunit alpha1 H ) | 0.700484 | 0 | 0 | 0 | 0 |
9 | hsa3782 ( potassium calcium-activated channel subfamily N member 3 ) | 0.668822 | 0 | 0 | 0 | 0 |
10 | hsa3763 ( potassium voltage-gated channel subfamily J member 6 ) | 0.652037 | 0 | 0 | 0 | 0 |
Rank | Target | Score | Validated | KEGG | DrugBank | Matador |
---|---|---|---|---|---|---|
1 | hsa27133 ( potassium voltage-gated channel subfamily H member 5 ) | 0.820102 | 0 | 0 | 0 | 0 |
2 | hsa3758 ( potassium voltage-gated channel subfamily J member 1 ) | 0.771093 | 0 | 0 | 0 | 0 |
3 | hsa3783 ( potassium calcium-activated channel subfamily N member 4 ) | 0.768458 | 0 | 0 | 0 | 0 |
4 | hsa3776 ( potassium two pore domain channel subfamily K member 2 ) | 0.75269 | 0 | 0 | 0 | 0 |
5 | hsa3767 ( potassium voltage-gated channel subfamily J member 11 ) | 0.73489 | 0 | 0 | 0 | 0 |
6 | hsa3744 ( potassium voltage-gated channel subfamily A member 10 ) | 0.719874 | 0 | 0 | 0 | 0 |
7 | hsa3782 ( potassium calcium-activated channel subfamily N member 3 ) | 0.708509 | 0 | 0 | 0 | 0 |
8 | hsa90134 ( potassium voltage-gated channel subfamily H member 7 ) | 0.705674 | 0 | 0 | 0 | 0 |
9 | hsa81033 ( potassium voltage-gated channel subfamily H member 6 ) | 0.702087 | 0 | 0 | 0 | 0 |
10 | hsa3781 ( potassium calcium-activated channel subfamily N member 2 ) | 0.697842 | 0 | 0 | 0 | 0 |
Rank | Target | Score | Validated | KEGG | DrugBank | Matador |
---|---|---|---|---|---|---|
1 | hsa170572 ( 5-hydroxytryptamine receptor 3C ) | 0.927938 | 0 | 0 | 0 | 0 |
2 | hsa200909 ( 5-hydroxytryptamine receptor 3D ) | 0.92472 | 0 | 0 | 0 | 0 |
3 | hsa6530 ( solute carrier family 6 member 2 ) | 0.807926 | 0 | 0 | 0 | 0 |
4 | hsa6532 ( solute carrier family 6 member 4 ) | 0.788612 | 0 | 0 | 0 | 0 |
5 | hsa1135 ( cholinergic receptor nicotinic alpha 2 subunit ) | 0.757935 | 0 | 0 | 0 | 0 |
6 | hsa3782 ( potassium calcium-activated channel subfamily N member 3 ) | 0.746146 | 0 | 0 | 0 | 0 |
7 | hsa1141 ( cholinergic receptor nicotinic beta 2 subunit ) | 0.714398 | 0 | 0 | 0 | 0 |
8 | hsa3781 ( potassium calcium-activated channel subfamily N member 2 ) | 0.708379 | 0 | 0 | 0 | 0 |
9 | hsa3758 ( potassium voltage-gated channel subfamily J member 1 ) | 0.686013 | 0 | 0 | 0 | 0 |
10 | hsa6331 ( sodium voltage-gated channel alpha subunit 5 ) | 0.676444 | 0 | 0 | 0 | 0 |
Rank | Target | Score | Validated | KEGG | DrugBank | Matador |
---|---|---|---|---|---|---|
1 | hsa3736 ( potassium voltage-gated channel subfamily A member 1 ) | 0.774291 | 0 | 0 | 0 | 0 |
2 | hsa116443 ( glutamate ionotropic receptor NMDA type subunit 3A ) | 0.76732 | 0 | 0 | 0 | 0 |
3 | hsa2890 ( glutamate ionotropic receptor AMPA type subunit 1 ) | 0.767191 | 0 | 0 | 0 | 0 |
4 | hsa6530 ( solute carrier family 6 member 2 ) | 0.718798 | 0 | 0 | 0 | 0 |
5 | hsa8001 ( glycine receptor alpha 3 ) | 0.688431 | 0 | 0 | 0 | 0 |
6 | hsa3359 ( 5-hydroxytryptamine receptor 3A ) | 0.664963 | 0 | 0 | 0 | 0 |
7 | hsa1135 ( cholinergic receptor nicotinic alpha 2 subunit ) | 0.657369 | 0 | 0 | 0 | 0 |
8 | hsa1141 ( cholinergic receptor nicotinic beta 2 subunit ) | 0.633673 | 0 | 0 | 0 | 0 |
9 | hsa6532 ( solute carrier family 6 member 4 ) | 0.618098 | 0 | 0 | 0 | 0 |
10 | hsa6531 ( solute carrier family 6 member 3 ) | 0.609575 | 0 | 0 | 0 | 0 |
Rank | Target | Score | Validated | KEGG | DrugBank | Matador |
---|---|---|---|---|---|---|
1 | hsa3767 ( potassium voltage-gated channel subfamily J member 11 ) | 0.888961 | 1 | 1 | 1 | 0 |
2 | hsa3776 ( potassium two pore domain channel subfamily K member 2 ) | 0.56603 | 0 | 0 | 0 | 0 |
3 | hsa6530 ( solute carrier family 6 member 2 ) | 0.54134 | 0 | 0 | 0 | 0 |
4 | hsa775 ( calcium voltage-gated channel subunit alpha1 C ) | 0.475583 | 0 | 0 | 0 | 0 |
5 | hsa6532 ( solute carrier family 6 member 4 ) | 0.464428 | 0 | 0 | 0 | 0 |
6 | hsa6331 ( sodium voltage-gated channel alpha subunit 5 ) | 0.450156 | 0 | 0 | 0 | 0 |
7 | hsa6328 ( sodium voltage-gated channel alpha subunit 3 ) | 0.415235 | 0 | 0 | 0 | 0 |
8 | hsa2554 ( gamma-aminobutyric acid type A receptor alpha1 subunit ) | 0.407425 | 0 | 0 | 0 | 0 |
9 | hsa779 ( calcium voltage-gated channel subunit alpha1 S ) | 0.406611 | 0 | 0 | 0 | 0 |
10 | hsa1080 ( cystic fibrosis transmembrane conductance regulator ) | 0.393881 | 0 | 0 | 0 | 0 |
Rank | Target | Score | Validated | KEGG | DrugBank | Matador |
---|---|---|---|---|---|---|
1 | hsa6323 ( sodium voltage-gated channel alpha subunit 1 ) | 0.907398 | 1 | 1 | 0 | 0 |
2 | hsa6326 ( sodium voltage-gated channel alpha subunit 2 ) | 0.848813 | 1 | 1 | 0 | 0 |
3 | hsa6334 ( sodium voltage-gated channel alpha subunit 8 ) | 0.846872 | 1 | 1 | 0 | 0 |
4 | hsa8913 ( calcium voltage-gated channel subunit alpha1 G ) | 0.846741 | 0 | 0 | 0 | 0 |
5 | hsa6335 ( sodium voltage-gated channel alpha subunit 9 ) | 0.823107 | 1 | 1 | 0 | 0 |
6 | hsa8911 ( calcium voltage-gated channel subunit alpha1 I ) | 0.803963 | 0 | 0 | 0 | 0 |
7 | hsa8912 ( calcium voltage-gated channel subunit alpha1 H ) | 0.770367 | 0 | 0 | 0 | 0 |
8 | hsa8645 ( potassium two pore domain channel subfamily K member 5 ) | 0.741661 | 0 | 0 | 0 | 0 |
9 | hsa116443 ( glutamate ionotropic receptor NMDA type subunit 3A ) | 0.687665 | 0 | 0 | 0 | 0 |
10 | hsa40 ( acid sensing ion channel subunit 2 ) | 0.664345 | 0 | 0 | 0 | 0 |
Rank | Target | Score | Validated | KEGG | DrugBank | Matador |
---|---|---|---|---|---|---|
1 | hsa786 ( calcium voltage-gated channel auxiliary subunit gamma 1 ) | 0.955601 | 1 | 0 | 0 | 1 |
2 | hsa93589 ( calcium voltage-gated channel auxiliary subunit alpha2delta 4 ) | 0.945709 | 0 | 0 | 0 | 0 |
3 | hsa783 ( calcium voltage-gated channel auxiliary subunit beta 2 ) | 0.941673 | 1 | 0 | 1 | 1 |
4 | hsa777 ( calcium voltage-gated channel subunit alpha1 E ) | 0.935418 | 1 | 0 | 0 | 1 |
5 | hsa781 ( calcium voltage-gated channel auxiliary subunit alpha2delta 1 ) | 0.926946 | 1 | 0 | 1 | 1 |
6 | hsa8912 ( calcium voltage-gated channel subunit alpha1 H ) | 0.9139 | 1 | 0 | 1 | 1 |
7 | hsa8911 ( calcium voltage-gated channel subunit alpha1 I ) | 0.908973 | 1 | 0 | 0 | 1 |
8 | hsa8913 ( calcium voltage-gated channel subunit alpha1 G ) | 0.903636 | 1 | 0 | 0 | 1 |
9 | hsa774 ( calcium voltage-gated channel subunit alpha1 B ) | 0.894641 | 1 | 0 | 0 | 1 |
10 | hsa55799 ( calcium voltage-gated channel auxiliary subunit alpha2delta 3 ) | 0.88802 | 0 | 0 | 0 | 0 |
Rank | Target | Score | Validated | KEGG | DrugBank | Matador |
---|---|---|---|---|---|---|
1 | hsa3783 ( potassium calcium-activated channel subfamily N member 4 ) | 0.865679 | 0 | 0 | 0 | 0 |
2 | hsa3758 ( potassium voltage-gated channel subfamily J member 1 ) | 0.789185 | 0 | 0 | 0 | 0 |
3 | hsa3767 ( potassium voltage-gated channel subfamily J member 11 ) | 0.7683 | 0 | 0 | 0 | 0 |
4 | hsa3784 ( potassium voltage-gated channel subfamily Q member 1 ) | 0.730474 | 0 | 0 | 0 | 0 |
5 | hsa3757 ( potassium voltage-gated channel subfamily H member 2 ) | 0.722721 | 0 | 0 | 0 | 0 |
6 | hsa9132 ( potassium voltage-gated channel subfamily Q member 4 ) | 0.709451 | 0 | 0 | 0 | 0 |
7 | hsa2554 ( gamma-aminobutyric acid type A receptor alpha1 subunit ) | 0.702797 | 0 | 0 | 0 | 0 |
8 | hsa6331 ( sodium voltage-gated channel alpha subunit 5 ) | 0.677351 | 0 | 0 | 0 | 0 |
9 | hsa3778 ( potassium calcium-activated channel subfamily M alpha 1 ) | 0.676504 | 0 | 0 | 0 | 0 |
10 | hsa3744 ( potassium voltage-gated channel subfamily A member 10 ) | 0.655586 | 0 | 0 | 0 | 0 |
Rank | Target | Score | Validated | KEGG | DrugBank | Matador |
---|---|---|---|---|---|---|
1 | hsa2570 ( gamma-aminobutyric acid type A receptor rho2 subunit ) | 0.874923 | 1 | 0 | 1 | 0 |
2 | hsa2741 ( glycine receptor alpha 1 ) | 0.868117 | 0 | 0 | 0 | 0 |
3 | hsa2743 ( glycine receptor beta ) | 0.831462 | 0 | 0 | 0 | 0 |
4 | hsa2742 ( glycine receptor alpha 2 ) | 0.81198 | 0 | 0 | 0 | 0 |
5 | hsa116443 ( glutamate ionotropic receptor NMDA type subunit 3A ) | 0.734566 | 0 | 0 | 0 | 0 |
6 | hsa6530 ( solute carrier family 6 member 2 ) | 0.714827 | 0 | 0 | 0 | 0 |
7 | hsa3736 ( potassium voltage-gated channel subfamily A member 1 ) | 0.701018 | 0 | 0 | 0 | 0 |
8 | hsa2890 ( glutamate ionotropic receptor AMPA type subunit 1 ) | 0.699619 | 0 | 0 | 0 | 0 |
9 | hsa3782 ( potassium calcium-activated channel subfamily N member 3 ) | 0.681393 | 0 | 0 | 0 | 0 |
10 | hsa3781 ( potassium calcium-activated channel subfamily N member 2 ) | 0.677675 | 0 | 0 | 0 | 0 |
Rank | Target | Score | Validated | KEGG | DrugBank | Matador |
---|---|---|---|---|---|---|
1 | hsa2564 ( gamma-aminobutyric acid type A receptor epsilon subunit ) | 0.876366 | 0 | 0 | 0 | 0 |
2 | hsa2566 ( gamma-aminobutyric acid type A receptor gamma2 subunit ) | 0.873876 | 0 | 0 | 0 | 0 |
3 | hsa2567 ( gamma-aminobutyric acid type A receptor gamma3 subunit ) | 0.873736 | 0 | 0 | 0 | 0 |
4 | hsa3778 ( potassium calcium-activated channel subfamily M alpha 1 ) | 0.851068 | 0 | 0 | 0 | 0 |
5 | hsa55879 ( gamma-aminobutyric acid type A receptor theta subunit ) | 0.826655 | 0 | 0 | 0 | 0 |
6 | hsa2561 ( gamma-aminobutyric acid type A receptor beta2 subunit ) | 0.825009 | 0 | 0 | 0 | 0 |
7 | hsa2563 ( gamma-aminobutyric acid type A receptor delta subunit ) | 0.824308 | 0 | 0 | 0 | 0 |
8 | hsa2569 ( gamma-aminobutyric acid type A receptor rho1 subunit ) | 0.822804 | 0 | 0 | 0 | 0 |
9 | hsa2562 ( gamma-aminobutyric acid type A receptor beta3 subunit ) | 0.8175 | 0 | 0 | 0 | 0 |
10 | hsa2560 ( gamma-aminobutyric acid type A receptor beta1 subunit ) | 0.808804 | 0 | 0 | 0 | 0 |
Rank | Target | Score | Validated | KEGG | DrugBank | Matador |
---|---|---|---|---|---|---|
1 | hsa6323 ( sodium voltage-gated channel alpha subunit 1 ) | 0.743221 | 0 | 0 | 0 | 0 |
2 | hsa6326 ( sodium voltage-gated channel alpha subunit 2 ) | 0.590677 | 0 | 0 | 0 | 0 |
3 | hsa6334 ( sodium voltage-gated channel alpha subunit 8 ) | 0.587723 | 0 | 0 | 0 | 0 |
4 | hsa3778 ( potassium calcium-activated channel subfamily M alpha 1 ) | 0.584871 | 0 | 0 | 0 | 0 |
5 | hsa3758 ( potassium voltage-gated channel subfamily J member 1 ) | 0.560957 | 0 | 0 | 0 | 0 |
6 | hsa6335 ( sodium voltage-gated channel alpha subunit 9 ) | 0.546541 | 0 | 0 | 0 | 0 |
7 | hsa8645 ( potassium two pore domain channel subfamily K member 5 ) | 0.497239 | 0 | 0 | 0 | 0 |
8 | hsa6530 ( solute carrier family 6 member 2 ) | 0.495639 | 0 | 0 | 0 | 0 |
9 | hsa40 ( acid sensing ion channel subunit 2 ) | 0.48604 | 0 | 0 | 0 | 0 |
10 | hsa1080 ( cystic fibrosis transmembrane conductance regulator ) | 0.452014 | 0 | 0 | 0 | 0 |
Rank | Target | Score | Validated | KEGG | DrugBank | Matador |
---|---|---|---|---|---|---|
1 | hsa6833 ( ATP binding cassette subfamily C member 8 ) | 0.913888 | 1 | 1 | 1 | 1 |
2 | hsa1080 ( cystic fibrosis transmembrane conductance regulator ) | 0.774638 | 0 | 0 | 0 | 0 |
3 | hsa3757 ( potassium voltage-gated channel subfamily H member 2 ) | 0.765187 | 0 | 0 | 0 | 0 |
4 | hsa3763 ( potassium voltage-gated channel subfamily J member 6 ) | 0.734329 | 0 | 0 | 0 | 0 |
5 | hsa3782 ( potassium calcium-activated channel subfamily N member 3 ) | 0.728062 | 0 | 0 | 0 | 0 |
6 | hsa3781 ( potassium calcium-activated channel subfamily N member 2 ) | 0.678479 | 0 | 0 | 0 | 0 |
7 | hsa6530 ( solute carrier family 6 member 2 ) | 0.642506 | 0 | 0 | 0 | 0 |
8 | hsa1135 ( cholinergic receptor nicotinic alpha 2 subunit ) | 0.63438 | 0 | 0 | 0 | 0 |
9 | hsa3778 ( potassium calcium-activated channel subfamily M alpha 1 ) | 0.633354 | 0 | 0 | 0 | 0 |
10 | hsa6331 ( sodium voltage-gated channel alpha subunit 5 ) | 0.62927 | 0 | 0 | 0 | 0 |
Rank | Target | Score | Validated | KEGG | DrugBank | Matador |
---|---|---|---|---|---|---|
1 | hsa3767 ( potassium voltage-gated channel subfamily J member 11 ) | 0.924312 | 1 | 1 | 1 | 0 |
2 | hsa3783 ( potassium calcium-activated channel subfamily N member 4 ) | 0.851648 | 0 | 0 | 0 | 0 |
3 | hsa6261 ( ryanodine receptor 1 ) | 0.78524 | 0 | 0 | 0 | 0 |
4 | hsa6263 ( ryanodine receptor 3 ) | 0.768128 | 0 | 0 | 0 | 0 |
5 | hsa3782 ( potassium calcium-activated channel subfamily N member 3 ) | 0.753254 | 0 | 0 | 0 | 0 |
6 | hsa6262 ( ryanodine receptor 2 ) | 0.751355 | 0 | 0 | 0 | 0 |
7 | hsa3757 ( potassium voltage-gated channel subfamily H member 2 ) | 0.74191 | 0 | 0 | 0 | 0 |
8 | hsa3781 ( potassium calcium-activated channel subfamily N member 2 ) | 0.689231 | 0 | 0 | 0 | 0 |
9 | hsa6530 ( solute carrier family 6 member 2 ) | 0.664543 | 0 | 0 | 0 | 0 |
10 | hsa3778 ( potassium calcium-activated channel subfamily M alpha 1 ) | 0.655357 | 0 | 0 | 0 | 0 |
Rank | Target | Score | Validated | KEGG | DrugBank | Matador |
---|---|---|---|---|---|---|
1 | hsa2555 ( gamma-aminobutyric acid type A receptor alpha2 subunit ) | 0.958636 | 1 | 0 | 1 | 0 |
2 | hsa2558 ( gamma-aminobutyric acid type A receptor alpha5 subunit ) | 0.955534 | 1 | 0 | 1 | 0 |
3 | hsa2556 ( gamma-aminobutyric acid type A receptor alpha3 subunit ) | 0.955476 | 1 | 0 | 1 | 0 |
4 | hsa2557 ( gamma-aminobutyric acid type A receptor alpha4 subunit ) | 0.95384 | 1 | 0 | 1 | 0 |
5 | hsa2559 ( gamma-aminobutyric acid type A receptor alpha6 subunit ) | 0.953358 | 1 | 0 | 1 | 0 |
6 | hsa2564 ( gamma-aminobutyric acid type A receptor epsilon subunit ) | 0.892353 | 1 | 0 | 1 | 0 |
7 | hsa2567 ( gamma-aminobutyric acid type A receptor gamma3 subunit ) | 0.888597 | 1 | 0 | 1 | 0 |
8 | hsa2566 ( gamma-aminobutyric acid type A receptor gamma2 subunit ) | 0.888078 | 1 | 0 | 1 | 0 |
9 | hsa55879 ( gamma-aminobutyric acid type A receptor theta subunit ) | 0.878844 | 1 | 0 | 1 | 0 |
10 | hsa2561 ( gamma-aminobutyric acid type A receptor beta2 subunit ) | 0.878776 | 1 | 0 | 1 | 0 |
Rank | Target | Score | Validated | KEGG | DrugBank | Matador |
---|---|---|---|---|---|---|
1 | hsa2891 ( glutamate ionotropic receptor AMPA type subunit 2 ) | 0.86595 | 0 | 0 | 0 | 0 |
2 | hsa3763 ( potassium voltage-gated channel subfamily J member 6 ) | 0.759429 | 0 | 0 | 0 | 0 |
3 | hsa3758 ( potassium voltage-gated channel subfamily J member 1 ) | 0.757191 | 0 | 0 | 0 | 0 |
4 | hsa2554 ( gamma-aminobutyric acid type A receptor alpha1 subunit ) | 0.743833 | 0 | 0 | 0 | 0 |
5 | hsa2890 ( glutamate ionotropic receptor AMPA type subunit 1 ) | 0.702124 | 0 | 0 | 0 | 0 |
6 | hsa9132 ( potassium voltage-gated channel subfamily Q member 4 ) | 0.696036 | 0 | 0 | 0 | 0 |
7 | hsa3757 ( potassium voltage-gated channel subfamily H member 2 ) | 0.68729 | 0 | 0 | 0 | 0 |
8 | hsa3784 ( potassium voltage-gated channel subfamily Q member 1 ) | 0.683674 | 0 | 0 | 0 | 0 |
9 | hsa3782 ( potassium calcium-activated channel subfamily N member 3 ) | 0.659531 | 0 | 0 | 0 | 0 |
10 | hsa3781 ( potassium calcium-activated channel subfamily N member 2 ) | 0.638495 | 0 | 0 | 0 | 0 |
Rank | Target | Score | Validated | KEGG | DrugBank | Matador |
---|---|---|---|---|---|---|
1 | hsa2554 ( gamma-aminobutyric acid type A receptor alpha1 subunit ) | 0.773364 | 0 | 0 | 0 | 0 |
2 | hsa3763 ( potassium voltage-gated channel subfamily J member 6 ) | 0.764982 | 0 | 0 | 0 | 0 |
3 | hsa3782 ( potassium calcium-activated channel subfamily N member 3 ) | 0.747805 | 0 | 0 | 0 | 0 |
4 | hsa3758 ( potassium voltage-gated channel subfamily J member 1 ) | 0.745761 | 0 | 0 | 0 | 0 |
5 | hsa3778 ( potassium calcium-activated channel subfamily M alpha 1 ) | 0.738893 | 0 | 0 | 0 | 0 |
6 | hsa9132 ( potassium voltage-gated channel subfamily Q member 4 ) | 0.714169 | 0 | 0 | 0 | 0 |
7 | hsa6331 ( sodium voltage-gated channel alpha subunit 5 ) | 0.711882 | 0 | 0 | 0 | 0 |
8 | hsa3781 ( potassium calcium-activated channel subfamily N member 2 ) | 0.711098 | 0 | 0 | 0 | 0 |
9 | hsa3767 ( potassium voltage-gated channel subfamily J member 11 ) | 0.701478 | 0 | 0 | 0 | 0 |
10 | hsa6530 ( solute carrier family 6 member 2 ) | 0.692791 | 0 | 0 | 0 | 0 |
Rank | Target | Score | Validated | KEGG | DrugBank | Matador |
---|---|---|---|---|---|---|
1 | hsa773 ( calcium voltage-gated channel subunit alpha1 A ) | 0.971273 | 0 | 0 | 0 | 0 |
2 | hsa777 ( calcium voltage-gated channel subunit alpha1 E ) | 0.944426 | 0 | 0 | 0 | 0 |
3 | hsa782 ( calcium voltage-gated channel auxiliary subunit beta 1 ) | 0.934002 | 0 | 0 | 0 | 0 |
4 | hsa55799 ( calcium voltage-gated channel auxiliary subunit alpha2delta 3 ) | 0.929054 | 0 | 0 | 0 | 0 |
5 | hsa9254 ( calcium voltage-gated channel auxiliary subunit alpha2delta 2 ) | 0.916037 | 1 | 0 | 1 | 0 |
6 | hsa59284 ( calcium voltage-gated channel auxiliary subunit gamma 7 ) | 0.908471 | 0 | 0 | 0 | 0 |
7 | hsa27092 ( calcium voltage-gated channel auxiliary subunit gamma 4 ) | 0.908189 | 0 | 0 | 0 | 0 |
8 | hsa774 ( calcium voltage-gated channel subunit alpha1 B ) | 0.904624 | 0 | 0 | 0 | 0 |
9 | hsa784 ( calcium voltage-gated channel auxiliary subunit beta 3 ) | 0.894488 | 0 | 0 | 0 | 0 |
10 | hsa3708 ( inositol 1,4,5-trisphosphate receptor type 1 ) | 0.887863 | 0 | 0 | 0 | 0 |
Rank | Target | Score | Validated | KEGG | DrugBank | Matador |
---|---|---|---|---|---|---|
1 | hsa3782 ( potassium calcium-activated channel subfamily N member 3 ) | 0.9056 | 0 | 0 | 0 | 0 |
2 | hsa3781 ( potassium calcium-activated channel subfamily N member 2 ) | 0.892684 | 0 | 0 | 0 | 0 |
3 | hsa3743 ( potassium voltage-gated channel subfamily A member 7 ) | 0.859229 | 0 | 0 | 0 | 0 |
4 | hsa3763 ( potassium voltage-gated channel subfamily J member 6 ) | 0.824566 | 0 | 0 | 0 | 0 |
5 | hsa3780 ( potassium calcium-activated channel subfamily N member 1 ) | 0.803749 | 0 | 0 | 0 | 0 |
6 | hsa3758 ( potassium voltage-gated channel subfamily J member 1 ) | 0.800371 | 0 | 0 | 0 | 0 |
7 | hsa3738 ( potassium voltage-gated channel subfamily A member 3 ) | 0.78114 | 0 | 0 | 0 | 0 |
8 | hsa1080 ( cystic fibrosis transmembrane conductance regulator ) | 0.768721 | 0 | 0 | 0 | 0 |
9 | hsa3747 ( potassium voltage-gated channel subfamily C member 2 ) | 0.760442 | 0 | 0 | 0 | 0 |
10 | hsa27133 ( potassium voltage-gated channel subfamily H member 5 ) | 0.748767 | 0 | 0 | 0 | 0 |
Rank | Target | Score | Validated | KEGG | DrugBank | Matador |
---|---|---|---|---|---|---|
1 | hsa6336 ( sodium voltage-gated channel alpha subunit 10 ) | 0.976322 | 1 | 0 | 0 | 1 |
2 | hsa8645 ( potassium two pore domain channel subfamily K member 5 ) | 0.93476 | 0 | 0 | 0 | 0 |
3 | hsa6332 ( sodium voltage-gated channel alpha subunit 7 ) | 0.825511 | 1 | 0 | 0 | 1 |
4 | hsa8913 ( calcium voltage-gated channel subunit alpha1 G ) | 0.766604 | 1 | 0 | 0 | 1 |
5 | hsa3741 ( potassium voltage-gated channel subfamily A member 5 ) | 0.74731 | 0 | 0 | 0 | 0 |
6 | hsa11280 ( sodium voltage-gated channel alpha subunit 11 ) | 0.69046 | 0 | 0 | 0 | 0 |
7 | hsa3763 ( potassium voltage-gated channel subfamily J member 6 ) | 0.681164 | 0 | 0 | 0 | 0 |
8 | hsa3758 ( potassium voltage-gated channel subfamily J member 1 ) | 0.67221 | 0 | 0 | 0 | 0 |
9 | hsa9311 ( acid sensing ion channel subunit 3 ) | 0.662876 | 1 | 0 | 0 | 1 |
10 | hsa55515 ( acid sensing ion channel subunit family member 4 ) | 0.65659 | 1 | 0 | 0 | 1 |
Rank | Target | Score | Validated | KEGG | DrugBank | Matador |
---|---|---|---|---|---|---|
1 | hsa6332 ( sodium voltage-gated channel alpha subunit 7 ) | 0.797697 | 1 | 0 | 0 | 1 |
2 | hsa3741 ( potassium voltage-gated channel subfamily A member 5 ) | 0.796453 | 0 | 0 | 0 | 0 |
3 | hsa8913 ( calcium voltage-gated channel subunit alpha1 G ) | 0.726833 | 0 | 0 | 0 | 0 |
4 | hsa11280 ( sodium voltage-gated channel alpha subunit 11 ) | 0.712517 | 0 | 0 | 0 | 0 |
5 | hsa3763 ( potassium voltage-gated channel subfamily J member 6 ) | 0.703739 | 0 | 0 | 0 | 0 |
6 | hsa3758 ( potassium voltage-gated channel subfamily J member 1 ) | 0.664474 | 0 | 0 | 0 | 0 |
7 | hsa3743 ( potassium voltage-gated channel subfamily A member 7 ) | 0.620918 | 0 | 0 | 0 | 0 |
8 | hsa3359 ( 5-hydroxytryptamine receptor 3A ) | 0.611827 | 0 | 0 | 0 | 0 |
9 | hsa54207 ( potassium two pore domain channel subfamily K member 10 ) | 0.592274 | 0 | 0 | 0 | 0 |
10 | hsa8911 ( calcium voltage-gated channel subunit alpha1 I ) | 0.589316 | 0 | 0 | 0 | 0 |
Rank | Target | Score | Validated | KEGG | DrugBank | Matador |
---|---|---|---|---|---|---|
1 | hsa6331 ( sodium voltage-gated channel alpha subunit 5 ) | 0.891457 | 0 | 0 | 0 | 0 |
2 | hsa3743 ( potassium voltage-gated channel subfamily A member 7 ) | 0.880795 | 0 | 0 | 0 | 0 |
3 | hsa3736 ( potassium voltage-gated channel subfamily A member 1 ) | 0.870976 | 0 | 0 | 0 | 0 |
4 | hsa6323 ( sodium voltage-gated channel alpha subunit 1 ) | 0.865171 | 0 | 0 | 0 | 0 |
5 | hsa3738 ( potassium voltage-gated channel subfamily A member 3 ) | 0.862275 | 0 | 0 | 0 | 0 |
6 | hsa6328 ( sodium voltage-gated channel alpha subunit 3 ) | 0.853827 | 0 | 0 | 0 | 0 |
7 | hsa3746 ( potassium voltage-gated channel subfamily C member 1 ) | 0.850728 | 0 | 0 | 0 | 0 |
8 | hsa3737 ( potassium voltage-gated channel subfamily A member 2 ) | 0.845168 | 0 | 0 | 0 | 0 |
9 | hsa6329 ( sodium voltage-gated channel alpha subunit 4 ) | 0.839836 | 0 | 0 | 0 | 0 |
10 | hsa6326 ( sodium voltage-gated channel alpha subunit 2 ) | 0.830108 | 0 | 0 | 0 | 0 |
Rank | Target | Score | Validated | KEGG | DrugBank | Matador |
---|---|---|---|---|---|---|
1 | hsa6532 ( solute carrier family 6 member 4 ) | 0.975173 | 1 | 1 | 1 | 0 |
2 | hsa11254 ( solute carrier family 6 member 14 ) | 0.871271 | 0 | 0 | 0 | 0 |
3 | hsa6534 ( solute carrier family 6 member 7 ) | 0.849153 | 0 | 0 | 0 | 0 |
4 | hsa6529 ( solute carrier family 6 member 1 ) | 0.83443 | 0 | 0 | 0 | 0 |
5 | hsa2554 ( gamma-aminobutyric acid type A receptor alpha1 subunit ) | 0.784722 | 0 | 0 | 0 | 0 |
6 | hsa3359 ( 5-hydroxytryptamine receptor 3A ) | 0.766521 | 0 | 0 | 0 | 0 |
7 | hsa116443 ( glutamate ionotropic receptor NMDA type subunit 3A ) | 0.720052 | 0 | 0 | 0 | 0 |
8 | hsa3782 ( potassium calcium-activated channel subfamily N member 3 ) | 0.687313 | 0 | 0 | 0 | 0 |
9 | hsa3758 ( potassium voltage-gated channel subfamily J member 1 ) | 0.679512 | 0 | 0 | 0 | 0 |
10 | hsa6331 ( sodium voltage-gated channel alpha subunit 5 ) | 0.677999 | 0 | 0 | 0 | 0 |
Rank | Target | Score | Validated | KEGG | DrugBank | Matador |
---|---|---|---|---|---|---|
1 | hsa3782 ( potassium calcium-activated channel subfamily N member 3 ) | 0.914161 | 0 | 0 | 0 | 0 |
2 | hsa3781 ( potassium calcium-activated channel subfamily N member 2 ) | 0.901469 | 0 | 0 | 0 | 0 |
3 | hsa3780 ( potassium calcium-activated channel subfamily N member 1 ) | 0.852416 | 0 | 0 | 0 | 0 |
4 | hsa6331 ( sodium voltage-gated channel alpha subunit 5 ) | 0.850263 | 0 | 0 | 0 | 0 |
5 | hsa3758 ( potassium voltage-gated channel subfamily J member 1 ) | 0.811981 | 0 | 0 | 0 | 0 |
6 | hsa3767 ( potassium voltage-gated channel subfamily J member 11 ) | 0.802151 | 0 | 0 | 0 | 0 |
7 | hsa6323 ( sodium voltage-gated channel alpha subunit 1 ) | 0.783863 | 0 | 0 | 0 | 0 |
8 | hsa6328 ( sodium voltage-gated channel alpha subunit 3 ) | 0.759238 | 0 | 0 | 0 | 0 |
9 | hsa6329 ( sodium voltage-gated channel alpha subunit 4 ) | 0.742332 | 0 | 0 | 0 | 0 |
10 | hsa3741 ( potassium voltage-gated channel subfamily A member 5 ) | 0.734055 | 0 | 0 | 0 | 0 |
Rank | Target | Score | Validated | KEGG | DrugBank | Matador |
---|---|---|---|---|---|---|
1 | hsa6833 ( ATP binding cassette subfamily C member 8 ) | 0.90547 | 1 | 1 | 0 | 0 |
2 | hsa3757 ( potassium voltage-gated channel subfamily H member 2 ) | 0.772668 | 0 | 0 | 0 | 0 |
3 | hsa3763 ( potassium voltage-gated channel subfamily J member 6 ) | 0.745691 | 0 | 0 | 0 | 0 |
4 | hsa1080 ( cystic fibrosis transmembrane conductance regulator ) | 0.744007 | 0 | 0 | 0 | 0 |
5 | hsa3782 ( potassium calcium-activated channel subfamily N member 3 ) | 0.739349 | 0 | 0 | 0 | 0 |
6 | hsa3781 ( potassium calcium-activated channel subfamily N member 2 ) | 0.696152 | 0 | 0 | 0 | 0 |
7 | hsa1135 ( cholinergic receptor nicotinic alpha 2 subunit ) | 0.650093 | 0 | 0 | 0 | 0 |
8 | hsa3784 ( potassium voltage-gated channel subfamily Q member 1 ) | 0.643702 | 0 | 0 | 0 | 0 |
9 | hsa3778 ( potassium calcium-activated channel subfamily M alpha 1 ) | 0.631673 | 0 | 0 | 0 | 0 |
10 | hsa6530 ( solute carrier family 6 member 2 ) | 0.628906 | 0 | 0 | 0 | 0 |
Rank | Target | Score | Validated | KEGG | DrugBank | Matador |
---|---|---|---|---|---|---|
1 | hsa3767 ( potassium voltage-gated channel subfamily J member 11 ) | 0.945084 | 1 | 1 | 0 | 0 |
2 | hsa1080 ( cystic fibrosis transmembrane conductance regulator ) | 0.847454 | 0 | 0 | 0 | 0 |
3 | hsa3757 ( potassium voltage-gated channel subfamily H member 2 ) | 0.718141 | 0 | 0 | 0 | 0 |
4 | hsa6331 ( sodium voltage-gated channel alpha subunit 5 ) | 0.714966 | 0 | 0 | 0 | 0 |
5 | hsa3782 ( potassium calcium-activated channel subfamily N member 3 ) | 0.691887 | 0 | 0 | 0 | 0 |
6 | hsa3763 ( potassium voltage-gated channel subfamily J member 6 ) | 0.675768 | 0 | 0 | 0 | 0 |
7 | hsa6530 ( solute carrier family 6 member 2 ) | 0.660411 | 0 | 0 | 0 | 0 |
8 | hsa3783 ( potassium calcium-activated channel subfamily N member 4 ) | 0.643411 | 0 | 0 | 0 | 0 |
9 | hsa6532 ( solute carrier family 6 member 4 ) | 0.628888 | 0 | 0 | 0 | 0 |
10 | hsa3778 ( potassium calcium-activated channel subfamily M alpha 1 ) | 0.628742 | 0 | 0 | 0 | 0 |
Rank | Target | Score | Validated | KEGG | DrugBank | Matador |
---|---|---|---|---|---|---|
1 | hsa8911 ( calcium voltage-gated channel subunit alpha1 I ) | 0.97175 | 0 | 0 | 0 | 0 |
2 | hsa8912 ( calcium voltage-gated channel subunit alpha1 H ) | 0.963862 | 0 | 0 | 0 | 0 |
3 | hsa2554 ( gamma-aminobutyric acid type A receptor alpha1 subunit ) | 0.784597 | 0 | 0 | 0 | 0 |
4 | hsa6323 ( sodium voltage-gated channel alpha subunit 1 ) | 0.782328 | 0 | 0 | 0 | 0 |
5 | hsa6331 ( sodium voltage-gated channel alpha subunit 5 ) | 0.771807 | 0 | 0 | 0 | 0 |
6 | hsa777 ( calcium voltage-gated channel subunit alpha1 E ) | 0.753246 | 0 | 0 | 0 | 0 |
7 | hsa775 ( calcium voltage-gated channel subunit alpha1 C ) | 0.745733 | 0 | 0 | 0 | 0 |
8 | hsa6261 ( ryanodine receptor 1 ) | 0.737077 | 0 | 0 | 0 | 0 |
9 | hsa773 ( calcium voltage-gated channel subunit alpha1 A ) | 0.719115 | 0 | 0 | 0 | 0 |
10 | hsa779 ( calcium voltage-gated channel subunit alpha1 S ) | 0.717416 | 0 | 0 | 0 | 0 |
Rank | Target | Score | Validated | KEGG | DrugBank | Matador |
---|---|---|---|---|---|---|
1 | hsa6531 ( solute carrier family 6 member 3 ) | 0.934614 | 1 | 0 | 1 | 0 |
2 | hsa3782 ( potassium calcium-activated channel subfamily N member 3 ) | 0.90326 | 0 | 0 | 0 | 0 |
3 | hsa3781 ( potassium calcium-activated channel subfamily N member 2 ) | 0.83417 | 0 | 0 | 0 | 0 |
4 | hsa11254 ( solute carrier family 6 member 14 ) | 0.830485 | 0 | 0 | 0 | 0 |
5 | hsa6534 ( solute carrier family 6 member 7 ) | 0.807744 | 0 | 0 | 0 | 0 |
6 | hsa116443 ( glutamate ionotropic receptor NMDA type subunit 3A ) | 0.796939 | 0 | 0 | 0 | 0 |
7 | hsa6529 ( solute carrier family 6 member 1 ) | 0.781356 | 0 | 0 | 0 | 0 |
8 | hsa3758 ( potassium voltage-gated channel subfamily J member 1 ) | 0.745085 | 0 | 0 | 0 | 0 |
9 | hsa3359 ( 5-hydroxytryptamine receptor 3A ) | 0.7197 | 1 | 0 | 1 | 0 |
10 | hsa3763 ( potassium voltage-gated channel subfamily J member 6 ) | 0.718191 | 0 | 0 | 0 | 0 |
Rank | Target | Score | Validated | KEGG | DrugBank | Matador |
---|---|---|---|---|---|---|
1 | hsa3767 ( potassium voltage-gated channel subfamily J member 11 ) | 0.916301 | 1 | 1 | 0 | 0 |
2 | hsa6833 ( ATP binding cassette subfamily C member 8 ) | 0.897581 | 1 | 1 | 0 | 0 |
3 | hsa6331 ( sodium voltage-gated channel alpha subunit 5 ) | 0.762545 | 0 | 0 | 0 | 0 |
4 | hsa1080 ( cystic fibrosis transmembrane conductance regulator ) | 0.747868 | 0 | 0 | 0 | 0 |
5 | hsa3763 ( potassium voltage-gated channel subfamily J member 6 ) | 0.732104 | 1 | 0 | 0 | 1 |
6 | hsa3757 ( potassium voltage-gated channel subfamily H member 2 ) | 0.724671 | 1 | 0 | 0 | 1 |
7 | hsa3782 ( potassium calcium-activated channel subfamily N member 3 ) | 0.714934 | 1 | 0 | 0 | 1 |
8 | hsa6323 ( sodium voltage-gated channel alpha subunit 1 ) | 0.682783 | 0 | 0 | 0 | 0 |
9 | hsa6530 ( solute carrier family 6 member 2 ) | 0.675518 | 0 | 0 | 0 | 0 |
10 | hsa3781 ( potassium calcium-activated channel subfamily N member 2 ) | 0.664221 | 1 | 0 | 0 | 1 |
Rank | Target | Score | Validated | KEGG | DrugBank | Matador |
---|---|---|---|---|---|---|
1 | hsa3783 ( potassium calcium-activated channel subfamily N member 4 ) | 0.695623 | 0 | 0 | 0 | 0 |
2 | hsa3757 ( potassium voltage-gated channel subfamily H member 2 ) | 0.670617 | 0 | 0 | 0 | 0 |
3 | hsa3778 ( potassium calcium-activated channel subfamily M alpha 1 ) | 0.645725 | 0 | 0 | 0 | 0 |
4 | hsa3739 ( potassium voltage-gated channel subfamily A member 4 ) | 0.58009 | 0 | 0 | 0 | 0 |
5 | hsa56659 ( potassium two pore domain channel subfamily K member 13 ) | 0.560955 | 0 | 0 | 0 | 0 |
6 | hsa3758 ( potassium voltage-gated channel subfamily J member 1 ) | 0.552418 | 0 | 0 | 0 | 0 |
7 | hsa6530 ( solute carrier family 6 member 2 ) | 0.552147 | 0 | 0 | 0 | 0 |
8 | hsa3763 ( potassium voltage-gated channel subfamily J member 6 ) | 0.534166 | 0 | 0 | 0 | 0 |
9 | hsa6340 ( sodium channel epithelial 1 gamma subunit ) | 0.515923 | 0 | 0 | 0 | 0 |
10 | hsa3738 ( potassium voltage-gated channel subfamily A member 3 ) | 0.512871 | 0 | 0 | 0 | 0 |
Rank | Target | Score | Validated | KEGG | DrugBank | Matador |
---|---|---|---|---|---|---|
1 | hsa779 ( calcium voltage-gated channel subunit alpha1 S ) | 0.987873 | 1 | 1 | 1 | 0 |
2 | hsa773 ( calcium voltage-gated channel subunit alpha1 A ) | 0.976376 | 0 | 0 | 0 | 0 |
3 | hsa781 ( calcium voltage-gated channel auxiliary subunit alpha2delta 1 ) | 0.963362 | 0 | 0 | 0 | 0 |
4 | hsa782 ( calcium voltage-gated channel auxiliary subunit beta 1 ) | 0.932148 | 1 | 0 | 1 | 0 |
5 | hsa777 ( calcium voltage-gated channel subunit alpha1 E ) | 0.93045 | 0 | 0 | 0 | 0 |
6 | hsa55799 ( calcium voltage-gated channel auxiliary subunit alpha2delta 3 ) | 0.927176 | 0 | 0 | 0 | 0 |
7 | hsa8912 ( calcium voltage-gated channel subunit alpha1 H ) | 0.915094 | 0 | 0 | 0 | 0 |
8 | hsa8911 ( calcium voltage-gated channel subunit alpha1 I ) | 0.912943 | 0 | 0 | 0 | 0 |
9 | hsa9254 ( calcium voltage-gated channel auxiliary subunit alpha2delta 2 ) | 0.911115 | 0 | 0 | 0 | 0 |
10 | hsa774 ( calcium voltage-gated channel subunit alpha1 B ) | 0.908606 | 0 | 0 | 0 | 0 |
Rank | Target | Score | Validated | KEGG | DrugBank | Matador |
---|---|---|---|---|---|---|
1 | hsa170572 ( 5-hydroxytryptamine receptor 3C ) | 0.938787 | 0 | 0 | 0 | 0 |
2 | hsa200909 ( 5-hydroxytryptamine receptor 3D ) | 0.936725 | 0 | 0 | 0 | 0 |
3 | hsa1135 ( cholinergic receptor nicotinic alpha 2 subunit ) | 0.786975 | 0 | 0 | 0 | 0 |
4 | hsa6530 ( solute carrier family 6 member 2 ) | 0.761222 | 0 | 0 | 0 | 0 |
5 | hsa6532 ( solute carrier family 6 member 4 ) | 0.750611 | 0 | 0 | 0 | 0 |
6 | hsa1141 ( cholinergic receptor nicotinic beta 2 subunit ) | 0.742047 | 0 | 0 | 0 | 0 |
7 | hsa6331 ( sodium voltage-gated channel alpha subunit 5 ) | 0.728947 | 0 | 0 | 0 | 0 |
8 | hsa3758 ( potassium voltage-gated channel subfamily J member 1 ) | 0.693103 | 0 | 0 | 0 | 0 |
9 | hsa3782 ( potassium calcium-activated channel subfamily N member 3 ) | 0.657727 | 0 | 0 | 0 | 0 |
10 | hsa8973 ( cholinergic receptor nicotinic alpha 6 subunit ) | 0.655975 | 0 | 0 | 0 | 0 |
Rank | Target | Score | Validated | KEGG | DrugBank | Matador |
---|---|---|---|---|---|---|
1 | hsa285242 ( 5-hydroxytryptamine receptor 3E ) | 0.965364 | 1 | 1 | 0 | 0 |
2 | hsa9177 ( 5-hydroxytryptamine receptor 3B ) | 0.956755 | 1 | 1 | 0 | 0 |
3 | hsa170572 ( 5-hydroxytryptamine receptor 3C ) | 0.912565 | 1 | 1 | 0 | 0 |
4 | hsa200909 ( 5-hydroxytryptamine receptor 3D ) | 0.90872 | 1 | 1 | 0 | 0 |
5 | hsa1135 ( cholinergic receptor nicotinic alpha 2 subunit ) | 0.807317 | 0 | 0 | 0 | 0 |
6 | hsa6530 ( solute carrier family 6 member 2 ) | 0.790162 | 0 | 0 | 0 | 0 |
7 | hsa6532 ( solute carrier family 6 member 4 ) | 0.771855 | 0 | 0 | 0 | 0 |
8 | hsa3782 ( potassium calcium-activated channel subfamily N member 3 ) | 0.769606 | 0 | 0 | 0 | 0 |
9 | hsa1141 ( cholinergic receptor nicotinic beta 2 subunit ) | 0.747065 | 0 | 0 | 0 | 0 |
10 | hsa3781 ( potassium calcium-activated channel subfamily N member 2 ) | 0.727158 | 0 | 0 | 0 | 0 |
Rank | Target | Score | Validated | KEGG | DrugBank | Matador |
---|---|---|---|---|---|---|
1 | hsa2555 ( gamma-aminobutyric acid type A receptor alpha2 subunit ) | 0.947145 | 1 | 1 | 1 | 0 |
2 | hsa2558 ( gamma-aminobutyric acid type A receptor alpha5 subunit ) | 0.943557 | 1 | 1 | 1 | 0 |
3 | hsa2556 ( gamma-aminobutyric acid type A receptor alpha3 subunit ) | 0.942975 | 1 | 1 | 1 | 0 |
4 | hsa2557 ( gamma-aminobutyric acid type A receptor alpha4 subunit ) | 0.940733 | 1 | 1 | 1 | 0 |
5 | hsa2559 ( gamma-aminobutyric acid type A receptor alpha6 subunit ) | 0.94072 | 1 | 1 | 1 | 0 |
6 | hsa2564 ( gamma-aminobutyric acid type A receptor epsilon subunit ) | 0.85325 | 1 | 1 | 1 | 0 |
7 | hsa2567 ( gamma-aminobutyric acid type A receptor gamma3 subunit ) | 0.851405 | 1 | 1 | 1 | 0 |
8 | hsa2566 ( gamma-aminobutyric acid type A receptor gamma2 subunit ) | 0.849526 | 1 | 1 | 1 | 0 |
9 | hsa55879 ( gamma-aminobutyric acid type A receptor theta subunit ) | 0.831157 | 1 | 1 | 1 | 0 |
10 | hsa2563 ( gamma-aminobutyric acid type A receptor delta subunit ) | 0.829616 | 1 | 1 | 1 | 0 |
Rank | Target | Score | Validated | KEGG | DrugBank | Matador |
---|---|---|---|---|---|---|
1 | hsa2555 ( gamma-aminobutyric acid type A receptor alpha2 subunit ) | 0.940017 | 1 | 0 | 1 | 0 |
2 | hsa2558 ( gamma-aminobutyric acid type A receptor alpha5 subunit ) | 0.935671 | 1 | 0 | 1 | 0 |
3 | hsa2556 ( gamma-aminobutyric acid type A receptor alpha3 subunit ) | 0.934987 | 1 | 0 | 1 | 0 |
4 | hsa2557 ( gamma-aminobutyric acid type A receptor alpha4 subunit ) | 0.93322 | 1 | 0 | 1 | 0 |
5 | hsa2559 ( gamma-aminobutyric acid type A receptor alpha6 subunit ) | 0.932913 | 1 | 0 | 1 | 0 |
6 | hsa2564 ( gamma-aminobutyric acid type A receptor epsilon subunit ) | 0.826738 | 1 | 0 | 1 | 0 |
7 | hsa2567 ( gamma-aminobutyric acid type A receptor gamma3 subunit ) | 0.826368 | 1 | 0 | 1 | 0 |
8 | hsa2566 ( gamma-aminobutyric acid type A receptor gamma2 subunit ) | 0.825273 | 1 | 0 | 1 | 0 |
9 | hsa55879 ( gamma-aminobutyric acid type A receptor theta subunit ) | 0.798744 | 1 | 0 | 1 | 0 |
10 | hsa2741 ( glycine receptor alpha 1 ) | 0.796338 | 0 | 0 | 0 | 0 |
Rank | Target | Score | Validated | KEGG | DrugBank | Matador |
---|---|---|---|---|---|---|
1 | hsa6336 ( sodium voltage-gated channel alpha subunit 10 ) | 0.973576 | 1 | 0 | 0 | 1 |
2 | hsa8645 ( potassium two pore domain channel subfamily K member 5 ) | 0.950547 | 0 | 0 | 0 | 0 |
3 | hsa3741 ( potassium voltage-gated channel subfamily A member 5 ) | 0.813704 | 0 | 0 | 0 | 0 |
4 | hsa6332 ( sodium voltage-gated channel alpha subunit 7 ) | 0.756403 | 1 | 0 | 0 | 1 |
5 | hsa8913 ( calcium voltage-gated channel subunit alpha1 G ) | 0.710896 | 0 | 0 | 0 | 0 |
6 | hsa3763 ( potassium voltage-gated channel subfamily J member 6 ) | 0.68825 | 0 | 0 | 0 | 0 |
7 | hsa11280 ( sodium voltage-gated channel alpha subunit 11 ) | 0.671587 | 0 | 0 | 0 | 0 |
8 | hsa3359 ( 5-hydroxytryptamine receptor 3A ) | 0.663373 | 0 | 0 | 0 | 0 |
9 | hsa3743 ( potassium voltage-gated channel subfamily A member 7 ) | 0.659036 | 0 | 0 | 0 | 0 |
10 | hsa3758 ( potassium voltage-gated channel subfamily J member 1 ) | 0.657788 | 0 | 0 | 0 | 0 |
Rank | Target | Score | Validated | KEGG | DrugBank | Matador |
---|---|---|---|---|---|---|
1 | hsa3781 ( potassium calcium-activated channel subfamily N member 2 ) | 0.97374 | 0 | 0 | 0 | 0 |
2 | hsa3780 ( potassium calcium-activated channel subfamily N member 1 ) | 0.94131 | 0 | 0 | 0 | 0 |
3 | hsa3763 ( potassium voltage-gated channel subfamily J member 6 ) | 0.870739 | 0 | 0 | 0 | 0 |
4 | hsa3783 ( potassium calcium-activated channel subfamily N member 4 ) | 0.851743 | 0 | 0 | 0 | 0 |
5 | hsa6530 ( solute carrier family 6 member 2 ) | 0.808228 | 0 | 0 | 0 | 0 |
6 | hsa6532 ( solute carrier family 6 member 4 ) | 0.789529 | 0 | 0 | 0 | 0 |
7 | hsa3758 ( potassium voltage-gated channel subfamily J member 1 ) | 0.784655 | 0 | 0 | 0 | 0 |
8 | hsa3757 ( potassium voltage-gated channel subfamily H member 2 ) | 0.727134 | 0 | 0 | 0 | 0 |
9 | hsa3767 ( potassium voltage-gated channel subfamily J member 11 ) | 0.719725 | 0 | 0 | 0 | 0 |
10 | hsa2554 ( gamma-aminobutyric acid type A receptor alpha1 subunit ) | 0.706185 | 0 | 0 | 0 | 0 |
Rank | Target | Score | Validated | KEGG | DrugBank | Matador |
---|---|---|---|---|---|---|
1 | hsa8913 ( calcium voltage-gated channel subunit alpha1 G ) | 0.984123 | 0 | 0 | 0 | 0 |
2 | hsa8912 ( calcium voltage-gated channel subunit alpha1 H ) | 0.975034 | 0 | 0 | 0 | 0 |
3 | hsa775 ( calcium voltage-gated channel subunit alpha1 C ) | 0.815508 | 0 | 0 | 0 | 0 |
4 | hsa777 ( calcium voltage-gated channel subunit alpha1 E ) | 0.812264 | 0 | 0 | 0 | 0 |
5 | hsa779 ( calcium voltage-gated channel subunit alpha1 S ) | 0.786811 | 0 | 0 | 0 | 0 |
6 | hsa773 ( calcium voltage-gated channel subunit alpha1 A ) | 0.785186 | 0 | 0 | 0 | 0 |
7 | hsa778 ( calcium voltage-gated channel subunit alpha1 F ) | 0.783052 | 0 | 0 | 0 | 0 |
8 | hsa786 ( calcium voltage-gated channel auxiliary subunit gamma 1 ) | 0.767555 | 0 | 0 | 0 | 0 |
9 | hsa776 ( calcium voltage-gated channel subunit alpha1 D ) | 0.766756 | 0 | 0 | 0 | 0 |
10 | hsa2554 ( gamma-aminobutyric acid type A receptor alpha1 subunit ) | 0.74067 | 0 | 0 | 0 | 0 |
Rank | Target | Score | Validated | KEGG | DrugBank | Matador |
---|---|---|---|---|---|---|
1 | hsa1138 ( cholinergic receptor nicotinic alpha 5 subunit ) | 0.887386 | 0 | 0 | 0 | 0 |
2 | hsa1134 ( cholinergic receptor nicotinic alpha 1 subunit ) | 0.876167 | 0 | 0 | 0 | 0 |
3 | hsa1139 ( cholinergic receptor nicotinic alpha 7 subunit ) | 0.875124 | 1 | 0 | 1 | 0 |
4 | hsa2570 ( gamma-aminobutyric acid type A receptor rho2 subunit ) | 0.7997 | 0 | 0 | 0 | 0 |
5 | hsa3359 ( 5-hydroxytryptamine receptor 3A ) | 0.797982 | 0 | 0 | 0 | 0 |
6 | hsa2741 ( glycine receptor alpha 1 ) | 0.785683 | 0 | 0 | 0 | 0 |
7 | hsa2743 ( glycine receptor beta ) | 0.718292 | 0 | 0 | 0 | 0 |
8 | hsa2742 ( glycine receptor alpha 2 ) | 0.712527 | 0 | 0 | 0 | 0 |
9 | hsa116443 ( glutamate ionotropic receptor NMDA type subunit 3A ) | 0.662887 | 1 | 0 | 1 | 0 |
10 | hsa6530 ( solute carrier family 6 member 2 ) | 0.640672 | 0 | 0 | 0 | 0 |
Rank | Target | Score | Validated | KEGG | DrugBank | Matador |
---|---|---|---|---|---|---|
1 | hsa6331 ( sodium voltage-gated channel alpha subunit 5 ) | 0.986129 | 0 | 0 | 0 | 0 |
2 | hsa6328 ( sodium voltage-gated channel alpha subunit 3 ) | 0.971803 | 0 | 0 | 0 | 0 |
3 | hsa6329 ( sodium voltage-gated channel alpha subunit 4 ) | 0.969702 | 0 | 0 | 0 | 0 |
4 | hsa6326 ( sodium voltage-gated channel alpha subunit 2 ) | 0.965211 | 0 | 0 | 0 | 0 |
5 | hsa6334 ( sodium voltage-gated channel alpha subunit 8 ) | 0.962377 | 0 | 0 | 0 | 0 |
6 | hsa6336 ( sodium voltage-gated channel alpha subunit 10 ) | 0.95857 | 0 | 0 | 0 | 0 |
7 | hsa6335 ( sodium voltage-gated channel alpha subunit 9 ) | 0.957941 | 0 | 0 | 0 | 0 |
8 | hsa8645 ( potassium two pore domain channel subfamily K member 5 ) | 0.923972 | 0 | 0 | 0 | 0 |
9 | hsa8913 ( calcium voltage-gated channel subunit alpha1 G ) | 0.808738 | 0 | 0 | 0 | 0 |
10 | hsa3741 ( potassium voltage-gated channel subfamily A member 5 ) | 0.774086 | 0 | 0 | 0 | 0 |
Rank | Target | Score | Validated | KEGG | DrugBank | Matador |
---|---|---|---|---|---|---|
1 | hsa6323 ( sodium voltage-gated channel alpha subunit 1 ) | 0.747702 | 1 | 1 | 1 | 0 |
2 | hsa3778 ( potassium calcium-activated channel subfamily M alpha 1 ) | 0.605337 | 0 | 0 | 0 | 0 |
3 | hsa6326 ( sodium voltage-gated channel alpha subunit 2 ) | 0.58995 | 1 | 1 | 0 | 0 |
4 | hsa6334 ( sodium voltage-gated channel alpha subunit 8 ) | 0.585449 | 1 | 1 | 0 | 0 |
5 | hsa2554 ( gamma-aminobutyric acid type A receptor alpha1 subunit ) | 0.551607 | 0 | 0 | 0 | 0 |
6 | hsa6335 ( sodium voltage-gated channel alpha subunit 9 ) | 0.544533 | 1 | 1 | 0 | 0 |
7 | hsa6530 ( solute carrier family 6 member 2 ) | 0.510659 | 0 | 0 | 0 | 0 |
8 | hsa40 ( acid sensing ion channel subunit 2 ) | 0.503611 | 0 | 0 | 0 | 0 |
9 | hsa8645 ( potassium two pore domain channel subfamily K member 5 ) | 0.492144 | 0 | 0 | 0 | 0 |
10 | hsa116443 ( glutamate ionotropic receptor NMDA type subunit 3A ) | 0.478764 | 0 | 0 | 0 | 0 |
Rank | Target | Score | Validated | KEGG | DrugBank | Matador |
---|---|---|---|---|---|---|
1 | hsa170572 ( 5-hydroxytryptamine receptor 3C ) | 0.936922 | 0 | 0 | 0 | 0 |
2 | hsa200909 ( 5-hydroxytryptamine receptor 3D ) | 0.934421 | 0 | 0 | 0 | 0 |
3 | hsa1135 ( cholinergic receptor nicotinic alpha 2 subunit ) | 0.773644 | 0 | 0 | 0 | 0 |
4 | hsa6530 ( solute carrier family 6 member 2 ) | 0.763731 | 0 | 0 | 0 | 0 |
5 | hsa6331 ( sodium voltage-gated channel alpha subunit 5 ) | 0.763112 | 0 | 0 | 0 | 0 |
6 | hsa6532 ( solute carrier family 6 member 4 ) | 0.745911 | 0 | 0 | 0 | 0 |
7 | hsa1141 ( cholinergic receptor nicotinic beta 2 subunit ) | 0.72888 | 0 | 0 | 0 | 0 |
8 | hsa6336 ( sodium voltage-gated channel alpha subunit 10 ) | 0.67146 | 0 | 0 | 0 | 0 |
9 | hsa3782 ( potassium calcium-activated channel subfamily N member 3 ) | 0.661337 | 0 | 0 | 0 | 0 |
10 | hsa6323 ( sodium voltage-gated channel alpha subunit 1 ) | 0.657625 | 0 | 0 | 0 | 0 |
Rank | Target | Score | Validated | KEGG | DrugBank | Matador |
---|---|---|---|---|---|---|
1 | hsa2891 ( glutamate ionotropic receptor AMPA type subunit 2 ) | 0.845812 | 0 | 0 | 0 | 0 |
2 | hsa3758 ( potassium voltage-gated channel subfamily J member 1 ) | 0.759255 | 0 | 0 | 0 | 0 |
3 | hsa2554 ( gamma-aminobutyric acid type A receptor alpha1 subunit ) | 0.7562 | 0 | 0 | 0 | 0 |
4 | hsa3763 ( potassium voltage-gated channel subfamily J member 6 ) | 0.752036 | 0 | 0 | 0 | 0 |
5 | hsa3757 ( potassium voltage-gated channel subfamily H member 2 ) | 0.692616 | 0 | 0 | 0 | 0 |
6 | hsa2890 ( glutamate ionotropic receptor AMPA type subunit 1 ) | 0.686098 | 0 | 0 | 0 | 0 |
7 | hsa9132 ( potassium voltage-gated channel subfamily Q member 4 ) | 0.685364 | 0 | 0 | 0 | 0 |
8 | hsa3784 ( potassium voltage-gated channel subfamily Q member 1 ) | 0.679923 | 0 | 0 | 0 | 0 |
9 | hsa3782 ( potassium calcium-activated channel subfamily N member 3 ) | 0.668187 | 0 | 0 | 0 | 0 |
10 | hsa3781 ( potassium calcium-activated channel subfamily N member 2 ) | 0.647903 | 0 | 0 | 0 | 0 |
Rank | Target | Score | Validated | KEGG | DrugBank | Matador |
---|---|---|---|---|---|---|
1 | hsa27133 ( potassium voltage-gated channel subfamily H member 5 ) | 0.814779 | 0 | 0 | 0 | 0 |
2 | hsa3783 ( potassium calcium-activated channel subfamily N member 4 ) | 0.765342 | 0 | 0 | 0 | 0 |
3 | hsa775 ( calcium voltage-gated channel subunit alpha1 C ) | 0.744315 | 0 | 0 | 0 | 0 |
4 | hsa3776 ( potassium two pore domain channel subfamily K member 2 ) | 0.730139 | 0 | 0 | 0 | 0 |
5 | hsa3758 ( potassium voltage-gated channel subfamily J member 1 ) | 0.729988 | 0 | 0 | 0 | 0 |
6 | hsa781 ( calcium voltage-gated channel auxiliary subunit alpha2delta 1 ) | 0.728412 | 0 | 0 | 0 | 0 |
7 | hsa8913 ( calcium voltage-gated channel subunit alpha1 G ) | 0.728006 | 0 | 0 | 0 | 0 |
8 | hsa786 ( calcium voltage-gated channel auxiliary subunit gamma 1 ) | 0.719839 | 0 | 0 | 0 | 0 |
9 | hsa90134 ( potassium voltage-gated channel subfamily H member 7 ) | 0.715181 | 0 | 0 | 0 | 0 |
10 | hsa8911 ( calcium voltage-gated channel subunit alpha1 I ) | 0.712077 | 0 | 0 | 0 | 0 |
Rank | Target | Score | Validated | KEGG | DrugBank | Matador |
---|---|---|---|---|---|---|
1 | hsa1139 ( cholinergic receptor nicotinic alpha 7 subunit ) | 0.964678 | 0 | 0 | 0 | 0 |
2 | hsa1138 ( cholinergic receptor nicotinic alpha 5 subunit ) | 0.96399 | 0 | 0 | 0 | 0 |
3 | hsa1134 ( cholinergic receptor nicotinic alpha 1 subunit ) | 0.960313 | 0 | 0 | 0 | 0 |
4 | hsa3359 ( 5-hydroxytryptamine receptor 3A ) | 0.878088 | 0 | 0 | 0 | 0 |
5 | hsa1144 ( cholinergic receptor nicotinic delta subunit ) | 0.81521 | 0 | 0 | 0 | 0 |
6 | hsa6331 ( sodium voltage-gated channel alpha subunit 5 ) | 0.769318 | 0 | 0 | 0 | 0 |
7 | hsa1140 ( cholinergic receptor nicotinic beta 1 subunit ) | 0.747931 | 0 | 0 | 0 | 0 |
8 | hsa2554 ( gamma-aminobutyric acid type A receptor alpha1 subunit ) | 0.732136 | 0 | 0 | 0 | 0 |
9 | hsa9177 ( 5-hydroxytryptamine receptor 3B ) | 0.717318 | 0 | 0 | 0 | 0 |
10 | hsa285242 ( 5-hydroxytryptamine receptor 3E ) | 0.711011 | 0 | 0 | 0 | 0 |
Rank | Target | Score | Validated | KEGG | DrugBank | Matador |
---|---|---|---|---|---|---|
1 | hsa1080 ( cystic fibrosis transmembrane conductance regulator ) | 0.955604 | 0 | 0 | 0 | 0 |
2 | hsa3783 ( potassium calcium-activated channel subfamily N member 4 ) | 0.921328 | 0 | 0 | 0 | 0 |
3 | hsa3359 ( 5-hydroxytryptamine receptor 3A ) | 0.776884 | 0 | 0 | 0 | 0 |
4 | hsa2554 ( gamma-aminobutyric acid type A receptor alpha1 subunit ) | 0.769335 | 0 | 0 | 0 | 0 |
5 | hsa1141 ( cholinergic receptor nicotinic beta 2 subunit ) | 0.749916 | 1 | 0 | 0 | 1 |
6 | hsa3758 ( potassium voltage-gated channel subfamily J member 1 ) | 0.71517 | 0 | 0 | 0 | 0 |
7 | hsa3782 ( potassium calcium-activated channel subfamily N member 3 ) | 0.687791 | 0 | 0 | 0 | 0 |
8 | hsa6833 ( ATP binding cassette subfamily C member 8 ) | 0.684463 | 0 | 0 | 0 | 0 |
9 | hsa285242 ( 5-hydroxytryptamine receptor 3E ) | 0.683399 | 0 | 0 | 0 | 0 |
10 | hsa9177 ( 5-hydroxytryptamine receptor 3B ) | 0.678848 | 0 | 0 | 0 | 0 |
Rank | Target | Score | Validated | KEGG | DrugBank | Matador |
---|---|---|---|---|---|---|
1 | hsa2741 ( glycine receptor alpha 1 ) | 0.846536 | 0 | 0 | 0 | 0 |
2 | hsa2743 ( glycine receptor beta ) | 0.804398 | 0 | 0 | 0 | 0 |
3 | hsa2742 ( glycine receptor alpha 2 ) | 0.782759 | 0 | 0 | 0 | 0 |
4 | hsa116443 ( glutamate ionotropic receptor NMDA type subunit 3A ) | 0.703945 | 0 | 0 | 0 | 0 |
5 | hsa2890 ( glutamate ionotropic receptor AMPA type subunit 1 ) | 0.69364 | 0 | 0 | 0 | 0 |
6 | hsa6530 ( solute carrier family 6 member 2 ) | 0.674694 | 0 | 0 | 0 | 0 |
7 | hsa3736 ( potassium voltage-gated channel subfamily A member 1 ) | 0.674088 | 0 | 0 | 0 | 0 |
8 | hsa3359 ( 5-hydroxytryptamine receptor 3A ) | 0.632815 | 0 | 0 | 0 | 0 |
9 | hsa1141 ( cholinergic receptor nicotinic beta 2 subunit ) | 0.627175 | 0 | 0 | 0 | 0 |
10 | hsa3781 ( potassium calcium-activated channel subfamily N member 2 ) | 0.626174 | 0 | 0 | 0 | 0 |
Rank | Target | Score | Validated | KEGG | DrugBank | Matador |
---|---|---|---|---|---|---|
1 | hsa6336 ( sodium voltage-gated channel alpha subunit 10 ) | 0.956998 | 0 | 0 | 0 | 0 |
2 | hsa6323 ( sodium voltage-gated channel alpha subunit 1 ) | 0.953485 | 1 | 1 | 0 | 0 |
3 | hsa6328 ( sodium voltage-gated channel alpha subunit 3 ) | 0.95238 | 1 | 1 | 0 | 0 |
4 | hsa6329 ( sodium voltage-gated channel alpha subunit 4 ) | 0.947299 | 1 | 1 | 0 | 0 |
5 | hsa6326 ( sodium voltage-gated channel alpha subunit 2 ) | 0.928957 | 1 | 1 | 0 | 0 |
6 | hsa6334 ( sodium voltage-gated channel alpha subunit 8 ) | 0.927283 | 1 | 1 | 0 | 0 |
7 | hsa6335 ( sodium voltage-gated channel alpha subunit 9 ) | 0.917014 | 1 | 1 | 0 | 0 |
8 | hsa8645 ( potassium two pore domain channel subfamily K member 5 ) | 0.889078 | 0 | 0 | 0 | 0 |
9 | hsa3763 ( potassium voltage-gated channel subfamily J member 6 ) | 0.75189 | 0 | 0 | 0 | 0 |
10 | hsa6332 ( sodium voltage-gated channel alpha subunit 7 ) | 0.723377 | 0 | 0 | 0 | 0 |
Rank | Target | Score | Validated | KEGG | DrugBank | Matador |
---|---|---|---|---|---|---|
1 | hsa2554 ( gamma-aminobutyric acid type A receptor alpha1 subunit ) | 0.891551 | 1 | 0 | 0 | 1 |
2 | hsa2890 ( glutamate ionotropic receptor AMPA type subunit 1 ) | 0.861639 | 1 | 0 | 0 | 1 |
3 | hsa8001 ( glycine receptor alpha 3 ) | 0.818774 | 0 | 0 | 0 | 0 |
4 | hsa6532 ( solute carrier family 6 member 4 ) | 0.774009 | 0 | 0 | 0 | 0 |
5 | hsa6530 ( solute carrier family 6 member 2 ) | 0.773376 | 0 | 0 | 0 | 0 |
6 | hsa6331 ( sodium voltage-gated channel alpha subunit 5 ) | 0.731288 | 0 | 0 | 0 | 0 |
7 | hsa2563 ( gamma-aminobutyric acid type A receptor delta subunit ) | 0.729882 | 1 | 0 | 0 | 1 |
8 | hsa3736 ( potassium voltage-gated channel subfamily A member 1 ) | 0.722229 | 0 | 0 | 0 | 0 |
9 | hsa2569 ( gamma-aminobutyric acid type A receptor rho1 subunit ) | 0.71627 | 1 | 0 | 0 | 1 |
10 | hsa55879 ( gamma-aminobutyric acid type A receptor theta subunit ) | 0.716244 | 1 | 0 | 0 | 1 |
Rank | Target | Score | Validated | KEGG | DrugBank | Matador |
---|---|---|---|---|---|---|
1 | hsa6331 ( sodium voltage-gated channel alpha subunit 5 ) | 0.939079 | 1 | 1 | 0 | 0 |
2 | hsa6328 ( sodium voltage-gated channel alpha subunit 3 ) | 0.891145 | 1 | 1 | 0 | 0 |
3 | hsa6326 ( sodium voltage-gated channel alpha subunit 2 ) | 0.89083 | 1 | 1 | 0 | 0 |
4 | hsa6329 ( sodium voltage-gated channel alpha subunit 4 ) | 0.885906 | 1 | 1 | 0 | 0 |
5 | hsa6334 ( sodium voltage-gated channel alpha subunit 8 ) | 0.878236 | 1 | 1 | 0 | 0 |
6 | hsa6335 ( sodium voltage-gated channel alpha subunit 9 ) | 0.866461 | 1 | 1 | 0 | 0 |
7 | hsa2555 ( gamma-aminobutyric acid type A receptor alpha2 subunit ) | 0.853005 | 1 | 0 | 1 | 0 |
8 | hsa6336 ( sodium voltage-gated channel alpha subunit 10 ) | 0.846249 | 0 | 0 | 0 | 0 |
9 | hsa2558 ( gamma-aminobutyric acid type A receptor alpha5 subunit ) | 0.843764 | 1 | 0 | 1 | 0 |
10 | hsa2559 ( gamma-aminobutyric acid type A receptor alpha6 subunit ) | 0.840097 | 1 | 0 | 1 | 0 |
Rank | Target | Score | Validated | KEGG | DrugBank | Matador |
---|---|---|---|---|---|---|
1 | hsa6331 ( sodium voltage-gated channel alpha subunit 5 ) | 0.95078 | 1 | 1 | 1 | 0 |
2 | hsa6326 ( sodium voltage-gated channel alpha subunit 2 ) | 0.828942 | 1 | 1 | 1 | 0 |
3 | hsa6334 ( sodium voltage-gated channel alpha subunit 8 ) | 0.820741 | 1 | 1 | 0 | 0 |
4 | hsa6335 ( sodium voltage-gated channel alpha subunit 9 ) | 0.797569 | 1 | 1 | 1 | 0 |
5 | hsa40 ( acid sensing ion channel subunit 2 ) | 0.713138 | 0 | 0 | 0 | 0 |
6 | hsa5310 ( polycystin 1, transient receptor potential channel interacting ) | 0.684373 | 0 | 0 | 0 | 0 |
7 | hsa8645 ( potassium two pore domain channel subfamily K member 5 ) | 0.683716 | 0 | 0 | 0 | 0 |
8 | hsa3778 ( potassium calcium-activated channel subfamily M alpha 1 ) | 0.660511 | 0 | 0 | 0 | 0 |
9 | hsa41 ( acid sensing ion channel subunit 1 ) | 0.655843 | 0 | 0 | 0 | 0 |
10 | hsa3758 ( potassium voltage-gated channel subfamily J member 1 ) | 0.638774 | 0 | 0 | 0 | 0 |
Rank | Target | Score | Validated | KEGG | DrugBank | Matador |
---|---|---|---|---|---|---|
1 | hsa777 ( calcium voltage-gated channel subunit alpha1 E ) | 0.801063 | 0 | 0 | 0 | 0 |
2 | hsa2554 ( gamma-aminobutyric acid type A receptor alpha1 subunit ) | 0.793441 | 0 | 0 | 0 | 0 |
3 | hsa775 ( calcium voltage-gated channel subunit alpha1 C ) | 0.789903 | 0 | 0 | 0 | 0 |
4 | hsa773 ( calcium voltage-gated channel subunit alpha1 A ) | 0.766788 | 0 | 0 | 0 | 0 |
5 | hsa779 ( calcium voltage-gated channel subunit alpha1 S ) | 0.762196 | 0 | 0 | 0 | 0 |
6 | hsa778 ( calcium voltage-gated channel subunit alpha1 F ) | 0.760654 | 0 | 0 | 0 | 0 |
7 | hsa776 ( calcium voltage-gated channel subunit alpha1 D ) | 0.740855 | 0 | 0 | 0 | 0 |
8 | hsa786 ( calcium voltage-gated channel auxiliary subunit gamma 1 ) | 0.737727 | 0 | 0 | 0 | 0 |
9 | hsa5310 ( polycystin 1, transient receptor potential channel interacting ) | 0.731102 | 0 | 0 | 0 | 0 |
10 | hsa781 ( calcium voltage-gated channel auxiliary subunit alpha2delta 1 ) | 0.713135 | 0 | 0 | 0 | 0 |
Rank | Target | Score | Validated | KEGG | DrugBank | Matador |
---|---|---|---|---|---|---|
1 | hsa6261 ( ryanodine receptor 1 ) | 0.853666 | 1 | 0 | 0 | 1 |
2 | hsa6263 ( ryanodine receptor 3 ) | 0.843711 | 1 | 0 | 0 | 1 |
3 | hsa6262 ( ryanodine receptor 2 ) | 0.790377 | 1 | 0 | 0 | 1 |
4 | hsa3736 ( potassium voltage-gated channel subfamily A member 1 ) | 0.764386 | 0 | 0 | 0 | 0 |
5 | hsa3757 ( potassium voltage-gated channel subfamily H member 2 ) | 0.664503 | 0 | 0 | 0 | 0 |
6 | hsa2742 ( glycine receptor alpha 2 ) | 0.586133 | 0 | 0 | 0 | 0 |
7 | hsa6530 ( solute carrier family 6 member 2 ) | 0.573278 | 0 | 0 | 0 | 0 |
8 | hsa3738 ( potassium voltage-gated channel subfamily A member 3 ) | 0.552702 | 0 | 0 | 0 | 0 |
9 | hsa3758 ( potassium voltage-gated channel subfamily J member 1 ) | 0.54704 | 0 | 0 | 0 | 0 |
10 | hsa2555 ( gamma-aminobutyric acid type A receptor alpha2 subunit ) | 0.535648 | 1 | 0 | 1 | 1 |
Rank | Target | Score | Validated | KEGG | DrugBank | Matador |
---|---|---|---|---|---|---|
1 | hsa2742 ( glycine receptor alpha 2 ) | 0.878594 | 0 | 0 | 0 | 0 |
2 | hsa2558 ( gamma-aminobutyric acid type A receptor alpha5 subunit ) | 0.865319 | 1 | 0 | 1 | 1 |
3 | hsa2557 ( gamma-aminobutyric acid type A receptor alpha4 subunit ) | 0.864571 | 1 | 0 | 1 | 1 |
4 | hsa2555 ( gamma-aminobutyric acid type A receptor alpha2 subunit ) | 0.860136 | 1 | 0 | 1 | 1 |
5 | hsa2556 ( gamma-aminobutyric acid type A receptor alpha3 subunit ) | 0.854844 | 1 | 0 | 1 | 1 |
6 | hsa2743 ( glycine receptor beta ) | 0.850679 | 1 | 0 | 1 | 0 |
7 | hsa2559 ( gamma-aminobutyric acid type A receptor alpha6 subunit ) | 0.845622 | 1 | 0 | 1 | 1 |
8 | hsa2563 ( gamma-aminobutyric acid type A receptor delta subunit ) | 0.788497 | 1 | 0 | 1 | 1 |
9 | hsa55879 ( gamma-aminobutyric acid type A receptor theta subunit ) | 0.788448 | 1 | 0 | 1 | 1 |
10 | hsa2567 ( gamma-aminobutyric acid type A receptor gamma3 subunit ) | 0.773603 | 1 | 0 | 1 | 1 |
Rank | Target | Score | Validated | KEGG | DrugBank | Matador |
---|---|---|---|---|---|---|
1 | hsa2742 ( glycine receptor alpha 2 ) | 0.872497 | 0 | 0 | 0 | 0 |
2 | hsa2558 ( gamma-aminobutyric acid type A receptor alpha5 subunit ) | 0.848292 | 1 | 0 | 1 | 0 |
3 | hsa2557 ( gamma-aminobutyric acid type A receptor alpha4 subunit ) | 0.847344 | 1 | 0 | 1 | 0 |
4 | hsa2743 ( glycine receptor beta ) | 0.842586 | 0 | 0 | 0 | 0 |
5 | hsa2555 ( gamma-aminobutyric acid type A receptor alpha2 subunit ) | 0.842388 | 1 | 0 | 1 | 0 |
6 | hsa2556 ( gamma-aminobutyric acid type A receptor alpha3 subunit ) | 0.836372 | 1 | 0 | 1 | 0 |
7 | hsa2559 ( gamma-aminobutyric acid type A receptor alpha6 subunit ) | 0.826375 | 1 | 0 | 1 | 0 |
8 | hsa2563 ( gamma-aminobutyric acid type A receptor delta subunit ) | 0.773608 | 1 | 0 | 1 | 0 |
9 | hsa55879 ( gamma-aminobutyric acid type A receptor theta subunit ) | 0.773576 | 1 | 0 | 1 | 0 |
10 | hsa3741 ( potassium voltage-gated channel subfamily A member 5 ) | 0.768177 | 0 | 0 | 0 | 0 |
Rank | Target | Score | Validated | KEGG | DrugBank | Matador |
---|---|---|---|---|---|---|
1 | hsa2742 ( glycine receptor alpha 2 ) | 0.887687 | 1 | 0 | 0 | 1 |
2 | hsa2743 ( glycine receptor beta ) | 0.88615 | 1 | 0 | 0 | 1 |
3 | hsa2570 ( gamma-aminobutyric acid type A receptor rho2 subunit ) | 0.848577 | 0 | 0 | 0 | 0 |
4 | hsa8001 ( glycine receptor alpha 3 ) | 0.678807 | 0 | 0 | 0 | 0 |
5 | hsa116443 ( glutamate ionotropic receptor NMDA type subunit 3A ) | 0.668767 | 0 | 0 | 0 | 0 |
6 | hsa3737 ( potassium voltage-gated channel subfamily A member 2 ) | 0.639852 | 0 | 0 | 0 | 0 |
7 | hsa3741 ( potassium voltage-gated channel subfamily A member 5 ) | 0.62359 | 0 | 0 | 0 | 0 |
8 | hsa6530 ( solute carrier family 6 member 2 ) | 0.620397 | 0 | 0 | 0 | 0 |
9 | hsa3778 ( potassium calcium-activated channel subfamily M alpha 1 ) | 0.598765 | 0 | 0 | 0 | 0 |
10 | hsa3359 ( 5-hydroxytryptamine receptor 3A ) | 0.590089 | 0 | 0 | 0 | 0 |
Rank | Target | Score | Validated | KEGG | DrugBank | Matador |
---|---|---|---|---|---|---|
1 | hsa2742 ( glycine receptor alpha 2 ) | 0.87753 | 0 | 0 | 0 | 0 |
2 | hsa2558 ( gamma-aminobutyric acid type A receptor alpha5 subunit ) | 0.875704 | 1 | 0 | 1 | 0 |
3 | hsa2557 ( gamma-aminobutyric acid type A receptor alpha4 subunit ) | 0.874922 | 1 | 0 | 1 | 0 |
4 | hsa2555 ( gamma-aminobutyric acid type A receptor alpha2 subunit ) | 0.871216 | 1 | 0 | 1 | 0 |
5 | hsa2556 ( gamma-aminobutyric acid type A receptor alpha3 subunit ) | 0.86611 | 1 | 0 | 1 | 0 |
6 | hsa2559 ( gamma-aminobutyric acid type A receptor alpha6 subunit ) | 0.857678 | 1 | 0 | 1 | 0 |
7 | hsa2743 ( glycine receptor beta ) | 0.853699 | 0 | 0 | 0 | 0 |
8 | hsa2563 ( gamma-aminobutyric acid type A receptor delta subunit ) | 0.812772 | 1 | 0 | 1 | 0 |
9 | hsa55879 ( gamma-aminobutyric acid type A receptor theta subunit ) | 0.811985 | 1 | 0 | 1 | 0 |
10 | hsa2561 ( gamma-aminobutyric acid type A receptor beta2 subunit ) | 0.798629 | 1 | 0 | 1 | 0 |
Rank | Target | Score | Validated | KEGG | DrugBank | Matador |
---|---|---|---|---|---|---|
1 | hsa2570 ( gamma-aminobutyric acid type A receptor rho2 subunit ) | 0.869443 | 0 | 0 | 0 | 0 |
2 | hsa116443 ( glutamate ionotropic receptor NMDA type subunit 3A ) | 0.750641 | 0 | 0 | 0 | 0 |
3 | hsa8001 ( glycine receptor alpha 3 ) | 0.740735 | 0 | 0 | 0 | 0 |
4 | hsa6530 ( solute carrier family 6 member 2 ) | 0.666059 | 0 | 0 | 0 | 0 |
5 | hsa3359 ( 5-hydroxytryptamine receptor 3A ) | 0.606516 | 0 | 0 | 0 | 0 |
6 | hsa2897 ( glutamate ionotropic receptor kainate type subunit 1 ) | 0.583207 | 0 | 0 | 0 | 0 |
7 | hsa3737 ( potassium voltage-gated channel subfamily A member 2 ) | 0.582989 | 0 | 0 | 0 | 0 |
8 | hsa3741 ( potassium voltage-gated channel subfamily A member 5 ) | 0.568328 | 0 | 0 | 0 | 0 |
9 | hsa6532 ( solute carrier family 6 member 4 ) | 0.561178 | 0 | 0 | 0 | 0 |
10 | hsa3778 ( potassium calcium-activated channel subfamily M alpha 1 ) | 0.560243 | 0 | 0 | 0 | 0 |
Rank | Target | Score | Validated | KEGG | DrugBank | Matador |
---|---|---|---|---|---|---|
1 | hsa2570 ( gamma-aminobutyric acid type A receptor rho2 subunit ) | 0.86201 | 0 | 0 | 0 | 0 |
2 | hsa2741 ( glycine receptor alpha 1 ) | 0.843492 | 0 | 0 | 0 | 0 |
3 | hsa2743 ( glycine receptor beta ) | 0.802124 | 0 | 0 | 0 | 0 |
4 | hsa2742 ( glycine receptor alpha 2 ) | 0.782986 | 0 | 0 | 0 | 0 |
5 | hsa116443 ( glutamate ionotropic receptor NMDA type subunit 3A ) | 0.69187 | 0 | 0 | 0 | 0 |
6 | hsa2890 ( glutamate ionotropic receptor AMPA type subunit 1 ) | 0.671782 | 0 | 0 | 0 | 0 |
7 | hsa3736 ( potassium voltage-gated channel subfamily A member 1 ) | 0.671371 | 0 | 0 | 0 | 0 |
8 | hsa6530 ( solute carrier family 6 member 2 ) | 0.648332 | 0 | 0 | 0 | 0 |
9 | hsa6331 ( sodium voltage-gated channel alpha subunit 5 ) | 0.64802 | 0 | 0 | 0 | 0 |
10 | hsa1141 ( cholinergic receptor nicotinic beta 2 subunit ) | 0.647648 | 0 | 0 | 0 | 0 |
Rank | Target | Score | Validated | KEGG | DrugBank | Matador |
---|---|---|---|---|---|---|
1 | hsa116443 ( glutamate ionotropic receptor NMDA type subunit 3A ) | 0.767268 | 0 | 0 | 0 | 0 |
2 | hsa3736 ( potassium voltage-gated channel subfamily A member 1 ) | 0.75952 | 0 | 0 | 0 | 0 |
3 | hsa2890 ( glutamate ionotropic receptor AMPA type subunit 1 ) | 0.749984 | 0 | 0 | 0 | 0 |
4 | hsa6331 ( sodium voltage-gated channel alpha subunit 5 ) | 0.745543 | 0 | 0 | 0 | 0 |
5 | hsa6323 ( sodium voltage-gated channel alpha subunit 1 ) | 0.710345 | 0 | 0 | 0 | 0 |
6 | hsa6530 ( solute carrier family 6 member 2 ) | 0.706299 | 0 | 0 | 0 | 0 |
7 | hsa8001 ( glycine receptor alpha 3 ) | 0.693269 | 0 | 0 | 0 | 0 |
8 | hsa3359 ( 5-hydroxytryptamine receptor 3A ) | 0.673208 | 0 | 0 | 0 | 0 |
9 | hsa6532 ( solute carrier family 6 member 4 ) | 0.620426 | 0 | 0 | 0 | 0 |
10 | hsa6336 ( sodium voltage-gated channel alpha subunit 10 ) | 0.608739 | 0 | 0 | 0 | 0 |
Rank | Target | Score | Validated | KEGG | DrugBank | Matador |
---|---|---|---|---|---|---|
1 | hsa2570 ( gamma-aminobutyric acid type A receptor rho2 subunit ) | 0.890114 | 1 | 0 | 1 | 0 |
2 | hsa2741 ( glycine receptor alpha 1 ) | 0.872689 | 0 | 0 | 0 | 0 |
3 | hsa2743 ( glycine receptor beta ) | 0.829992 | 0 | 0 | 0 | 0 |
4 | hsa2742 ( glycine receptor alpha 2 ) | 0.811343 | 0 | 0 | 0 | 0 |
5 | hsa6530 ( solute carrier family 6 member 2 ) | 0.735544 | 0 | 0 | 0 | 0 |
6 | hsa3736 ( potassium voltage-gated channel subfamily A member 1 ) | 0.713285 | 0 | 0 | 0 | 0 |
7 | hsa2890 ( glutamate ionotropic receptor AMPA type subunit 1 ) | 0.696578 | 0 | 0 | 0 | 0 |
8 | hsa1135 ( cholinergic receptor nicotinic alpha 2 subunit ) | 0.681328 | 0 | 0 | 0 | 0 |
9 | hsa1141 ( cholinergic receptor nicotinic beta 2 subunit ) | 0.678355 | 0 | 0 | 0 | 0 |
10 | hsa116443 ( glutamate ionotropic receptor NMDA type subunit 3A ) | 0.677832 | 0 | 0 | 0 | 0 |
Rank | Target | Score | Validated | KEGG | DrugBank | Matador |
---|---|---|---|---|---|---|
1 | hsa6331 ( sodium voltage-gated channel alpha subunit 5 ) | 0.9645 | 1 | 1 | 0 | 0 |
2 | hsa6323 ( sodium voltage-gated channel alpha subunit 1 ) | 0.917409 | 1 | 1 | 0 | 0 |
3 | hsa6326 ( sodium voltage-gated channel alpha subunit 2 ) | 0.864065 | 1 | 1 | 0 | 0 |
4 | hsa6334 ( sodium voltage-gated channel alpha subunit 8 ) | 0.860247 | 1 | 1 | 0 | 0 |
5 | hsa6335 ( sodium voltage-gated channel alpha subunit 9 ) | 0.838561 | 1 | 1 | 0 | 0 |
6 | hsa8913 ( calcium voltage-gated channel subunit alpha1 G ) | 0.828177 | 0 | 0 | 0 | 0 |
7 | hsa8911 ( calcium voltage-gated channel subunit alpha1 I ) | 0.770018 | 0 | 0 | 0 | 0 |
8 | hsa8912 ( calcium voltage-gated channel subunit alpha1 H ) | 0.744226 | 0 | 0 | 0 | 0 |
9 | hsa8645 ( potassium two pore domain channel subfamily K member 5 ) | 0.741453 | 0 | 0 | 0 | 0 |
10 | hsa40 ( acid sensing ion channel subunit 2 ) | 0.676932 | 0 | 0 | 0 | 0 |
Rank | Target | Score | Validated | KEGG | DrugBank | Matador |
---|---|---|---|---|---|---|
1 | hsa6323 ( sodium voltage-gated channel alpha subunit 1 ) | 0.976596 | 1 | 1 | 0 | 0 |
2 | hsa6328 ( sodium voltage-gated channel alpha subunit 3 ) | 0.972393 | 1 | 1 | 0 | 0 |
3 | hsa6336 ( sodium voltage-gated channel alpha subunit 10 ) | 0.971735 | 1 | 1 | 0 | 0 |
4 | hsa6329 ( sodium voltage-gated channel alpha subunit 4 ) | 0.96983 | 0 | 0 | 0 | 0 |
5 | hsa6326 ( sodium voltage-gated channel alpha subunit 2 ) | 0.961552 | 1 | 1 | 0 | 0 |
6 | hsa6334 ( sodium voltage-gated channel alpha subunit 8 ) | 0.959913 | 0 | 0 | 0 | 0 |
7 | hsa6335 ( sodium voltage-gated channel alpha subunit 9 ) | 0.953796 | 0 | 0 | 0 | 0 |
8 | hsa8645 ( potassium two pore domain channel subfamily K member 5 ) | 0.928952 | 0 | 0 | 0 | 0 |
9 | hsa6332 ( sodium voltage-gated channel alpha subunit 7 ) | 0.7503 | 1 | 1 | 0 | 0 |
10 | hsa3741 ( potassium voltage-gated channel subfamily A member 5 ) | 0.74542 | 0 | 0 | 0 | 0 |
Rank | Target | Score | Validated | KEGG | DrugBank | Matador |
---|---|---|---|---|---|---|
1 | hsa3757 ( potassium voltage-gated channel subfamily H member 2 ) | 0.823786 | 1 | 0 | 1 | 0 |
2 | hsa3783 ( potassium calcium-activated channel subfamily N member 4 ) | 0.721176 | 0 | 0 | 0 | 0 |
3 | hsa3778 ( potassium calcium-activated channel subfamily M alpha 1 ) | 0.611682 | 0 | 0 | 0 | 0 |
4 | hsa3758 ( potassium voltage-gated channel subfamily J member 1 ) | 0.562723 | 0 | 0 | 0 | 0 |
5 | hsa3763 ( potassium voltage-gated channel subfamily J member 6 ) | 0.553401 | 0 | 0 | 0 | 0 |
6 | hsa56659 ( potassium two pore domain channel subfamily K member 13 ) | 0.540849 | 0 | 0 | 0 | 0 |
7 | hsa6530 ( solute carrier family 6 member 2 ) | 0.53971 | 0 | 0 | 0 | 0 |
8 | hsa3739 ( potassium voltage-gated channel subfamily A member 4 ) | 0.520876 | 0 | 0 | 0 | 0 |
9 | hsa1080 ( cystic fibrosis transmembrane conductance regulator ) | 0.513396 | 0 | 0 | 0 | 0 |
10 | hsa3784 ( potassium voltage-gated channel subfamily Q member 1 ) | 0.513281 | 0 | 0 | 0 | 0 |
Rank | Target | Score | Validated | KEGG | DrugBank | Matador |
---|---|---|---|---|---|---|
1 | hsa285242 ( 5-hydroxytryptamine receptor 3E ) | 0.963786 | 1 | 1 | 0 | 0 |
2 | hsa9177 ( 5-hydroxytryptamine receptor 3B ) | 0.955764 | 1 | 1 | 0 | 0 |
3 | hsa170572 ( 5-hydroxytryptamine receptor 3C ) | 0.905305 | 1 | 1 | 0 | 0 |
4 | hsa200909 ( 5-hydroxytryptamine receptor 3D ) | 0.900624 | 1 | 1 | 0 | 0 |
5 | hsa6530 ( solute carrier family 6 member 2 ) | 0.824518 | 1 | 0 | 1 | 0 |
6 | hsa6532 ( solute carrier family 6 member 4 ) | 0.810904 | 1 | 0 | 1 | 0 |
7 | hsa1135 ( cholinergic receptor nicotinic alpha 2 subunit ) | 0.798283 | 0 | 0 | 0 | 0 |
8 | hsa1141 ( cholinergic receptor nicotinic beta 2 subunit ) | 0.743091 | 0 | 0 | 0 | 0 |
9 | hsa3782 ( potassium calcium-activated channel subfamily N member 3 ) | 0.696825 | 0 | 0 | 0 | 0 |
10 | hsa6331 ( sodium voltage-gated channel alpha subunit 5 ) | 0.694978 | 0 | 0 | 0 | 0 |
Rank | Target | Score | Validated | KEGG | DrugBank | Matador |
---|---|---|---|---|---|---|
1 | hsa1135 ( cholinergic receptor nicotinic alpha 2 subunit ) | 0.941173 | 0 | 0 | 0 | 0 |
2 | hsa8973 ( cholinergic receptor nicotinic alpha 6 subunit ) | 0.893672 | 0 | 0 | 0 | 0 |
3 | hsa1136 ( cholinergic receptor nicotinic alpha 3 subunit ) | 0.8737 | 0 | 0 | 0 | 0 |
4 | hsa55584 ( cholinergic receptor nicotinic alpha 9 subunit ) | 0.848087 | 0 | 0 | 0 | 0 |
5 | hsa1137 ( cholinergic receptor nicotinic alpha 4 subunit ) | 0.846103 | 0 | 0 | 0 | 0 |
6 | hsa57053 ( cholinergic receptor nicotinic alpha 10 subunit ) | 0.841056 | 0 | 0 | 0 | 0 |
7 | hsa1134 ( cholinergic receptor nicotinic alpha 1 subunit ) | 0.809888 | 0 | 0 | 0 | 0 |
8 | hsa1145 ( cholinergic receptor nicotinic epsilon subunit ) | 0.80331 | 0 | 0 | 0 | 0 |
9 | hsa3359 ( 5-hydroxytryptamine receptor 3A ) | 0.789439 | 0 | 0 | 0 | 0 |
10 | hsa1139 ( cholinergic receptor nicotinic alpha 7 subunit ) | 0.788762 | 0 | 0 | 0 | 0 |
Rank | Target | Score | Validated | KEGG | DrugBank | Matador |
---|---|---|---|---|---|---|
1 | hsa3767 ( potassium voltage-gated channel subfamily J member 11 ) | 0.948154 | 1 | 0 | 1 | 0 |
2 | hsa6833 ( ATP binding cassette subfamily C member 8 ) | 0.915822 | 1 | 1 | 1 | 0 |
3 | hsa1080 ( cystic fibrosis transmembrane conductance regulator ) | 0.779849 | 0 | 0 | 0 | 0 |
4 | hsa3757 ( potassium voltage-gated channel subfamily H member 2 ) | 0.750197 | 0 | 0 | 0 | 0 |
5 | hsa3782 ( potassium calcium-activated channel subfamily N member 3 ) | 0.736279 | 0 | 0 | 0 | 0 |
6 | hsa3763 ( potassium voltage-gated channel subfamily J member 6 ) | 0.729443 | 0 | 0 | 0 | 0 |
7 | hsa3781 ( potassium calcium-activated channel subfamily N member 2 ) | 0.679748 | 0 | 0 | 0 | 0 |
8 | hsa6331 ( sodium voltage-gated channel alpha subunit 5 ) | 0.673584 | 0 | 0 | 0 | 0 |
9 | hsa3778 ( potassium calcium-activated channel subfamily M alpha 1 ) | 0.673051 | 0 | 0 | 0 | 0 |
10 | hsa6530 ( solute carrier family 6 member 2 ) | 0.663718 | 0 | 0 | 0 | 0 |
Rank | Target | Score | Validated | KEGG | DrugBank | Matador |
---|---|---|---|---|---|---|
1 | hsa3767 ( potassium voltage-gated channel subfamily J member 11 ) | 0.92645 | 0 | 0 | 0 | 0 |
2 | hsa6833 ( ATP binding cassette subfamily C member 8 ) | 0.883678 | 1 | 1 | 1 | 0 |
3 | hsa3763 ( potassium voltage-gated channel subfamily J member 6 ) | 0.816168 | 0 | 0 | 0 | 0 |
4 | hsa3782 ( potassium calcium-activated channel subfamily N member 3 ) | 0.771734 | 0 | 0 | 0 | 0 |
5 | hsa6331 ( sodium voltage-gated channel alpha subunit 5 ) | 0.750972 | 0 | 0 | 0 | 0 |
6 | hsa3757 ( potassium voltage-gated channel subfamily H member 2 ) | 0.73785 | 0 | 0 | 0 | 0 |
7 | hsa3781 ( potassium calcium-activated channel subfamily N member 2 ) | 0.719494 | 0 | 0 | 0 | 0 |
8 | hsa1080 ( cystic fibrosis transmembrane conductance regulator ) | 0.71626 | 0 | 0 | 0 | 0 |
9 | hsa3778 ( potassium calcium-activated channel subfamily M alpha 1 ) | 0.682454 | 0 | 0 | 0 | 0 |
10 | hsa6530 ( solute carrier family 6 member 2 ) | 0.665537 | 0 | 0 | 0 | 0 |
Rank | Target | Score | Validated | KEGG | DrugBank | Matador |
---|---|---|---|---|---|---|
1 | hsa6532 ( solute carrier family 6 member 4 ) | 0.965793 | 0 | 0 | 0 | 0 |
2 | hsa6531 ( solute carrier family 6 member 3 ) | 0.957051 | 0 | 0 | 0 | 0 |
3 | hsa11254 ( solute carrier family 6 member 14 ) | 0.84161 | 0 | 0 | 0 | 0 |
4 | hsa6534 ( solute carrier family 6 member 7 ) | 0.817621 | 0 | 0 | 0 | 0 |
5 | hsa6529 ( solute carrier family 6 member 1 ) | 0.797115 | 0 | 0 | 0 | 0 |
6 | hsa1135 ( cholinergic receptor nicotinic alpha 2 subunit ) | 0.748788 | 0 | 0 | 0 | 0 |
7 | hsa2554 ( gamma-aminobutyric acid type A receptor alpha1 subunit ) | 0.742894 | 0 | 0 | 0 | 0 |
8 | hsa1141 ( cholinergic receptor nicotinic beta 2 subunit ) | 0.73025 | 0 | 0 | 0 | 0 |
9 | hsa3359 ( 5-hydroxytryptamine receptor 3A ) | 0.700722 | 0 | 0 | 0 | 0 |
10 | hsa3782 ( potassium calcium-activated channel subfamily N member 3 ) | 0.699118 | 0 | 0 | 0 | 0 |
Rank | Target | Score | Validated | KEGG | DrugBank | Matador |
---|---|---|---|---|---|---|
1 | hsa1141 ( cholinergic receptor nicotinic beta 2 subunit ) | 0.969627 | 1 | 1 | 0 | 1 |
2 | hsa1145 ( cholinergic receptor nicotinic epsilon subunit ) | 0.879936 | 1 | 1 | 0 | 1 |
3 | hsa3359 ( 5-hydroxytryptamine receptor 3A ) | 0.862807 | 0 | 0 | 0 | 0 |
4 | hsa2554 ( gamma-aminobutyric acid type A receptor alpha1 subunit ) | 0.795789 | 0 | 0 | 0 | 0 |
5 | hsa1144 ( cholinergic receptor nicotinic delta subunit ) | 0.771892 | 1 | 1 | 0 | 0 |
6 | hsa9312 ( potassium voltage-gated channel subfamily B member 2 ) | 0.714263 | 0 | 0 | 0 | 0 |
7 | hsa3752 ( potassium voltage-gated channel subfamily D member 3 ) | 0.712232 | 0 | 0 | 0 | 0 |
8 | hsa1140 ( cholinergic receptor nicotinic beta 1 subunit ) | 0.704974 | 1 | 1 | 0 | 0 |
9 | hsa9177 ( 5-hydroxytryptamine receptor 3B ) | 0.696377 | 0 | 0 | 0 | 0 |
10 | hsa285242 ( 5-hydroxytryptamine receptor 3E ) | 0.688184 | 0 | 0 | 0 | 0 |
Rank | Target | Score | Validated | KEGG | DrugBank | Matador |
---|---|---|---|---|---|---|
1 | hsa786 ( calcium voltage-gated channel auxiliary subunit gamma 1 ) | 0.94111 | 1 | 0 | 0 | 1 |
2 | hsa93589 ( calcium voltage-gated channel auxiliary subunit alpha2delta 4 ) | 0.92772 | 0 | 0 | 0 | 0 |
3 | hsa777 ( calcium voltage-gated channel subunit alpha1 E ) | 0.924116 | 0 | 0 | 0 | 0 |
4 | hsa783 ( calcium voltage-gated channel auxiliary subunit beta 2 ) | 0.921714 | 1 | 0 | 1 | 1 |
5 | hsa781 ( calcium voltage-gated channel auxiliary subunit alpha2delta 1 ) | 0.904916 | 1 | 0 | 1 | 0 |
6 | hsa774 ( calcium voltage-gated channel subunit alpha1 B ) | 0.874697 | 1 | 0 | 1 | 0 |
7 | hsa8912 ( calcium voltage-gated channel subunit alpha1 H ) | 0.873312 | 0 | 0 | 0 | 0 |
8 | hsa8911 ( calcium voltage-gated channel subunit alpha1 I ) | 0.865928 | 0 | 0 | 0 | 0 |
9 | hsa8913 ( calcium voltage-gated channel subunit alpha1 G ) | 0.855905 | 0 | 0 | 0 | 0 |
10 | hsa782 ( calcium voltage-gated channel auxiliary subunit beta 1 ) | 0.854774 | 0 | 0 | 0 | 0 |
Rank | Target | Score | Validated | KEGG | DrugBank | Matador |
---|---|---|---|---|---|---|
1 | hsa3743 ( potassium voltage-gated channel subfamily A member 7 ) | 0.938098 | 0 | 0 | 0 | 0 |
2 | hsa776 ( calcium voltage-gated channel subunit alpha1 D ) | 0.909023 | 1 | 1 | 0 | 0 |
3 | hsa773 ( calcium voltage-gated channel subunit alpha1 A ) | 0.902748 | 0 | 0 | 0 | 0 |
4 | hsa3739 ( potassium voltage-gated channel subfamily A member 4 ) | 0.902101 | 0 | 0 | 0 | 0 |
5 | hsa3744 ( potassium voltage-gated channel subfamily A member 10 ) | 0.869009 | 0 | 0 | 0 | 0 |
6 | hsa3747 ( potassium voltage-gated channel subfamily C member 2 ) | 0.836308 | 0 | 0 | 0 | 0 |
7 | hsa2554 ( gamma-aminobutyric acid type A receptor alpha1 subunit ) | 0.809855 | 0 | 0 | 0 | 0 |
8 | hsa9312 ( potassium voltage-gated channel subfamily B member 2 ) | 0.798466 | 0 | 0 | 0 | 0 |
9 | hsa3763 ( potassium voltage-gated channel subfamily J member 6 ) | 0.771478 | 0 | 0 | 0 | 0 |
10 | hsa2890 ( glutamate ionotropic receptor AMPA type subunit 1 ) | 0.733536 | 0 | 0 | 0 | 0 |
Rank | Target | Score | Validated | KEGG | DrugBank | Matador |
---|---|---|---|---|---|---|
1 | hsa786 ( calcium voltage-gated channel auxiliary subunit gamma 1 ) | 0.916038 | 0 | 0 | 0 | 0 |
2 | hsa777 ( calcium voltage-gated channel subunit alpha1 E ) | 0.910829 | 0 | 0 | 0 | 0 |
3 | hsa93589 ( calcium voltage-gated channel auxiliary subunit alpha2delta 4 ) | 0.901247 | 0 | 0 | 0 | 0 |
4 | hsa783 ( calcium voltage-gated channel auxiliary subunit beta 2 ) | 0.89464 | 1 | 0 | 1 | 0 |
5 | hsa3738 ( potassium voltage-gated channel subfamily A member 3 ) | 0.893225 | 0 | 0 | 0 | 0 |
6 | hsa781 ( calcium voltage-gated channel auxiliary subunit alpha2delta 1 ) | 0.872893 | 1 | 0 | 1 | 0 |
7 | hsa3741 ( potassium voltage-gated channel subfamily A member 5 ) | 0.852872 | 0 | 0 | 0 | 0 |
8 | hsa774 ( calcium voltage-gated channel subunit alpha1 B ) | 0.84336 | 0 | 0 | 0 | 0 |
9 | hsa8912 ( calcium voltage-gated channel subunit alpha1 H ) | 0.837343 | 0 | 0 | 0 | 0 |
10 | hsa3743 ( potassium voltage-gated channel subfamily A member 7 ) | 0.835671 | 0 | 0 | 0 | 0 |
Rank | Target | Score | Validated | KEGG | DrugBank | Matador |
---|---|---|---|---|---|---|
1 | hsa3783 ( potassium calcium-activated channel subfamily N member 4 ) | 0.694272 | 0 | 0 | 0 | 0 |
2 | hsa3778 ( potassium calcium-activated channel subfamily M alpha 1 ) | 0.655559 | 0 | 0 | 0 | 0 |
3 | hsa3757 ( potassium voltage-gated channel subfamily H member 2 ) | 0.647692 | 0 | 0 | 0 | 0 |
4 | hsa3739 ( potassium voltage-gated channel subfamily A member 4 ) | 0.579472 | 0 | 0 | 0 | 0 |
5 | hsa56659 ( potassium two pore domain channel subfamily K member 13 ) | 0.559771 | 0 | 0 | 0 | 0 |
6 | hsa3758 ( potassium voltage-gated channel subfamily J member 1 ) | 0.553701 | 0 | 0 | 0 | 0 |
7 | hsa6340 ( sodium channel epithelial 1 gamma subunit ) | 0.546757 | 0 | 0 | 0 | 0 |
8 | hsa6530 ( solute carrier family 6 member 2 ) | 0.53538 | 0 | 0 | 0 | 0 |
9 | hsa3763 ( potassium voltage-gated channel subfamily J member 6 ) | 0.533067 | 0 | 0 | 0 | 0 |
10 | hsa6324 ( sodium voltage-gated channel beta subunit 1 ) | 0.519301 | 0 | 0 | 0 | 0 |
Rank | Target | Score | Validated | KEGG | DrugBank | Matador |
---|---|---|---|---|---|---|
1 | hsa778 ( calcium voltage-gated channel subunit alpha1 F ) | 0.950995 | 1 | 1 | 1 | 1 |
2 | hsa3741 ( potassium voltage-gated channel subfamily A member 5 ) | 0.929047 | 1 | 0 | 0 | 1 |
3 | hsa3739 ( potassium voltage-gated channel subfamily A member 4 ) | 0.917527 | 1 | 0 | 0 | 1 |
4 | hsa773 ( calcium voltage-gated channel subunit alpha1 A ) | 0.902834 | 1 | 0 | 1 | 1 |
5 | hsa776 ( calcium voltage-gated channel subunit alpha1 D ) | 0.896146 | 1 | 1 | 1 | 1 |
6 | hsa3746 ( potassium voltage-gated channel subfamily C member 1 ) | 0.892087 | 1 | 0 | 0 | 1 |
7 | hsa3736 ( potassium voltage-gated channel subfamily A member 1 ) | 0.885799 | 1 | 0 | 0 | 1 |
8 | hsa3737 ( potassium voltage-gated channel subfamily A member 2 ) | 0.882314 | 1 | 0 | 0 | 1 |
9 | hsa3782 ( potassium calcium-activated channel subfamily N member 3 ) | 0.85526 | 1 | 0 | 0 | 1 |
10 | hsa3757 ( potassium voltage-gated channel subfamily H member 2 ) | 0.851592 | 1 | 0 | 1 | 1 |
Rank | Target | Score | Validated | KEGG | DrugBank | Matador |
---|---|---|---|---|---|---|
1 | hsa3783 ( potassium calcium-activated channel subfamily N member 4 ) | 0.701304 | 0 | 0 | 0 | 0 |
2 | hsa3757 ( potassium voltage-gated channel subfamily H member 2 ) | 0.676411 | 0 | 0 | 0 | 0 |
3 | hsa3778 ( potassium calcium-activated channel subfamily M alpha 1 ) | 0.650964 | 0 | 0 | 0 | 0 |
4 | hsa3739 ( potassium voltage-gated channel subfamily A member 4 ) | 0.61177 | 0 | 0 | 0 | 0 |
5 | hsa56659 ( potassium two pore domain channel subfamily K member 13 ) | 0.562142 | 0 | 0 | 0 | 0 |
6 | hsa3758 ( potassium voltage-gated channel subfamily J member 1 ) | 0.55467 | 0 | 0 | 0 | 0 |
7 | hsa3763 ( potassium voltage-gated channel subfamily J member 6 ) | 0.543686 | 0 | 0 | 0 | 0 |
8 | hsa3738 ( potassium voltage-gated channel subfamily A member 3 ) | 0.542654 | 0 | 0 | 0 | 0 |
9 | hsa6530 ( solute carrier family 6 member 2 ) | 0.540834 | 0 | 0 | 0 | 0 |
10 | hsa6340 ( sodium channel epithelial 1 gamma subunit ) | 0.518005 | 0 | 0 | 0 | 0 |
Rank | Target | Score | Validated | KEGG | DrugBank | Matador |
---|---|---|---|---|---|---|
1 | hsa3782 ( potassium calcium-activated channel subfamily N member 3 ) | 0.87222 | 0 | 0 | 0 | 0 |
2 | hsa3781 ( potassium calcium-activated channel subfamily N member 2 ) | 0.858448 | 0 | 0 | 0 | 0 |
3 | hsa3784 ( potassium voltage-gated channel subfamily Q member 1 ) | 0.855338 | 1 | 1 | 1 | 0 |
4 | hsa3763 ( potassium voltage-gated channel subfamily J member 6 ) | 0.834299 | 0 | 0 | 0 | 0 |
5 | hsa6530 ( solute carrier family 6 member 2 ) | 0.808199 | 0 | 0 | 0 | 0 |
6 | hsa3778 ( potassium calcium-activated channel subfamily M alpha 1 ) | 0.805932 | 0 | 0 | 0 | 0 |
7 | hsa3767 ( potassium voltage-gated channel subfamily J member 11 ) | 0.772409 | 1 | 1 | 0 | 0 |
8 | hsa6532 ( solute carrier family 6 member 4 ) | 0.771533 | 0 | 0 | 0 | 0 |
9 | hsa3758 ( potassium voltage-gated channel subfamily J member 1 ) | 0.764415 | 0 | 0 | 0 | 0 |
10 | hsa6331 ( sodium voltage-gated channel alpha subunit 5 ) | 0.752413 | 0 | 0 | 0 | 0 |
Rank | Target | Score | Validated | KEGG | DrugBank | Matador |
---|---|---|---|---|---|---|
1 | hsa6331 ( sodium voltage-gated channel alpha subunit 5 ) | 0.802381 | 0 | 0 | 0 | 0 |
2 | hsa6336 ( sodium voltage-gated channel alpha subunit 10 ) | 0.726925 | 0 | 0 | 0 | 0 |
3 | hsa6323 ( sodium voltage-gated channel alpha subunit 1 ) | 0.697565 | 0 | 0 | 0 | 0 |
4 | hsa6328 ( sodium voltage-gated channel alpha subunit 3 ) | 0.695836 | 0 | 0 | 0 | 0 |
5 | hsa1135 ( cholinergic receptor nicotinic alpha 2 subunit ) | 0.686825 | 0 | 0 | 0 | 0 |
6 | hsa6329 ( sodium voltage-gated channel alpha subunit 4 ) | 0.686778 | 0 | 0 | 0 | 0 |
7 | hsa6261 ( ryanodine receptor 1 ) | 0.683828 | 0 | 0 | 0 | 0 |
8 | hsa1141 ( cholinergic receptor nicotinic beta 2 subunit ) | 0.676776 | 0 | 0 | 0 | 0 |
9 | hsa2741 ( glycine receptor alpha 1 ) | 0.673835 | 0 | 0 | 0 | 0 |
10 | hsa8001 ( glycine receptor alpha 3 ) | 0.664989 | 0 | 0 | 0 | 0 |
Rank | Target | Score | Validated | KEGG | DrugBank | Matador |
---|---|---|---|---|---|---|
1 | hsa3741 ( potassium voltage-gated channel subfamily A member 5 ) | 0.940225 | 0 | 0 | 0 | 0 |
2 | hsa3738 ( potassium voltage-gated channel subfamily A member 3 ) | 0.920528 | 0 | 0 | 0 | 0 |
3 | hsa3744 ( potassium voltage-gated channel subfamily A member 10 ) | 0.891493 | 0 | 0 | 0 | 0 |
4 | hsa3736 ( potassium voltage-gated channel subfamily A member 1 ) | 0.884539 | 0 | 0 | 0 | 0 |
5 | hsa3737 ( potassium voltage-gated channel subfamily A member 2 ) | 0.86173 | 0 | 0 | 0 | 0 |
6 | hsa3739 ( potassium voltage-gated channel subfamily A member 4 ) | 0.8549 | 0 | 0 | 0 | 0 |
7 | hsa3746 ( potassium voltage-gated channel subfamily C member 1 ) | 0.833729 | 0 | 0 | 0 | 0 |
8 | hsa3763 ( potassium voltage-gated channel subfamily J member 6 ) | 0.82249 | 0 | 0 | 0 | 0 |
9 | hsa6331 ( sodium voltage-gated channel alpha subunit 5 ) | 0.821237 | 0 | 0 | 0 | 0 |
10 | hsa3747 ( potassium voltage-gated channel subfamily C member 2 ) | 0.806464 | 0 | 0 | 0 | 0 |
Rank | Target | Score | Validated | KEGG | DrugBank | Matador |
---|---|---|---|---|---|---|
1 | hsa6336 ( sodium voltage-gated channel alpha subunit 10 ) | 0.951505 | 0 | 0 | 0 | 0 |
2 | hsa8645 ( potassium two pore domain channel subfamily K member 5 ) | 0.92935 | 0 | 0 | 0 | 0 |
3 | hsa3738 ( potassium voltage-gated channel subfamily A member 3 ) | 0.88519 | 0 | 0 | 0 | 0 |
4 | hsa3739 ( potassium voltage-gated channel subfamily A member 4 ) | 0.808794 | 0 | 0 | 0 | 0 |
5 | hsa3763 ( potassium voltage-gated channel subfamily J member 6 ) | 0.799033 | 0 | 0 | 0 | 0 |
6 | hsa3744 ( potassium voltage-gated channel subfamily A member 10 ) | 0.747488 | 0 | 0 | 0 | 0 |
7 | hsa6332 ( sodium voltage-gated channel alpha subunit 7 ) | 0.710233 | 0 | 0 | 0 | 0 |
8 | hsa3758 ( potassium voltage-gated channel subfamily J member 1 ) | 0.704492 | 0 | 0 | 0 | 0 |
9 | hsa2554 ( gamma-aminobutyric acid type A receptor alpha1 subunit ) | 0.703214 | 0 | 0 | 0 | 0 |
10 | hsa3752 ( potassium voltage-gated channel subfamily D member 3 ) | 0.700993 | 1 | 1 | 0 | 0 |
Rank | Target | Score | Validated | KEGG | DrugBank | Matador |
---|---|---|---|---|---|---|
1 | hsa6336 ( sodium voltage-gated channel alpha subunit 10 ) | 0.978837 | 1 | 0 | 0 | 1 |
2 | hsa8645 ( potassium two pore domain channel subfamily K member 5 ) | 0.952055 | 0 | 0 | 0 | 0 |
3 | hsa3741 ( potassium voltage-gated channel subfamily A member 5 ) | 0.81315 | 0 | 0 | 0 | 0 |
4 | hsa6332 ( sodium voltage-gated channel alpha subunit 7 ) | 0.793518 | 1 | 0 | 0 | 1 |
5 | hsa8913 ( calcium voltage-gated channel subunit alpha1 G ) | 0.750014 | 0 | 0 | 0 | 0 |
6 | hsa3763 ( potassium voltage-gated channel subfamily J member 6 ) | 0.717781 | 0 | 0 | 0 | 0 |
7 | hsa11280 ( sodium voltage-gated channel alpha subunit 11 ) | 0.69626 | 0 | 0 | 0 | 0 |
8 | hsa3758 ( potassium voltage-gated channel subfamily J member 1 ) | 0.659314 | 0 | 0 | 0 | 0 |
9 | hsa3743 ( potassium voltage-gated channel subfamily A member 7 ) | 0.651215 | 0 | 0 | 0 | 0 |
10 | hsa8911 ( calcium voltage-gated channel subunit alpha1 I ) | 0.612249 | 0 | 0 | 0 | 0 |
Rank | Target | Score | Validated | KEGG | DrugBank | Matador |
---|---|---|---|---|---|---|
1 | hsa6336 ( sodium voltage-gated channel alpha subunit 10 ) | 0.957755 | 0 | 0 | 0 | 0 |
2 | hsa3763 ( potassium voltage-gated channel subfamily J member 6 ) | 0.810058 | 0 | 0 | 0 | 0 |
3 | hsa3743 ( potassium voltage-gated channel subfamily A member 7 ) | 0.786655 | 0 | 0 | 0 | 0 |
4 | hsa3782 ( potassium calcium-activated channel subfamily N member 3 ) | 0.714586 | 0 | 0 | 0 | 0 |
5 | hsa3758 ( potassium voltage-gated channel subfamily J member 1 ) | 0.712433 | 0 | 0 | 0 | 0 |
6 | hsa54207 ( potassium two pore domain channel subfamily K member 10 ) | 0.687058 | 0 | 0 | 0 | 0 |
7 | hsa6332 ( sodium voltage-gated channel alpha subunit 7 ) | 0.679643 | 0 | 0 | 0 | 0 |
8 | hsa9424 ( potassium two pore domain channel subfamily K member 6 ) | 0.673947 | 0 | 0 | 0 | 0 |
9 | hsa3781 ( potassium calcium-activated channel subfamily N member 2 ) | 0.671973 | 0 | 0 | 0 | 0 |
10 | hsa3738 ( potassium voltage-gated channel subfamily A member 3 ) | 0.671326 | 0 | 0 | 0 | 0 |
Rank | Target | Score | Validated | KEGG | DrugBank | Matador |
---|---|---|---|---|---|---|
1 | hsa6336 ( sodium voltage-gated channel alpha subunit 10 ) | 0.907586 | 0 | 0 | 0 | 0 |
2 | hsa3738 ( potassium voltage-gated channel subfamily A member 3 ) | 0.899129 | 0 | 0 | 0 | 0 |
3 | hsa3757 ( potassium voltage-gated channel subfamily H member 2 ) | 0.889687 | 1 | 0 | 1 | 0 |
4 | hsa9312 ( potassium voltage-gated channel subfamily B member 2 ) | 0.807111 | 0 | 0 | 0 | 0 |
5 | hsa3737 ( potassium voltage-gated channel subfamily A member 2 ) | 0.794827 | 0 | 0 | 0 | 0 |
6 | hsa3736 ( potassium voltage-gated channel subfamily A member 1 ) | 0.790506 | 0 | 0 | 0 | 0 |
7 | hsa3746 ( potassium voltage-gated channel subfamily C member 1 ) | 0.744829 | 0 | 0 | 0 | 0 |
8 | hsa3744 ( potassium voltage-gated channel subfamily A member 10 ) | 0.736237 | 0 | 0 | 0 | 0 |
9 | hsa3763 ( potassium voltage-gated channel subfamily J member 6 ) | 0.731125 | 0 | 0 | 0 | 0 |
10 | hsa3758 ( potassium voltage-gated channel subfamily J member 1 ) | 0.717802 | 0 | 0 | 0 | 0 |
Rank | Target | Score | Validated | KEGG | DrugBank | Matador |
---|---|---|---|---|---|---|
1 | hsa9424 ( potassium two pore domain channel subfamily K member 6 ) | 0.862996 | 0 | 0 | 0 | 0 |
2 | hsa54207 ( potassium two pore domain channel subfamily K member 10 ) | 0.862872 | 0 | 0 | 0 | 0 |
3 | hsa3756 ( potassium voltage-gated channel subfamily H member 1 ) | 0.859274 | 0 | 0 | 0 | 0 |
4 | hsa83795 ( potassium two pore domain channel subfamily K member 16 ) | 0.80294 | 0 | 0 | 0 | 0 |
5 | hsa8645 ( potassium two pore domain channel subfamily K member 5 ) | 0.797808 | 0 | 0 | 0 | 0 |
6 | hsa90134 ( potassium voltage-gated channel subfamily H member 7 ) | 0.746961 | 0 | 0 | 0 | 0 |
7 | hsa6331 ( sodium voltage-gated channel alpha subunit 5 ) | 0.743062 | 0 | 0 | 0 | 0 |
8 | hsa3743 ( potassium voltage-gated channel subfamily A member 7 ) | 0.731479 | 0 | 0 | 0 | 0 |
9 | hsa81033 ( potassium voltage-gated channel subfamily H member 6 ) | 0.725576 | 0 | 0 | 0 | 0 |
10 | hsa3778 ( potassium calcium-activated channel subfamily M alpha 1 ) | 0.722758 | 0 | 0 | 0 | 0 |
Rank | Target | Score | Validated | KEGG | DrugBank | Matador |
---|---|---|---|---|---|---|
1 | hsa27133 ( potassium voltage-gated channel subfamily H member 5 ) | 0.882406 | 0 | 0 | 0 | 0 |
2 | hsa779 ( calcium voltage-gated channel subunit alpha1 S ) | 0.861544 | 0 | 0 | 0 | 0 |
3 | hsa3758 ( potassium voltage-gated channel subfamily J member 1 ) | 0.844301 | 0 | 0 | 0 | 0 |
4 | hsa778 ( calcium voltage-gated channel subunit alpha1 F ) | 0.840006 | 0 | 0 | 0 | 0 |
5 | hsa776 ( calcium voltage-gated channel subunit alpha1 D ) | 0.837741 | 0 | 0 | 0 | 0 |
6 | hsa783 ( calcium voltage-gated channel auxiliary subunit beta 2 ) | 0.818083 | 0 | 0 | 0 | 0 |
7 | hsa3756 ( potassium voltage-gated channel subfamily H member 1 ) | 0.771487 | 0 | 0 | 0 | 0 |
8 | hsa3738 ( potassium voltage-gated channel subfamily A member 3 ) | 0.757339 | 0 | 0 | 0 | 0 |
9 | hsa3744 ( potassium voltage-gated channel subfamily A member 10 ) | 0.756396 | 0 | 0 | 0 | 0 |
10 | hsa773 ( calcium voltage-gated channel subunit alpha1 A ) | 0.753698 | 0 | 0 | 0 | 0 |
Rank | Target | Score | Validated | KEGG | DrugBank | Matador |
---|---|---|---|---|---|---|
1 | hsa6330 ( sodium voltage-gated channel beta subunit 4 ) | 0.930276 | 1 | 0 | 0 | 1 |
2 | hsa8911 ( calcium voltage-gated channel subunit alpha1 I ) | 0.929398 | 1 | 0 | 0 | 1 |
3 | hsa55800 ( sodium voltage-gated channel beta subunit 3 ) | 0.899396 | 1 | 0 | 0 | 1 |
4 | hsa6324 ( sodium voltage-gated channel beta subunit 1 ) | 0.845717 | 1 | 0 | 0 | 1 |
5 | hsa6332 ( sodium voltage-gated channel alpha subunit 7 ) | 0.834395 | 1 | 0 | 0 | 1 |
6 | hsa6336 ( sodium voltage-gated channel alpha subunit 10 ) | 0.751104 | 1 | 0 | 0 | 1 |
7 | hsa1141 ( cholinergic receptor nicotinic beta 2 subunit ) | 0.750113 | 0 | 0 | 0 | 0 |
8 | hsa1135 ( cholinergic receptor nicotinic alpha 2 subunit ) | 0.742095 | 0 | 0 | 0 | 0 |
9 | hsa6530 ( solute carrier family 6 member 2 ) | 0.703903 | 0 | 0 | 0 | 0 |
10 | hsa6331 ( sodium voltage-gated channel alpha subunit 5 ) | 0.690101 | 0 | 0 | 0 | 0 |
Rank | Target | Score | Validated | KEGG | DrugBank | Matador |
---|---|---|---|---|---|---|
1 | hsa2891 ( glutamate ionotropic receptor AMPA type subunit 2 ) | 0.845259 | 0 | 0 | 0 | 0 |
2 | hsa3758 ( potassium voltage-gated channel subfamily J member 1 ) | 0.761797 | 0 | 0 | 0 | 0 |
3 | hsa2554 ( gamma-aminobutyric acid type A receptor alpha1 subunit ) | 0.761578 | 0 | 0 | 0 | 0 |
4 | hsa3763 ( potassium voltage-gated channel subfamily J member 6 ) | 0.760287 | 0 | 0 | 0 | 0 |
5 | hsa3757 ( potassium voltage-gated channel subfamily H member 2 ) | 0.706386 | 0 | 0 | 0 | 0 |
6 | hsa9132 ( potassium voltage-gated channel subfamily Q member 4 ) | 0.692748 | 0 | 0 | 0 | 0 |
7 | hsa3784 ( potassium voltage-gated channel subfamily Q member 1 ) | 0.686765 | 0 | 0 | 0 | 0 |
8 | hsa2890 ( glutamate ionotropic receptor AMPA type subunit 1 ) | 0.677925 | 0 | 0 | 0 | 0 |
9 | hsa3782 ( potassium calcium-activated channel subfamily N member 3 ) | 0.672041 | 0 | 0 | 0 | 0 |
10 | hsa3781 ( potassium calcium-activated channel subfamily N member 2 ) | 0.653517 | 0 | 0 | 0 | 0 |
Rank | Target | Score | Validated | KEGG | DrugBank | Matador |
---|---|---|---|---|---|---|
1 | hsa2891 ( glutamate ionotropic receptor AMPA type subunit 2 ) | 0.843834 | 0 | 0 | 0 | 0 |
2 | hsa2554 ( gamma-aminobutyric acid type A receptor alpha1 subunit ) | 0.807249 | 0 | 0 | 0 | 0 |
3 | hsa3758 ( potassium voltage-gated channel subfamily J member 1 ) | 0.755992 | 0 | 0 | 0 | 0 |
4 | hsa3763 ( potassium voltage-gated channel subfamily J member 6 ) | 0.744324 | 0 | 0 | 0 | 0 |
5 | hsa2890 ( glutamate ionotropic receptor AMPA type subunit 1 ) | 0.693932 | 0 | 0 | 0 | 0 |
6 | hsa3757 ( potassium voltage-gated channel subfamily H member 2 ) | 0.679911 | 0 | 0 | 0 | 0 |
7 | hsa9132 ( potassium voltage-gated channel subfamily Q member 4 ) | 0.679556 | 0 | 0 | 0 | 0 |
8 | hsa3784 ( potassium voltage-gated channel subfamily Q member 1 ) | 0.672786 | 0 | 0 | 0 | 0 |
9 | hsa3782 ( potassium calcium-activated channel subfamily N member 3 ) | 0.670145 | 0 | 0 | 0 | 0 |
10 | hsa3781 ( potassium calcium-activated channel subfamily N member 2 ) | 0.654907 | 0 | 0 | 0 | 0 |
Rank | Target | Score | Validated | KEGG | DrugBank | Matador |
---|---|---|---|---|---|---|
1 | hsa2891 ( glutamate ionotropic receptor AMPA type subunit 2 ) | 0.84915 | 0 | 0 | 0 | 0 |
2 | hsa3758 ( potassium voltage-gated channel subfamily J member 1 ) | 0.760948 | 0 | 0 | 0 | 0 |
3 | hsa3763 ( potassium voltage-gated channel subfamily J member 6 ) | 0.756197 | 0 | 0 | 0 | 0 |
4 | hsa2554 ( gamma-aminobutyric acid type A receptor alpha1 subunit ) | 0.746746 | 0 | 0 | 0 | 0 |
5 | hsa9132 ( potassium voltage-gated channel subfamily Q member 4 ) | 0.690577 | 0 | 0 | 0 | 0 |
6 | hsa3757 ( potassium voltage-gated channel subfamily H member 2 ) | 0.686886 | 0 | 0 | 0 | 0 |
7 | hsa2890 ( glutamate ionotropic receptor AMPA type subunit 1 ) | 0.686665 | 0 | 0 | 0 | 0 |
8 | hsa3784 ( potassium voltage-gated channel subfamily Q member 1 ) | 0.674881 | 0 | 0 | 0 | 0 |
9 | hsa3782 ( potassium calcium-activated channel subfamily N member 3 ) | 0.664413 | 0 | 0 | 0 | 0 |
10 | hsa3781 ( potassium calcium-activated channel subfamily N member 2 ) | 0.643153 | 0 | 0 | 0 | 0 |
Rank | Target | Score | Validated | KEGG | DrugBank | Matador |
---|---|---|---|---|---|---|
1 | hsa2891 ( glutamate ionotropic receptor AMPA type subunit 2 ) | 0.863935 | 0 | 0 | 0 | 0 |
2 | hsa3763 ( potassium voltage-gated channel subfamily J member 6 ) | 0.759263 | 0 | 0 | 0 | 0 |
3 | hsa3758 ( potassium voltage-gated channel subfamily J member 1 ) | 0.757327 | 0 | 0 | 0 | 0 |
4 | hsa2554 ( gamma-aminobutyric acid type A receptor alpha1 subunit ) | 0.748443 | 0 | 0 | 0 | 0 |
5 | hsa3757 ( potassium voltage-gated channel subfamily H member 2 ) | 0.702924 | 0 | 0 | 0 | 0 |
6 | hsa2890 ( glutamate ionotropic receptor AMPA type subunit 1 ) | 0.697838 | 0 | 0 | 0 | 0 |
7 | hsa9132 ( potassium voltage-gated channel subfamily Q member 4 ) | 0.694195 | 0 | 0 | 0 | 0 |
8 | hsa3784 ( potassium voltage-gated channel subfamily Q member 1 ) | 0.680313 | 0 | 0 | 0 | 0 |
9 | hsa3782 ( potassium calcium-activated channel subfamily N member 3 ) | 0.66176 | 0 | 0 | 0 | 0 |
10 | hsa3781 ( potassium calcium-activated channel subfamily N member 2 ) | 0.642297 | 0 | 0 | 0 | 0 |
Rank | Target | Score | Validated | KEGG | DrugBank | Matador |
---|---|---|---|---|---|---|
1 | hsa2891 ( glutamate ionotropic receptor AMPA type subunit 2 ) | 0.859855 | 0 | 0 | 0 | 0 |
2 | hsa3763 ( potassium voltage-gated channel subfamily J member 6 ) | 0.760016 | 0 | 0 | 0 | 0 |
3 | hsa3758 ( potassium voltage-gated channel subfamily J member 1 ) | 0.758479 | 0 | 0 | 0 | 0 |
4 | hsa2554 ( gamma-aminobutyric acid type A receptor alpha1 subunit ) | 0.742657 | 0 | 0 | 0 | 0 |
5 | hsa3757 ( potassium voltage-gated channel subfamily H member 2 ) | 0.700154 | 0 | 0 | 0 | 0 |
6 | hsa9132 ( potassium voltage-gated channel subfamily Q member 4 ) | 0.693037 | 0 | 0 | 0 | 0 |
7 | hsa2890 ( glutamate ionotropic receptor AMPA type subunit 1 ) | 0.689712 | 0 | 0 | 0 | 0 |
8 | hsa3784 ( potassium voltage-gated channel subfamily Q member 1 ) | 0.681732 | 0 | 0 | 0 | 0 |
9 | hsa3782 ( potassium calcium-activated channel subfamily N member 3 ) | 0.664112 | 0 | 0 | 0 | 0 |
10 | hsa3781 ( potassium calcium-activated channel subfamily N member 2 ) | 0.643127 | 0 | 0 | 0 | 0 |
Rank | Target | Score | Validated | KEGG | DrugBank | Matador |
---|---|---|---|---|---|---|
1 | hsa6331 ( sodium voltage-gated channel alpha subunit 5 ) | 0.766479 | 0 | 0 | 0 | 0 |
2 | hsa2741 ( glycine receptor alpha 1 ) | 0.725745 | 0 | 0 | 0 | 0 |
3 | hsa1135 ( cholinergic receptor nicotinic alpha 2 subunit ) | 0.724831 | 0 | 0 | 0 | 0 |
4 | hsa3758 ( potassium voltage-gated channel subfamily J member 1 ) | 0.714335 | 0 | 0 | 0 | 0 |
5 | hsa8001 ( glycine receptor alpha 3 ) | 0.711826 | 0 | 0 | 0 | 0 |
6 | hsa2742 ( glycine receptor alpha 2 ) | 0.703551 | 0 | 0 | 0 | 0 |
7 | hsa1141 ( cholinergic receptor nicotinic beta 2 subunit ) | 0.698444 | 0 | 0 | 0 | 0 |
8 | hsa6530 ( solute carrier family 6 member 2 ) | 0.69231 | 0 | 0 | 0 | 0 |
9 | hsa6261 ( ryanodine receptor 1 ) | 0.678368 | 0 | 0 | 0 | 0 |
10 | hsa6532 ( solute carrier family 6 member 4 ) | 0.671329 | 0 | 0 | 0 | 0 |
Rank | Target | Score | Validated | KEGG | DrugBank | Matador |
---|---|---|---|---|---|---|
1 | hsa3782 ( potassium calcium-activated channel subfamily N member 3 ) | 0.7809 | 0 | 0 | 0 | 0 |
2 | hsa6530 ( solute carrier family 6 member 2 ) | 0.742269 | 0 | 0 | 0 | 0 |
3 | hsa3781 ( potassium calcium-activated channel subfamily N member 2 ) | 0.74172 | 0 | 0 | 0 | 0 |
4 | hsa1135 ( cholinergic receptor nicotinic alpha 2 subunit ) | 0.733133 | 0 | 0 | 0 | 0 |
5 | hsa6532 ( solute carrier family 6 member 4 ) | 0.72381 | 0 | 0 | 0 | 0 |
6 | hsa6261 ( ryanodine receptor 1 ) | 0.700444 | 0 | 0 | 0 | 0 |
7 | hsa1141 ( cholinergic receptor nicotinic beta 2 subunit ) | 0.693932 | 0 | 0 | 0 | 0 |
8 | hsa6331 ( sodium voltage-gated channel alpha subunit 5 ) | 0.683659 | 0 | 0 | 0 | 0 |
9 | hsa8001 ( glycine receptor alpha 3 ) | 0.679126 | 0 | 0 | 0 | 0 |
10 | hsa2741 ( glycine receptor alpha 1 ) | 0.6788 | 0 | 0 | 0 | 0 |
Rank | Target | Score | Validated | KEGG | DrugBank | Matador |
---|---|---|---|---|---|---|
1 | hsa2555 ( gamma-aminobutyric acid type A receptor alpha2 subunit ) | 0.956629 | 1 | 1 | 1 | 0 |
2 | hsa2558 ( gamma-aminobutyric acid type A receptor alpha5 subunit ) | 0.953429 | 1 | 1 | 1 | 0 |
3 | hsa2556 ( gamma-aminobutyric acid type A receptor alpha3 subunit ) | 0.953156 | 1 | 1 | 1 | 0 |
4 | hsa2557 ( gamma-aminobutyric acid type A receptor alpha4 subunit ) | 0.951327 | 1 | 1 | 1 | 0 |
5 | hsa2559 ( gamma-aminobutyric acid type A receptor alpha6 subunit ) | 0.951048 | 1 | 1 | 1 | 0 |
6 | hsa2564 ( gamma-aminobutyric acid type A receptor epsilon subunit ) | 0.876394 | 1 | 1 | 1 | 0 |
7 | hsa2567 ( gamma-aminobutyric acid type A receptor gamma3 subunit ) | 0.873995 | 1 | 1 | 1 | 0 |
8 | hsa2566 ( gamma-aminobutyric acid type A receptor gamma2 subunit ) | 0.873689 | 1 | 1 | 1 | 0 |
9 | hsa55879 ( gamma-aminobutyric acid type A receptor theta subunit ) | 0.858162 | 1 | 1 | 1 | 0 |
10 | hsa2561 ( gamma-aminobutyric acid type A receptor beta2 subunit ) | 0.856419 | 1 | 1 | 1 | 0 |
Rank | Target | Score | Validated | KEGG | DrugBank | Matador |
---|---|---|---|---|---|---|
1 | hsa2555 ( gamma-aminobutyric acid type A receptor alpha2 subunit ) | 0.948773 | 1 | 1 | 1 | 0 |
2 | hsa2558 ( gamma-aminobutyric acid type A receptor alpha5 subunit ) | 0.945075 | 1 | 1 | 1 | 0 |
3 | hsa2556 ( gamma-aminobutyric acid type A receptor alpha3 subunit ) | 0.945029 | 1 | 1 | 1 | 0 |
4 | hsa2557 ( gamma-aminobutyric acid type A receptor alpha4 subunit ) | 0.942991 | 1 | 1 | 1 | 0 |
5 | hsa2559 ( gamma-aminobutyric acid type A receptor alpha6 subunit ) | 0.942567 | 1 | 1 | 1 | 0 |
6 | hsa2564 ( gamma-aminobutyric acid type A receptor epsilon subunit ) | 0.858136 | 1 | 1 | 1 | 0 |
7 | hsa2567 ( gamma-aminobutyric acid type A receptor gamma3 subunit ) | 0.85677 | 1 | 1 | 1 | 0 |
8 | hsa2566 ( gamma-aminobutyric acid type A receptor gamma2 subunit ) | 0.854583 | 1 | 1 | 1 | 0 |
9 | hsa55879 ( gamma-aminobutyric acid type A receptor theta subunit ) | 0.839268 | 1 | 1 | 1 | 0 |
10 | hsa2561 ( gamma-aminobutyric acid type A receptor beta2 subunit ) | 0.837985 | 1 | 1 | 1 | 0 |
Rank | Target | Score | Validated | KEGG | DrugBank | Matador |
---|---|---|---|---|---|---|
1 | hsa2555 ( gamma-aminobutyric acid type A receptor alpha2 subunit ) | 0.944619 | 1 | 0 | 1 | 0 |
2 | hsa2558 ( gamma-aminobutyric acid type A receptor alpha5 subunit ) | 0.941135 | 1 | 0 | 1 | 0 |
3 | hsa2556 ( gamma-aminobutyric acid type A receptor alpha3 subunit ) | 0.940424 | 1 | 0 | 1 | 0 |
4 | hsa2557 ( gamma-aminobutyric acid type A receptor alpha4 subunit ) | 0.938525 | 1 | 0 | 1 | 0 |
5 | hsa2559 ( gamma-aminobutyric acid type A receptor alpha6 subunit ) | 0.937808 | 1 | 0 | 1 | 0 |
6 | hsa2567 ( gamma-aminobutyric acid type A receptor gamma3 subunit ) | 0.838919 | 1 | 0 | 1 | 0 |
7 | hsa2566 ( gamma-aminobutyric acid type A receptor gamma2 subunit ) | 0.836938 | 1 | 0 | 1 | 0 |
8 | hsa2564 ( gamma-aminobutyric acid type A receptor epsilon subunit ) | 0.836588 | 1 | 0 | 1 | 0 |
9 | hsa2741 ( glycine receptor alpha 1 ) | 0.834024 | 0 | 0 | 0 | 0 |
10 | hsa55879 ( gamma-aminobutyric acid type A receptor theta subunit ) | 0.814066 | 1 | 0 | 1 | 0 |
Rank | Target | Score | Validated | KEGG | DrugBank | Matador |
---|---|---|---|---|---|---|
1 | hsa6323 ( sodium voltage-gated channel alpha subunit 1 ) | 0.961813 | 0 | 0 | 0 | 0 |
2 | hsa6336 ( sodium voltage-gated channel alpha subunit 10 ) | 0.955887 | 0 | 0 | 0 | 0 |
3 | hsa6328 ( sodium voltage-gated channel alpha subunit 3 ) | 0.95348 | 0 | 0 | 0 | 0 |
4 | hsa6329 ( sodium voltage-gated channel alpha subunit 4 ) | 0.949405 | 0 | 0 | 0 | 0 |
5 | hsa6326 ( sodium voltage-gated channel alpha subunit 2 ) | 0.936231 | 0 | 0 | 0 | 0 |
6 | hsa6334 ( sodium voltage-gated channel alpha subunit 8 ) | 0.932979 | 0 | 0 | 0 | 0 |
7 | hsa6335 ( sodium voltage-gated channel alpha subunit 9 ) | 0.923457 | 0 | 0 | 0 | 0 |
8 | hsa8645 ( potassium two pore domain channel subfamily K member 5 ) | 0.88546 | 0 | 0 | 0 | 0 |
9 | hsa2554 ( gamma-aminobutyric acid type A receptor alpha1 subunit ) | 0.727956 | 0 | 0 | 0 | 0 |
10 | hsa6332 ( sodium voltage-gated channel alpha subunit 7 ) | 0.71035 | 0 | 0 | 0 | 0 |
Rank | Target | Score | Validated | KEGG | DrugBank | Matador |
---|---|---|---|---|---|---|
1 | hsa6331 ( sodium voltage-gated channel alpha subunit 5 ) | 0.973636 | 0 | 0 | 0 | 0 |
2 | hsa6328 ( sodium voltage-gated channel alpha subunit 3 ) | 0.954678 | 0 | 0 | 0 | 0 |
3 | hsa6329 ( sodium voltage-gated channel alpha subunit 4 ) | 0.954436 | 0 | 0 | 0 | 0 |
4 | hsa8911 ( calcium voltage-gated channel subunit alpha1 I ) | 0.94641 | 0 | 0 | 0 | 0 |
5 | hsa6326 ( sodium voltage-gated channel alpha subunit 2 ) | 0.940374 | 0 | 0 | 0 | 0 |
6 | hsa6336 ( sodium voltage-gated channel alpha subunit 10 ) | 0.937299 | 0 | 0 | 0 | 0 |
7 | hsa8912 ( calcium voltage-gated channel subunit alpha1 H ) | 0.932226 | 0 | 0 | 0 | 0 |
8 | hsa6334 ( sodium voltage-gated channel alpha subunit 8 ) | 0.932147 | 0 | 0 | 0 | 0 |
9 | hsa6335 ( sodium voltage-gated channel alpha subunit 9 ) | 0.926393 | 0 | 0 | 0 | 0 |
10 | hsa8645 ( potassium two pore domain channel subfamily K member 5 ) | 0.852543 | 0 | 0 | 0 | 0 |
Rank | Target | Score | Validated | KEGG | DrugBank | Matador |
---|---|---|---|---|---|---|
1 | hsa2564 ( gamma-aminobutyric acid type A receptor epsilon subunit ) | 0.848193 | 1 | 0 | 0 | 1 |
2 | hsa2566 ( gamma-aminobutyric acid type A receptor gamma2 subunit ) | 0.843368 | 1 | 0 | 0 | 1 |
3 | hsa2567 ( gamma-aminobutyric acid type A receptor gamma3 subunit ) | 0.838687 | 1 | 0 | 0 | 1 |
4 | hsa1135 ( cholinergic receptor nicotinic alpha 2 subunit ) | 0.797821 | 1 | 0 | 0 | 1 |
5 | hsa55879 ( gamma-aminobutyric acid type A receptor theta subunit ) | 0.78541 | 1 | 0 | 0 | 1 |
6 | hsa2569 ( gamma-aminobutyric acid type A receptor rho1 subunit ) | 0.777286 | 1 | 0 | 0 | 1 |
7 | hsa2563 ( gamma-aminobutyric acid type A receptor delta subunit ) | 0.773667 | 1 | 0 | 0 | 1 |
8 | hsa2562 ( gamma-aminobutyric acid type A receptor beta3 subunit ) | 0.764346 | 1 | 0 | 0 | 1 |
9 | hsa2561 ( gamma-aminobutyric acid type A receptor beta2 subunit ) | 0.760914 | 1 | 0 | 0 | 1 |
10 | hsa2741 ( glycine receptor alpha 1 ) | 0.758519 | 0 | 0 | 0 | 0 |
Rank | Target | Score | Validated | KEGG | DrugBank | Matador |
---|---|---|---|---|---|---|
1 | hsa1138 ( cholinergic receptor nicotinic alpha 5 subunit ) | 0.955479 | 0 | 0 | 0 | 0 |
2 | hsa170572 ( 5-hydroxytryptamine receptor 3C ) | 0.790065 | 1 | 1 | 0 | 0 |
3 | hsa200909 ( 5-hydroxytryptamine receptor 3D ) | 0.784197 | 1 | 1 | 0 | 0 |
4 | hsa6331 ( sodium voltage-gated channel alpha subunit 5 ) | 0.775571 | 0 | 0 | 0 | 0 |
5 | hsa2554 ( gamma-aminobutyric acid type A receptor alpha1 subunit ) | 0.69478 | 0 | 0 | 0 | 0 |
6 | hsa6336 ( sodium voltage-gated channel alpha subunit 10 ) | 0.688024 | 0 | 0 | 0 | 0 |
7 | hsa6530 ( solute carrier family 6 member 2 ) | 0.683219 | 0 | 0 | 0 | 0 |
8 | hsa6323 ( sodium voltage-gated channel alpha subunit 1 ) | 0.672123 | 0 | 0 | 0 | 0 |
9 | hsa6532 ( solute carrier family 6 member 4 ) | 0.669418 | 0 | 0 | 0 | 0 |
10 | hsa3752 ( potassium voltage-gated channel subfamily D member 3 ) | 0.629975 | 0 | 0 | 0 | 0 |
Rank | Target | Score | Validated | KEGG | DrugBank | Matador |
---|---|---|---|---|---|---|
1 | hsa6332 ( sodium voltage-gated channel alpha subunit 7 ) | 0.786675 | 0 | 0 | 0 | 0 |
2 | hsa3741 ( potassium voltage-gated channel subfamily A member 5 ) | 0.774245 | 0 | 0 | 0 | 0 |
3 | hsa8913 ( calcium voltage-gated channel subunit alpha1 G ) | 0.718483 | 0 | 0 | 0 | 0 |
4 | hsa11280 ( sodium voltage-gated channel alpha subunit 11 ) | 0.705355 | 0 | 0 | 0 | 0 |
5 | hsa3763 ( potassium voltage-gated channel subfamily J member 6 ) | 0.674164 | 0 | 0 | 0 | 0 |
6 | hsa3359 ( 5-hydroxytryptamine receptor 3A ) | 0.658572 | 1 | 0 | 1 | 0 |
7 | hsa3758 ( potassium voltage-gated channel subfamily J member 1 ) | 0.648816 | 0 | 0 | 0 | 0 |
8 | hsa6261 ( ryanodine receptor 1 ) | 0.635026 | 0 | 0 | 0 | 0 |
9 | hsa6263 ( ryanodine receptor 3 ) | 0.603661 | 0 | 0 | 0 | 0 |
10 | hsa6530 ( solute carrier family 6 member 2 ) | 0.60005 | 0 | 0 | 0 | 0 |
Rank | Target | Score | Validated | KEGG | DrugBank | Matador |
---|---|---|---|---|---|---|
1 | hsa6328 ( sodium voltage-gated channel alpha subunit 3 ) | 0.958448 | 1 | 1 | 0 | 0 |
2 | hsa6323 ( sodium voltage-gated channel alpha subunit 1 ) | 0.957783 | 1 | 1 | 0 | 0 |
3 | hsa6329 ( sodium voltage-gated channel alpha subunit 4 ) | 0.954119 | 1 | 1 | 0 | 0 |
4 | hsa6326 ( sodium voltage-gated channel alpha subunit 2 ) | 0.931988 | 1 | 1 | 0 | 0 |
5 | hsa6334 ( sodium voltage-gated channel alpha subunit 8 ) | 0.929403 | 1 | 1 | 0 | 0 |
6 | hsa6335 ( sodium voltage-gated channel alpha subunit 9 ) | 0.916311 | 1 | 1 | 0 | 0 |
7 | hsa8645 ( potassium two pore domain channel subfamily K member 5 ) | 0.881059 | 0 | 0 | 0 | 0 |
8 | hsa6332 ( sodium voltage-gated channel alpha subunit 7 ) | 0.798135 | 0 | 0 | 0 | 0 |
9 | hsa8913 ( calcium voltage-gated channel subunit alpha1 G ) | 0.749136 | 0 | 0 | 0 | 0 |
10 | hsa6324 ( sodium voltage-gated channel beta subunit 1 ) | 0.736682 | 0 | 0 | 0 | 0 |
Rank | Target | Score | Validated | KEGG | DrugBank | Matador |
---|---|---|---|---|---|---|
1 | hsa3741 ( potassium voltage-gated channel subfamily A member 5 ) | 0.793749 | 0 | 0 | 0 | 0 |
2 | hsa6332 ( sodium voltage-gated channel alpha subunit 7 ) | 0.778477 | 0 | 0 | 0 | 0 |
3 | hsa8913 ( calcium voltage-gated channel subunit alpha1 G ) | 0.735858 | 0 | 0 | 0 | 0 |
4 | hsa3763 ( potassium voltage-gated channel subfamily J member 6 ) | 0.705718 | 0 | 0 | 0 | 0 |
5 | hsa11280 ( sodium voltage-gated channel alpha subunit 11 ) | 0.702767 | 0 | 0 | 0 | 0 |
6 | hsa3758 ( potassium voltage-gated channel subfamily J member 1 ) | 0.656499 | 0 | 0 | 0 | 0 |
7 | hsa3743 ( potassium voltage-gated channel subfamily A member 7 ) | 0.61861 | 0 | 0 | 0 | 0 |
8 | hsa3359 ( 5-hydroxytryptamine receptor 3A ) | 0.613417 | 0 | 0 | 0 | 0 |
9 | hsa6530 ( solute carrier family 6 member 2 ) | 0.602637 | 0 | 0 | 0 | 0 |
10 | hsa54207 ( potassium two pore domain channel subfamily K member 10 ) | 0.597125 | 0 | 0 | 0 | 0 |
Rank | Target | Score | Validated | KEGG | DrugBank | Matador |
---|---|---|---|---|---|---|
1 | hsa3741 ( potassium voltage-gated channel subfamily A member 5 ) | 0.827025 | 0 | 0 | 0 | 0 |
2 | hsa6332 ( sodium voltage-gated channel alpha subunit 7 ) | 0.788697 | 0 | 0 | 0 | 0 |
3 | hsa3763 ( potassium voltage-gated channel subfamily J member 6 ) | 0.746124 | 0 | 0 | 0 | 0 |
4 | hsa8913 ( calcium voltage-gated channel subunit alpha1 G ) | 0.71464 | 0 | 0 | 0 | 0 |
5 | hsa11280 ( sodium voltage-gated channel alpha subunit 11 ) | 0.699678 | 0 | 0 | 0 | 0 |
6 | hsa3758 ( potassium voltage-gated channel subfamily J member 1 ) | 0.67499 | 0 | 0 | 0 | 0 |
7 | hsa3743 ( potassium voltage-gated channel subfamily A member 7 ) | 0.649859 | 0 | 0 | 0 | 0 |
8 | hsa3752 ( potassium voltage-gated channel subfamily D member 3 ) | 0.623409 | 0 | 0 | 0 | 0 |
9 | hsa54207 ( potassium two pore domain channel subfamily K member 10 ) | 0.598822 | 0 | 0 | 0 | 0 |
10 | hsa3767 ( potassium voltage-gated channel subfamily J member 11 ) | 0.591468 | 0 | 0 | 0 | 0 |
Rank | Target | Score | Validated | KEGG | DrugBank | Matador |
---|---|---|---|---|---|---|
1 | hsa3741 ( potassium voltage-gated channel subfamily A member 5 ) | 0.807393 | 0 | 0 | 0 | 0 |
2 | hsa6332 ( sodium voltage-gated channel alpha subunit 7 ) | 0.775277 | 0 | 0 | 0 | 0 |
3 | hsa3763 ( potassium voltage-gated channel subfamily J member 6 ) | 0.719747 | 0 | 0 | 0 | 0 |
4 | hsa8913 ( calcium voltage-gated channel subunit alpha1 G ) | 0.719469 | 0 | 0 | 0 | 0 |
5 | hsa11280 ( sodium voltage-gated channel alpha subunit 11 ) | 0.694139 | 0 | 0 | 0 | 0 |
6 | hsa3758 ( potassium voltage-gated channel subfamily J member 1 ) | 0.664573 | 0 | 0 | 0 | 0 |
7 | hsa3743 ( potassium voltage-gated channel subfamily A member 7 ) | 0.634865 | 0 | 0 | 0 | 0 |
8 | hsa54207 ( potassium two pore domain channel subfamily K member 10 ) | 0.610832 | 0 | 0 | 0 | 0 |
9 | hsa3359 ( 5-hydroxytryptamine receptor 3A ) | 0.604227 | 0 | 0 | 0 | 0 |
10 | hsa3767 ( potassium voltage-gated channel subfamily J member 11 ) | 0.595692 | 0 | 0 | 0 | 0 |
Rank | Target | Score | Validated | KEGG | DrugBank | Matador |
---|---|---|---|---|---|---|
1 | hsa6332 ( sodium voltage-gated channel alpha subunit 7 ) | 0.783337 | 1 | 0 | 0 | 1 |
2 | hsa8913 ( calcium voltage-gated channel subunit alpha1 G ) | 0.763651 | 1 | 0 | 0 | 1 |
3 | hsa3741 ( potassium voltage-gated channel subfamily A member 5 ) | 0.721423 | 0 | 0 | 0 | 0 |
4 | hsa11280 ( sodium voltage-gated channel alpha subunit 11 ) | 0.693489 | 0 | 0 | 0 | 0 |
5 | hsa3758 ( potassium voltage-gated channel subfamily J member 1 ) | 0.657757 | 0 | 0 | 0 | 0 |
6 | hsa3763 ( potassium voltage-gated channel subfamily J member 6 ) | 0.639533 | 0 | 0 | 0 | 0 |
7 | hsa1080 ( cystic fibrosis transmembrane conductance regulator ) | 0.625766 | 0 | 0 | 0 | 0 |
8 | hsa8911 ( calcium voltage-gated channel subunit alpha1 I ) | 0.619775 | 1 | 0 | 0 | 1 |
9 | hsa3359 ( 5-hydroxytryptamine receptor 3A ) | 0.618011 | 1 | 0 | 1 | 1 |
10 | hsa6530 ( solute carrier family 6 member 2 ) | 0.574459 | 0 | 0 | 0 | 0 |
Rank | Target | Score | Validated | KEGG | DrugBank | Matador |
---|---|---|---|---|---|---|
1 | hsa6332 ( sodium voltage-gated channel alpha subunit 7 ) | 0.804028 | 0 | 0 | 0 | 0 |
2 | hsa3741 ( potassium voltage-gated channel subfamily A member 5 ) | 0.781855 | 0 | 0 | 0 | 0 |
3 | hsa8913 ( calcium voltage-gated channel subunit alpha1 G ) | 0.737496 | 0 | 0 | 0 | 0 |
4 | hsa11280 ( sodium voltage-gated channel alpha subunit 11 ) | 0.718388 | 0 | 0 | 0 | 0 |
5 | hsa3763 ( potassium voltage-gated channel subfamily J member 6 ) | 0.687548 | 0 | 0 | 0 | 0 |
6 | hsa3758 ( potassium voltage-gated channel subfamily J member 1 ) | 0.664202 | 0 | 0 | 0 | 0 |
7 | hsa6261 ( ryanodine receptor 1 ) | 0.612449 | 1 | 0 | 0 | 1 |
8 | hsa3359 ( 5-hydroxytryptamine receptor 3A ) | 0.612075 | 0 | 0 | 0 | 0 |
9 | hsa8911 ( calcium voltage-gated channel subunit alpha1 I ) | 0.598873 | 0 | 0 | 0 | 0 |
10 | hsa6530 ( solute carrier family 6 member 2 ) | 0.593462 | 0 | 0 | 0 | 0 |
Rank | Target | Score | Validated | KEGG | DrugBank | Matador |
---|---|---|---|---|---|---|
1 | hsa8973 ( cholinergic receptor nicotinic alpha 6 subunit ) | 0.959511 | 0 | 0 | 0 | 0 |
2 | hsa1136 ( cholinergic receptor nicotinic alpha 3 subunit ) | 0.950053 | 0 | 0 | 0 | 0 |
3 | hsa57053 ( cholinergic receptor nicotinic alpha 10 subunit ) | 0.948675 | 0 | 0 | 0 | 0 |
4 | hsa55584 ( cholinergic receptor nicotinic alpha 9 subunit ) | 0.943746 | 0 | 0 | 0 | 0 |
5 | hsa1141 ( cholinergic receptor nicotinic beta 2 subunit ) | 0.942496 | 0 | 0 | 0 | 0 |
6 | hsa1137 ( cholinergic receptor nicotinic alpha 4 subunit ) | 0.939167 | 0 | 0 | 0 | 0 |
7 | hsa1139 ( cholinergic receptor nicotinic alpha 7 subunit ) | 0.935586 | 0 | 0 | 0 | 0 |
8 | hsa1138 ( cholinergic receptor nicotinic alpha 5 subunit ) | 0.933353 | 0 | 0 | 0 | 0 |
9 | hsa1134 ( cholinergic receptor nicotinic alpha 1 subunit ) | 0.924952 | 1 | 1 | 0 | 0 |
10 | hsa3359 ( 5-hydroxytryptamine receptor 3A ) | 0.834391 | 0 | 0 | 0 | 0 |
Rank | Target | Score | Validated | KEGG | DrugBank | Matador |
---|---|---|---|---|---|---|
1 | hsa8973 ( cholinergic receptor nicotinic alpha 6 subunit ) | 0.957548 | 0 | 0 | 0 | 0 |
2 | hsa1136 ( cholinergic receptor nicotinic alpha 3 subunit ) | 0.947639 | 0 | 0 | 0 | 0 |
3 | hsa57053 ( cholinergic receptor nicotinic alpha 10 subunit ) | 0.945814 | 0 | 0 | 0 | 0 |
4 | hsa1141 ( cholinergic receptor nicotinic beta 2 subunit ) | 0.941801 | 0 | 0 | 0 | 0 |
5 | hsa55584 ( cholinergic receptor nicotinic alpha 9 subunit ) | 0.940765 | 0 | 0 | 0 | 0 |
6 | hsa1137 ( cholinergic receptor nicotinic alpha 4 subunit ) | 0.936358 | 0 | 0 | 0 | 0 |
7 | hsa1139 ( cholinergic receptor nicotinic alpha 7 subunit ) | 0.932015 | 0 | 0 | 0 | 0 |
8 | hsa1138 ( cholinergic receptor nicotinic alpha 5 subunit ) | 0.929745 | 0 | 0 | 0 | 0 |
9 | hsa1134 ( cholinergic receptor nicotinic alpha 1 subunit ) | 0.920809 | 1 | 1 | 0 | 0 |
10 | hsa3359 ( 5-hydroxytryptamine receptor 3A ) | 0.831677 | 0 | 0 | 0 | 0 |
Rank | Target | Score | Validated | KEGG | DrugBank | Matador |
---|---|---|---|---|---|---|
1 | hsa8973 ( cholinergic receptor nicotinic alpha 6 subunit ) | 0.959814 | 0 | 0 | 0 | 0 |
2 | hsa1136 ( cholinergic receptor nicotinic alpha 3 subunit ) | 0.950538 | 0 | 0 | 0 | 0 |
3 | hsa57053 ( cholinergic receptor nicotinic alpha 10 subunit ) | 0.949049 | 0 | 0 | 0 | 0 |
4 | hsa1141 ( cholinergic receptor nicotinic beta 2 subunit ) | 0.945095 | 0 | 0 | 0 | 0 |
5 | hsa55584 ( cholinergic receptor nicotinic alpha 9 subunit ) | 0.944211 | 0 | 0 | 0 | 0 |
6 | hsa1137 ( cholinergic receptor nicotinic alpha 4 subunit ) | 0.939807 | 0 | 0 | 0 | 0 |
7 | hsa1139 ( cholinergic receptor nicotinic alpha 7 subunit ) | 0.935604 | 0 | 0 | 0 | 0 |
8 | hsa1138 ( cholinergic receptor nicotinic alpha 5 subunit ) | 0.933747 | 0 | 0 | 0 | 0 |
9 | hsa1134 ( cholinergic receptor nicotinic alpha 1 subunit ) | 0.925246 | 0 | 0 | 0 | 0 |
10 | hsa3359 ( 5-hydroxytryptamine receptor 3A ) | 0.815609 | 0 | 0 | 0 | 0 |
Rank | Target | Score | Validated | KEGG | DrugBank | Matador |
---|---|---|---|---|---|---|
1 | hsa8973 ( cholinergic receptor nicotinic alpha 6 subunit ) | 0.960688 | 0 | 0 | 0 | 0 |
2 | hsa1141 ( cholinergic receptor nicotinic beta 2 subunit ) | 0.953745 | 0 | 0 | 0 | 0 |
3 | hsa1136 ( cholinergic receptor nicotinic alpha 3 subunit ) | 0.95119 | 0 | 0 | 0 | 0 |
4 | hsa57053 ( cholinergic receptor nicotinic alpha 10 subunit ) | 0.948982 | 0 | 0 | 0 | 0 |
5 | hsa55584 ( cholinergic receptor nicotinic alpha 9 subunit ) | 0.944933 | 0 | 0 | 0 | 0 |
6 | hsa1137 ( cholinergic receptor nicotinic alpha 4 subunit ) | 0.940245 | 0 | 0 | 0 | 0 |
7 | hsa1139 ( cholinergic receptor nicotinic alpha 7 subunit ) | 0.934451 | 0 | 0 | 0 | 0 |
8 | hsa1138 ( cholinergic receptor nicotinic alpha 5 subunit ) | 0.93274 | 0 | 0 | 0 | 0 |
9 | hsa1134 ( cholinergic receptor nicotinic alpha 1 subunit ) | 0.925158 | 1 | 1 | 0 | 0 |
10 | hsa3359 ( 5-hydroxytryptamine receptor 3A ) | 0.828001 | 1 | 0 | 1 | 0 |
Rank | Target | Score | Validated | KEGG | DrugBank | Matador |
---|---|---|---|---|---|---|
1 | hsa2891 ( glutamate ionotropic receptor AMPA type subunit 2 ) | 0.84406 | 0 | 0 | 0 | 0 |
2 | hsa3758 ( potassium voltage-gated channel subfamily J member 1 ) | 0.781412 | 0 | 0 | 0 | 0 |
3 | hsa3763 ( potassium voltage-gated channel subfamily J member 6 ) | 0.775804 | 0 | 0 | 0 | 0 |
4 | hsa3782 ( potassium calcium-activated channel subfamily N member 3 ) | 0.701814 | 0 | 0 | 0 | 0 |
5 | hsa3757 ( potassium voltage-gated channel subfamily H member 2 ) | 0.699529 | 0 | 0 | 0 | 0 |
6 | hsa3784 ( potassium voltage-gated channel subfamily Q member 1 ) | 0.695975 | 0 | 0 | 0 | 0 |
7 | hsa9132 ( potassium voltage-gated channel subfamily Q member 4 ) | 0.695157 | 0 | 0 | 0 | 0 |
8 | hsa2554 ( gamma-aminobutyric acid type A receptor alpha1 subunit ) | 0.675275 | 0 | 0 | 0 | 0 |
9 | hsa2890 ( glutamate ionotropic receptor AMPA type subunit 1 ) | 0.674295 | 0 | 0 | 0 | 0 |
10 | hsa3781 ( potassium calcium-activated channel subfamily N member 2 ) | 0.672562 | 0 | 0 | 0 | 0 |
Rank | Target | Score | Validated | KEGG | DrugBank | Matador |
---|---|---|---|---|---|---|
1 | hsa6323 ( sodium voltage-gated channel alpha subunit 1 ) | 0.842849 | 0 | 0 | 0 | 0 |
2 | hsa3778 ( potassium calcium-activated channel subfamily M alpha 1 ) | 0.809645 | 0 | 0 | 0 | 0 |
3 | hsa2898 ( glutamate ionotropic receptor kainate type subunit 2 ) | 0.772445 | 1 | 0 | 0 | 1 |
4 | hsa6334 ( sodium voltage-gated channel alpha subunit 8 ) | 0.760157 | 0 | 0 | 0 | 0 |
5 | hsa6326 ( sodium voltage-gated channel alpha subunit 2 ) | 0.758562 | 0 | 0 | 0 | 0 |
6 | hsa6335 ( sodium voltage-gated channel alpha subunit 9 ) | 0.724128 | 0 | 0 | 0 | 0 |
7 | hsa2554 ( gamma-aminobutyric acid type A receptor alpha1 subunit ) | 0.685926 | 1 | 0 | 0 | 1 |
8 | hsa40 ( acid sensing ion channel subunit 2 ) | 0.683321 | 0 | 0 | 0 | 0 |
9 | hsa8645 ( potassium two pore domain channel subfamily K member 5 ) | 0.666691 | 0 | 0 | 0 | 0 |
10 | hsa41 ( acid sensing ion channel subunit 1 ) | 0.652452 | 0 | 0 | 0 | 0 |
Rank | Target | Score | Validated | KEGG | DrugBank | Matador |
---|---|---|---|---|---|---|
1 | hsa8973 ( cholinergic receptor nicotinic alpha 6 subunit ) | 0.954187 | 0 | 0 | 0 | 0 |
2 | hsa1141 ( cholinergic receptor nicotinic beta 2 subunit ) | 0.944625 | 0 | 0 | 0 | 0 |
3 | hsa1136 ( cholinergic receptor nicotinic alpha 3 subunit ) | 0.943493 | 0 | 0 | 0 | 0 |
4 | hsa57053 ( cholinergic receptor nicotinic alpha 10 subunit ) | 0.941248 | 0 | 0 | 0 | 0 |
5 | hsa55584 ( cholinergic receptor nicotinic alpha 9 subunit ) | 0.936846 | 0 | 0 | 0 | 0 |
6 | hsa1137 ( cholinergic receptor nicotinic alpha 4 subunit ) | 0.93116 | 0 | 0 | 0 | 0 |
7 | hsa1139 ( cholinergic receptor nicotinic alpha 7 subunit ) | 0.924698 | 0 | 0 | 0 | 0 |
8 | hsa1138 ( cholinergic receptor nicotinic alpha 5 subunit ) | 0.92315 | 0 | 0 | 0 | 0 |
9 | hsa1134 ( cholinergic receptor nicotinic alpha 1 subunit ) | 0.914489 | 0 | 0 | 0 | 0 |
10 | hsa3359 ( 5-hydroxytryptamine receptor 3A ) | 0.835207 | 0 | 0 | 0 | 0 |
Rank | Target | Score | Validated | KEGG | DrugBank | Matador |
---|---|---|---|---|---|---|
1 | hsa3781 ( potassium calcium-activated channel subfamily N member 2 ) | 0.978653 | 0 | 0 | 0 | 0 |
2 | hsa3780 ( potassium calcium-activated channel subfamily N member 1 ) | 0.951277 | 0 | 0 | 0 | 0 |
3 | hsa3763 ( potassium voltage-gated channel subfamily J member 6 ) | 0.90634 | 0 | 0 | 0 | 0 |
4 | hsa3783 ( potassium calcium-activated channel subfamily N member 4 ) | 0.859905 | 0 | 0 | 0 | 0 |
5 | hsa3758 ( potassium voltage-gated channel subfamily J member 1 ) | 0.793705 | 0 | 0 | 0 | 0 |
6 | hsa3767 ( potassium voltage-gated channel subfamily J member 11 ) | 0.74299 | 0 | 0 | 0 | 0 |
7 | hsa3757 ( potassium voltage-gated channel subfamily H member 2 ) | 0.735665 | 0 | 0 | 0 | 0 |
8 | hsa6530 ( solute carrier family 6 member 2 ) | 0.720767 | 0 | 0 | 0 | 0 |
9 | hsa3784 ( potassium voltage-gated channel subfamily Q member 1 ) | 0.70923 | 0 | 0 | 0 | 0 |
10 | hsa2554 ( gamma-aminobutyric acid type A receptor alpha1 subunit ) | 0.683927 | 0 | 0 | 0 | 0 |
Rank | Target | Score | Validated | KEGG | DrugBank | Matador |
---|---|---|---|---|---|---|
1 | hsa3782 ( potassium calcium-activated channel subfamily N member 3 ) | 0.920305 | 0 | 0 | 0 | 0 |
2 | hsa3781 ( potassium calcium-activated channel subfamily N member 2 ) | 0.908394 | 0 | 0 | 0 | 0 |
3 | hsa3780 ( potassium calcium-activated channel subfamily N member 1 ) | 0.860879 | 0 | 0 | 0 | 0 |
4 | hsa6331 ( sodium voltage-gated channel alpha subunit 5 ) | 0.829509 | 0 | 0 | 0 | 0 |
5 | hsa3758 ( potassium voltage-gated channel subfamily J member 1 ) | 0.822208 | 0 | 0 | 0 | 0 |
6 | hsa3767 ( potassium voltage-gated channel subfamily J member 11 ) | 0.808895 | 0 | 0 | 0 | 0 |
7 | hsa6323 ( sodium voltage-gated channel alpha subunit 1 ) | 0.762257 | 0 | 0 | 0 | 0 |
8 | hsa3741 ( potassium voltage-gated channel subfamily A member 5 ) | 0.740728 | 0 | 0 | 0 | 0 |
9 | hsa6328 ( sodium voltage-gated channel alpha subunit 3 ) | 0.737041 | 0 | 0 | 0 | 0 |
10 | hsa6329 ( sodium voltage-gated channel alpha subunit 4 ) | 0.719126 | 0 | 0 | 0 | 0 |
Rank | Target | Score | Validated | KEGG | DrugBank | Matador |
---|---|---|---|---|---|---|
1 | hsa3782 ( potassium calcium-activated channel subfamily N member 3 ) | 0.982761 | 0 | 0 | 0 | 0 |
2 | hsa3780 ( potassium calcium-activated channel subfamily N member 1 ) | 0.958268 | 0 | 0 | 0 | 0 |
3 | hsa3763 ( potassium voltage-gated channel subfamily J member 6 ) | 0.916579 | 0 | 0 | 0 | 0 |
4 | hsa3783 ( potassium calcium-activated channel subfamily N member 4 ) | 0.86601 | 0 | 0 | 0 | 0 |
5 | hsa3758 ( potassium voltage-gated channel subfamily J member 1 ) | 0.792444 | 0 | 0 | 0 | 0 |
6 | hsa3767 ( potassium voltage-gated channel subfamily J member 11 ) | 0.755998 | 0 | 0 | 0 | 0 |
7 | hsa3757 ( potassium voltage-gated channel subfamily H member 2 ) | 0.74945 | 0 | 0 | 0 | 0 |
8 | hsa2554 ( gamma-aminobutyric acid type A receptor alpha1 subunit ) | 0.714902 | 0 | 0 | 0 | 0 |
9 | hsa3784 ( potassium voltage-gated channel subfamily Q member 1 ) | 0.712619 | 0 | 0 | 0 | 0 |
10 | hsa9132 ( potassium voltage-gated channel subfamily Q member 4 ) | 0.701736 | 0 | 0 | 0 | 0 |
Rank | Target | Score | Validated | KEGG | DrugBank | Matador |
---|---|---|---|---|---|---|
1 | hsa3780 ( potassium calcium-activated channel subfamily N member 1 ) | 0.949185 | 0 | 0 | 0 | 0 |
2 | hsa3763 ( potassium voltage-gated channel subfamily J member 6 ) | 0.875663 | 0 | 0 | 0 | 0 |
3 | hsa3783 ( potassium calcium-activated channel subfamily N member 4 ) | 0.858999 | 0 | 0 | 0 | 0 |
4 | hsa6530 ( solute carrier family 6 member 2 ) | 0.792404 | 1 | 1 | 1 | 0 |
5 | hsa3758 ( potassium voltage-gated channel subfamily J member 1 ) | 0.777573 | 0 | 0 | 0 | 0 |
6 | hsa6532 ( solute carrier family 6 member 4 ) | 0.766722 | 1 | 1 | 1 | 0 |
7 | hsa3757 ( potassium voltage-gated channel subfamily H member 2 ) | 0.740892 | 0 | 0 | 0 | 0 |
8 | hsa3767 ( potassium voltage-gated channel subfamily J member 11 ) | 0.721068 | 0 | 0 | 0 | 0 |
9 | hsa2554 ( gamma-aminobutyric acid type A receptor alpha1 subunit ) | 0.71017 | 0 | 0 | 0 | 0 |
10 | hsa3784 ( potassium voltage-gated channel subfamily Q member 1 ) | 0.704018 | 0 | 0 | 0 | 0 |
Rank | Target | Score | Validated | KEGG | DrugBank | Matador |
---|---|---|---|---|---|---|
1 | hsa3781 ( potassium calcium-activated channel subfamily N member 2 ) | 0.973907 | 0 | 0 | 0 | 0 |
2 | hsa3780 ( potassium calcium-activated channel subfamily N member 1 ) | 0.940062 | 0 | 0 | 0 | 0 |
3 | hsa3763 ( potassium voltage-gated channel subfamily J member 6 ) | 0.867325 | 0 | 0 | 0 | 0 |
4 | hsa3783 ( potassium calcium-activated channel subfamily N member 4 ) | 0.857094 | 0 | 0 | 0 | 0 |
5 | hsa6530 ( solute carrier family 6 member 2 ) | 0.839121 | 1 | 1 | 1 | 1 |
6 | hsa6532 ( solute carrier family 6 member 4 ) | 0.814438 | 1 | 1 | 1 | 0 |
7 | hsa3758 ( potassium voltage-gated channel subfamily J member 1 ) | 0.788884 | 0 | 0 | 0 | 0 |
8 | hsa3757 ( potassium voltage-gated channel subfamily H member 2 ) | 0.723139 | 0 | 0 | 0 | 0 |
9 | hsa3767 ( potassium voltage-gated channel subfamily J member 11 ) | 0.721658 | 0 | 0 | 0 | 0 |
10 | hsa3784 ( potassium voltage-gated channel subfamily Q member 1 ) | 0.702205 | 0 | 0 | 0 | 0 |
Rank | Target | Score | Validated | KEGG | DrugBank | Matador |
---|---|---|---|---|---|---|
1 | hsa3781 ( potassium calcium-activated channel subfamily N member 2 ) | 0.974583 | 0 | 0 | 0 | 0 |
2 | hsa3780 ( potassium calcium-activated channel subfamily N member 1 ) | 0.939233 | 0 | 0 | 0 | 0 |
3 | hsa3763 ( potassium voltage-gated channel subfamily J member 6 ) | 0.868372 | 0 | 0 | 0 | 0 |
4 | hsa3783 ( potassium calcium-activated channel subfamily N member 4 ) | 0.853209 | 0 | 0 | 0 | 0 |
5 | hsa6530 ( solute carrier family 6 member 2 ) | 0.841677 | 1 | 1 | 1 | 1 |
6 | hsa6532 ( solute carrier family 6 member 4 ) | 0.817073 | 1 | 1 | 1 | 0 |
7 | hsa3758 ( potassium voltage-gated channel subfamily J member 1 ) | 0.787672 | 0 | 0 | 0 | 0 |
8 | hsa3757 ( potassium voltage-gated channel subfamily H member 2 ) | 0.732791 | 0 | 0 | 0 | 0 |
9 | hsa3767 ( potassium voltage-gated channel subfamily J member 11 ) | 0.721517 | 0 | 0 | 0 | 0 |
10 | hsa3784 ( potassium voltage-gated channel subfamily Q member 1 ) | 0.707314 | 0 | 0 | 0 | 0 |
Rank | Target | Score | Validated | KEGG | DrugBank | Matador |
---|---|---|---|---|---|---|
1 | hsa3783 ( potassium calcium-activated channel subfamily N member 4 ) | 0.846993 | 0 | 0 | 0 | 0 |
2 | hsa3758 ( potassium voltage-gated channel subfamily J member 1 ) | 0.78618 | 0 | 0 | 0 | 0 |
3 | hsa3767 ( potassium voltage-gated channel subfamily J member 11 ) | 0.767154 | 0 | 0 | 0 | 0 |
4 | hsa3784 ( potassium voltage-gated channel subfamily Q member 1 ) | 0.736924 | 0 | 0 | 0 | 0 |
5 | hsa2554 ( gamma-aminobutyric acid type A receptor alpha1 subunit ) | 0.711774 | 0 | 0 | 0 | 0 |
6 | hsa9132 ( potassium voltage-gated channel subfamily Q member 4 ) | 0.709619 | 0 | 0 | 0 | 0 |
7 | hsa3757 ( potassium voltage-gated channel subfamily H member 2 ) | 0.708133 | 0 | 0 | 0 | 0 |
8 | hsa6331 ( sodium voltage-gated channel alpha subunit 5 ) | 0.686628 | 0 | 0 | 0 | 0 |
9 | hsa3778 ( potassium calcium-activated channel subfamily M alpha 1 ) | 0.659752 | 0 | 0 | 0 | 0 |
10 | hsa3741 ( potassium voltage-gated channel subfamily A member 5 ) | 0.657681 | 0 | 0 | 0 | 0 |
Rank | Target | Score | Validated | KEGG | DrugBank | Matador |
---|---|---|---|---|---|---|
1 | hsa3753 ( potassium voltage-gated channel subfamily E regulatory subunit 1 ) | 0.894264 | 0 | 0 | 0 | 0 |
2 | hsa3763 ( potassium voltage-gated channel subfamily J member 6 ) | 0.825492 | 0 | 0 | 0 | 0 |
3 | hsa3782 ( potassium calcium-activated channel subfamily N member 3 ) | 0.809134 | 0 | 0 | 0 | 0 |
4 | hsa3781 ( potassium calcium-activated channel subfamily N member 2 ) | 0.788985 | 0 | 0 | 0 | 0 |
5 | hsa9132 ( potassium voltage-gated channel subfamily Q member 4 ) | 0.784658 | 0 | 0 | 0 | 0 |
6 | hsa3758 ( potassium voltage-gated channel subfamily J member 1 ) | 0.759675 | 0 | 0 | 0 | 0 |
7 | hsa6331 ( sodium voltage-gated channel alpha subunit 5 ) | 0.749187 | 0 | 0 | 0 | 0 |
8 | hsa3767 ( potassium voltage-gated channel subfamily J member 11 ) | 0.731028 | 0 | 0 | 0 | 0 |
9 | hsa3778 ( potassium calcium-activated channel subfamily M alpha 1 ) | 0.714004 | 0 | 0 | 0 | 0 |
10 | hsa3757 ( potassium voltage-gated channel subfamily H member 2 ) | 0.709912 | 0 | 0 | 0 | 0 |
Rank | Target | Score | Validated | KEGG | DrugBank | Matador |
---|---|---|---|---|---|---|
1 | hsa1135 ( cholinergic receptor nicotinic alpha 2 subunit ) | 0.94035 | 0 | 0 | 0 | 0 |
2 | hsa8973 ( cholinergic receptor nicotinic alpha 6 subunit ) | 0.892658 | 0 | 0 | 0 | 0 |
3 | hsa1136 ( cholinergic receptor nicotinic alpha 3 subunit ) | 0.872452 | 0 | 0 | 0 | 0 |
4 | hsa1137 ( cholinergic receptor nicotinic alpha 4 subunit ) | 0.843504 | 0 | 0 | 0 | 0 |
5 | hsa55584 ( cholinergic receptor nicotinic alpha 9 subunit ) | 0.842252 | 0 | 0 | 0 | 0 |
6 | hsa57053 ( cholinergic receptor nicotinic alpha 10 subunit ) | 0.83536 | 0 | 0 | 0 | 0 |
7 | hsa1134 ( cholinergic receptor nicotinic alpha 1 subunit ) | 0.806675 | 0 | 0 | 0 | 0 |
8 | hsa1145 ( cholinergic receptor nicotinic epsilon subunit ) | 0.804744 | 0 | 0 | 0 | 0 |
9 | hsa1139 ( cholinergic receptor nicotinic alpha 7 subunit ) | 0.78077 | 0 | 0 | 0 | 0 |
10 | hsa1138 ( cholinergic receptor nicotinic alpha 5 subunit ) | 0.779672 | 0 | 0 | 0 | 0 |
Rank | Target | Score | Validated | KEGG | DrugBank | Matador |
---|---|---|---|---|---|---|
1 | hsa1135 ( cholinergic receptor nicotinic alpha 2 subunit ) | 0.954587 | 0 | 0 | 0 | 0 |
2 | hsa8973 ( cholinergic receptor nicotinic alpha 6 subunit ) | 0.915522 | 0 | 0 | 0 | 0 |
3 | hsa1136 ( cholinergic receptor nicotinic alpha 3 subunit ) | 0.897479 | 0 | 0 | 0 | 0 |
4 | hsa55584 ( cholinergic receptor nicotinic alpha 9 subunit ) | 0.874833 | 0 | 0 | 0 | 0 |
5 | hsa1137 ( cholinergic receptor nicotinic alpha 4 subunit ) | 0.87229 | 0 | 0 | 0 | 0 |
6 | hsa57053 ( cholinergic receptor nicotinic alpha 10 subunit ) | 0.870093 | 0 | 0 | 0 | 0 |
7 | hsa1134 ( cholinergic receptor nicotinic alpha 1 subunit ) | 0.841568 | 0 | 0 | 0 | 0 |
8 | hsa1145 ( cholinergic receptor nicotinic epsilon subunit ) | 0.827425 | 0 | 0 | 0 | 0 |
9 | hsa1139 ( cholinergic receptor nicotinic alpha 7 subunit ) | 0.822859 | 0 | 0 | 0 | 0 |
10 | hsa1138 ( cholinergic receptor nicotinic alpha 5 subunit ) | 0.821528 | 0 | 0 | 0 | 0 |
Rank | Target | Score | Validated | KEGG | DrugBank | Matador |
---|---|---|---|---|---|---|
1 | hsa1135 ( cholinergic receptor nicotinic alpha 2 subunit ) | 0.943693 | 0 | 0 | 0 | 0 |
2 | hsa8973 ( cholinergic receptor nicotinic alpha 6 subunit ) | 0.901119 | 0 | 0 | 0 | 0 |
3 | hsa1136 ( cholinergic receptor nicotinic alpha 3 subunit ) | 0.880726 | 0 | 0 | 0 | 0 |
4 | hsa55584 ( cholinergic receptor nicotinic alpha 9 subunit ) | 0.854615 | 0 | 0 | 0 | 0 |
5 | hsa1137 ( cholinergic receptor nicotinic alpha 4 subunit ) | 0.853048 | 0 | 0 | 0 | 0 |
6 | hsa57053 ( cholinergic receptor nicotinic alpha 10 subunit ) | 0.848794 | 0 | 0 | 0 | 0 |
7 | hsa1134 ( cholinergic receptor nicotinic alpha 1 subunit ) | 0.818847 | 0 | 0 | 0 | 0 |
8 | hsa1145 ( cholinergic receptor nicotinic epsilon subunit ) | 0.809524 | 0 | 0 | 0 | 0 |
9 | hsa1139 ( cholinergic receptor nicotinic alpha 7 subunit ) | 0.799175 | 0 | 0 | 0 | 0 |
10 | hsa1138 ( cholinergic receptor nicotinic alpha 5 subunit ) | 0.798414 | 0 | 0 | 0 | 0 |
Rank | Target | Score | Validated | KEGG | DrugBank | Matador |
---|---|---|---|---|---|---|
1 | hsa2555 ( gamma-aminobutyric acid type A receptor alpha2 subunit ) | 0.945705 | 1 | 1 | 1 | 0 |
2 | hsa2558 ( gamma-aminobutyric acid type A receptor alpha5 subunit ) | 0.941448 | 1 | 1 | 1 | 0 |
3 | hsa2556 ( gamma-aminobutyric acid type A receptor alpha3 subunit ) | 0.941305 | 1 | 1 | 1 | 0 |
4 | hsa2559 ( gamma-aminobutyric acid type A receptor alpha6 subunit ) | 0.938785 | 1 | 1 | 1 | 0 |
5 | hsa2557 ( gamma-aminobutyric acid type A receptor alpha4 subunit ) | 0.938623 | 1 | 1 | 1 | 0 |
6 | hsa2564 ( gamma-aminobutyric acid type A receptor epsilon subunit ) | 0.839957 | 1 | 1 | 0 | 0 |
7 | hsa2566 ( gamma-aminobutyric acid type A receptor gamma2 subunit ) | 0.839201 | 1 | 1 | 0 | 0 |
8 | hsa2567 ( gamma-aminobutyric acid type A receptor gamma3 subunit ) | 0.839112 | 1 | 1 | 0 | 0 |
9 | hsa55879 ( gamma-aminobutyric acid type A receptor theta subunit ) | 0.814228 | 1 | 1 | 0 | 0 |
10 | hsa2561 ( gamma-aminobutyric acid type A receptor beta2 subunit ) | 0.809143 | 1 | 1 | 0 | 0 |
Rank | Target | Score | Validated | KEGG | DrugBank | Matador |
---|---|---|---|---|---|---|
1 | hsa779 ( calcium voltage-gated channel subunit alpha1 S ) | 0.957015 | 1 | 0 | 1 | 0 |
2 | hsa776 ( calcium voltage-gated channel subunit alpha1 D ) | 0.956484 | 0 | 0 | 0 | 0 |
3 | hsa778 ( calcium voltage-gated channel subunit alpha1 F ) | 0.953831 | 0 | 0 | 0 | 0 |
4 | hsa783 ( calcium voltage-gated channel auxiliary subunit beta 2 ) | 0.931318 | 1 | 0 | 1 | 0 |
5 | hsa93589 ( calcium voltage-gated channel auxiliary subunit alpha2delta 4 ) | 0.926095 | 0 | 0 | 0 | 0 |
6 | hsa782 ( calcium voltage-gated channel auxiliary subunit beta 1 ) | 0.924671 | 1 | 0 | 1 | 0 |
7 | hsa773 ( calcium voltage-gated channel subunit alpha1 A ) | 0.912074 | 0 | 0 | 0 | 0 |
8 | hsa55799 ( calcium voltage-gated channel auxiliary subunit alpha2delta 3 ) | 0.863027 | 0 | 0 | 0 | 0 |
9 | hsa9254 ( calcium voltage-gated channel auxiliary subunit alpha2delta 2 ) | 0.851596 | 0 | 0 | 0 | 0 |
10 | hsa8911 ( calcium voltage-gated channel subunit alpha1 I ) | 0.845025 | 0 | 0 | 0 | 0 |
Rank | Target | Score | Validated | KEGG | DrugBank | Matador |
---|---|---|---|---|---|---|
1 | hsa3767 ( potassium voltage-gated channel subfamily J member 11 ) | 0.934868 | 0 | 0 | 0 | 0 |
2 | hsa6833 ( ATP binding cassette subfamily C member 8 ) | 0.901478 | 1 | 1 | 1 | 0 |
3 | hsa1080 ( cystic fibrosis transmembrane conductance regulator ) | 0.765247 | 0 | 0 | 0 | 0 |
4 | hsa3782 ( potassium calcium-activated channel subfamily N member 3 ) | 0.743976 | 0 | 0 | 0 | 0 |
5 | hsa3757 ( potassium voltage-gated channel subfamily H member 2 ) | 0.738995 | 0 | 0 | 0 | 0 |
6 | hsa3359 ( 5-hydroxytryptamine receptor 3A ) | 0.736527 | 0 | 0 | 0 | 0 |
7 | hsa3763 ( potassium voltage-gated channel subfamily J member 6 ) | 0.710689 | 0 | 0 | 0 | 0 |
8 | hsa3781 ( potassium calcium-activated channel subfamily N member 2 ) | 0.690783 | 0 | 0 | 0 | 0 |
9 | hsa6530 ( solute carrier family 6 member 2 ) | 0.674241 | 0 | 0 | 0 | 0 |
10 | hsa3778 ( potassium calcium-activated channel subfamily M alpha 1 ) | 0.655584 | 0 | 0 | 0 | 0 |
Rank | Target | Score | Validated | KEGG | DrugBank | Matador |
---|---|---|---|---|---|---|
1 | hsa6532 ( solute carrier family 6 member 4 ) | 0.862673 | 0 | 0 | 0 | 0 |
2 | hsa2554 ( gamma-aminobutyric acid type A receptor alpha1 subunit ) | 0.833872 | 0 | 0 | 0 | 0 |
3 | hsa6530 ( solute carrier family 6 member 2 ) | 0.824069 | 0 | 0 | 0 | 0 |
4 | hsa3782 ( potassium calcium-activated channel subfamily N member 3 ) | 0.806181 | 0 | 0 | 0 | 0 |
5 | hsa116444 ( glutamate ionotropic receptor NMDA type subunit 3B ) | 0.772817 | 0 | 0 | 0 | 0 |
6 | hsa3763 ( potassium voltage-gated channel subfamily J member 6 ) | 0.727325 | 0 | 0 | 0 | 0 |
7 | hsa3781 ( potassium calcium-activated channel subfamily N member 2 ) | 0.724894 | 0 | 0 | 0 | 0 |
8 | hsa2904 ( glutamate ionotropic receptor NMDA type subunit 2B ) | 0.718873 | 0 | 0 | 0 | 0 |
9 | hsa2902 ( glutamate ionotropic receptor NMDA type subunit 1 ) | 0.717833 | 0 | 0 | 0 | 0 |
10 | hsa2906 ( glutamate ionotropic receptor NMDA type subunit 2D ) | 0.7154 | 0 | 0 | 0 | 0 |
Rank | Target | Score | Validated | KEGG | DrugBank | Matador |
---|---|---|---|---|---|---|
1 | hsa3781 ( potassium calcium-activated channel subfamily N member 2 ) | 0.973511 | 0 | 0 | 0 | 0 |
2 | hsa3780 ( potassium calcium-activated channel subfamily N member 1 ) | 0.941491 | 0 | 0 | 0 | 0 |
3 | hsa3763 ( potassium voltage-gated channel subfamily J member 6 ) | 0.874147 | 0 | 0 | 0 | 0 |
4 | hsa3783 ( potassium calcium-activated channel subfamily N member 4 ) | 0.852634 | 0 | 0 | 0 | 0 |
5 | hsa3758 ( potassium voltage-gated channel subfamily J member 1 ) | 0.785877 | 0 | 0 | 0 | 0 |
6 | hsa6530 ( solute carrier family 6 member 2 ) | 0.78422 | 0 | 0 | 0 | 0 |
7 | hsa6532 ( solute carrier family 6 member 4 ) | 0.76139 | 0 | 0 | 0 | 0 |
8 | hsa3757 ( potassium voltage-gated channel subfamily H member 2 ) | 0.727294 | 0 | 0 | 0 | 0 |
9 | hsa3767 ( potassium voltage-gated channel subfamily J member 11 ) | 0.718583 | 0 | 0 | 0 | 0 |
10 | hsa2554 ( gamma-aminobutyric acid type A receptor alpha1 subunit ) | 0.699648 | 0 | 0 | 0 | 0 |
Rank | Target | Score | Validated | KEGG | DrugBank | Matador |
---|---|---|---|---|---|---|
1 | hsa3741 ( potassium voltage-gated channel subfamily A member 5 ) | 0.806308 | 0 | 0 | 0 | 0 |
2 | hsa6332 ( sodium voltage-gated channel alpha subunit 7 ) | 0.793478 | 1 | 1 | 0 | 0 |
3 | hsa3763 ( potassium voltage-gated channel subfamily J member 6 ) | 0.722403 | 0 | 0 | 0 | 0 |
4 | hsa8913 ( calcium voltage-gated channel subunit alpha1 G ) | 0.7201 | 0 | 0 | 0 | 0 |
5 | hsa11280 ( sodium voltage-gated channel alpha subunit 11 ) | 0.712138 | 0 | 0 | 0 | 0 |
6 | hsa3758 ( potassium voltage-gated channel subfamily J member 1 ) | 0.656668 | 0 | 0 | 0 | 0 |
7 | hsa3743 ( potassium voltage-gated channel subfamily A member 7 ) | 0.634912 | 0 | 0 | 0 | 0 |
8 | hsa54207 ( potassium two pore domain channel subfamily K member 10 ) | 0.608527 | 0 | 0 | 0 | 0 |
9 | hsa3359 ( 5-hydroxytryptamine receptor 3A ) | 0.602038 | 0 | 0 | 0 | 0 |
10 | hsa6530 ( solute carrier family 6 member 2 ) | 0.589429 | 0 | 0 | 0 | 0 |
Rank | Target | Score | Validated | KEGG | DrugBank | Matador |
---|---|---|---|---|---|---|
1 | hsa2555 ( gamma-aminobutyric acid type A receptor alpha2 subunit ) | 0.960533 | 1 | 1 | 1 | 0 |
2 | hsa2558 ( gamma-aminobutyric acid type A receptor alpha5 subunit ) | 0.957518 | 1 | 1 | 1 | 0 |
3 | hsa2556 ( gamma-aminobutyric acid type A receptor alpha3 subunit ) | 0.9574 | 1 | 1 | 1 | 0 |
4 | hsa2557 ( gamma-aminobutyric acid type A receptor alpha4 subunit ) | 0.955772 | 1 | 1 | 1 | 0 |
5 | hsa2559 ( gamma-aminobutyric acid type A receptor alpha6 subunit ) | 0.955417 | 1 | 1 | 1 | 0 |
6 | hsa2564 ( gamma-aminobutyric acid type A receptor epsilon subunit ) | 0.890938 | 1 | 1 | 1 | 0 |
7 | hsa2567 ( gamma-aminobutyric acid type A receptor gamma3 subunit ) | 0.887659 | 1 | 1 | 1 | 0 |
8 | hsa2566 ( gamma-aminobutyric acid type A receptor gamma2 subunit ) | 0.887461 | 1 | 1 | 1 | 0 |
9 | hsa55879 ( gamma-aminobutyric acid type A receptor theta subunit ) | 0.875184 | 1 | 1 | 1 | 0 |
10 | hsa2561 ( gamma-aminobutyric acid type A receptor beta2 subunit ) | 0.874317 | 1 | 1 | 1 | 0 |
Rank | Target | Score | Validated | KEGG | DrugBank | Matador |
---|---|---|---|---|---|---|
1 | hsa2890 ( glutamate ionotropic receptor AMPA type subunit 1 ) | 0.855 | 1 | 0 | 0 | 1 |
2 | hsa3763 ( potassium voltage-gated channel subfamily J member 6 ) | 0.753835 | 0 | 0 | 0 | 0 |
3 | hsa2893 ( glutamate ionotropic receptor AMPA type subunit 4 ) | 0.750694 | 1 | 0 | 0 | 1 |
4 | hsa3758 ( potassium voltage-gated channel subfamily J member 1 ) | 0.750639 | 0 | 0 | 0 | 0 |
5 | hsa2554 ( gamma-aminobutyric acid type A receptor alpha1 subunit ) | 0.749077 | 1 | 0 | 0 | 1 |
6 | hsa2892 ( glutamate ionotropic receptor AMPA type subunit 3 ) | 0.745722 | 1 | 0 | 0 | 1 |
7 | hsa2897 ( glutamate ionotropic receptor kainate type subunit 1 ) | 0.723153 | 1 | 0 | 0 | 1 |
8 | hsa3757 ( potassium voltage-gated channel subfamily H member 2 ) | 0.699386 | 0 | 0 | 0 | 0 |
9 | hsa9132 ( potassium voltage-gated channel subfamily Q member 4 ) | 0.698206 | 0 | 0 | 0 | 0 |
10 | hsa3784 ( potassium voltage-gated channel subfamily Q member 1 ) | 0.67522 | 0 | 0 | 0 | 0 |
Rank | Target | Score | Validated | KEGG | DrugBank | Matador |
---|---|---|---|---|---|---|
1 | hsa1080 ( cystic fibrosis transmembrane conductance regulator ) | 0.876178 | 0 | 0 | 0 | 0 |
2 | hsa3783 ( potassium calcium-activated channel subfamily N member 4 ) | 0.860084 | 0 | 0 | 0 | 0 |
3 | hsa6331 ( sodium voltage-gated channel alpha subunit 5 ) | 0.744454 | 0 | 0 | 0 | 0 |
4 | hsa8913 ( calcium voltage-gated channel subunit alpha1 G ) | 0.735823 | 0 | 0 | 0 | 0 |
5 | hsa775 ( calcium voltage-gated channel subunit alpha1 C ) | 0.731117 | 0 | 0 | 0 | 0 |
6 | hsa3359 ( 5-hydroxytryptamine receptor 3A ) | 0.694957 | 0 | 0 | 0 | 0 |
7 | hsa3758 ( potassium voltage-gated channel subfamily J member 1 ) | 0.684993 | 0 | 0 | 0 | 0 |
8 | hsa779 ( calcium voltage-gated channel subunit alpha1 S ) | 0.663882 | 0 | 0 | 0 | 0 |
9 | hsa6323 ( sodium voltage-gated channel alpha subunit 1 ) | 0.662928 | 0 | 0 | 0 | 0 |
10 | hsa6336 ( sodium voltage-gated channel alpha subunit 10 ) | 0.662481 | 0 | 0 | 0 | 0 |
Rank | Target | Score | Validated | KEGG | DrugBank | Matador |
---|---|---|---|---|---|---|
1 | hsa3741 ( potassium voltage-gated channel subfamily A member 5 ) | 0.833434 | 0 | 0 | 0 | 0 |
2 | hsa6332 ( sodium voltage-gated channel alpha subunit 7 ) | 0.782593 | 0 | 0 | 0 | 0 |
3 | hsa3763 ( potassium voltage-gated channel subfamily J member 6 ) | 0.742168 | 0 | 0 | 0 | 0 |
4 | hsa11280 ( sodium voltage-gated channel alpha subunit 11 ) | 0.699075 | 0 | 0 | 0 | 0 |
5 | hsa3758 ( potassium voltage-gated channel subfamily J member 1 ) | 0.685949 | 0 | 0 | 0 | 0 |
6 | hsa8913 ( calcium voltage-gated channel subunit alpha1 G ) | 0.680661 | 0 | 0 | 0 | 0 |
7 | hsa3743 ( potassium voltage-gated channel subfamily A member 7 ) | 0.650156 | 0 | 0 | 0 | 0 |
8 | hsa3752 ( potassium voltage-gated channel subfamily D member 3 ) | 0.628585 | 0 | 0 | 0 | 0 |
9 | hsa54207 ( potassium two pore domain channel subfamily K member 10 ) | 0.60863 | 0 | 0 | 0 | 0 |
10 | hsa3359 ( 5-hydroxytryptamine receptor 3A ) | 0.598817 | 0 | 0 | 0 | 0 |
Rank | Target | Score | Validated | KEGG | DrugBank | Matador |
---|---|---|---|---|---|---|
1 | hsa3757 ( potassium voltage-gated channel subfamily H member 2 ) | 0.777855 | 0 | 0 | 0 | 0 |
2 | hsa3783 ( potassium calcium-activated channel subfamily N member 4 ) | 0.706341 | 0 | 0 | 0 | 0 |
3 | hsa3778 ( potassium calcium-activated channel subfamily M alpha 1 ) | 0.599619 | 0 | 0 | 0 | 0 |
4 | hsa3758 ( potassium voltage-gated channel subfamily J member 1 ) | 0.551191 | 0 | 0 | 0 | 0 |
5 | hsa3763 ( potassium voltage-gated channel subfamily J member 6 ) | 0.540442 | 0 | 0 | 0 | 0 |
6 | hsa3739 ( potassium voltage-gated channel subfamily A member 4 ) | 0.533945 | 0 | 0 | 0 | 0 |
7 | hsa56659 ( potassium two pore domain channel subfamily K member 13 ) | 0.531939 | 0 | 0 | 0 | 0 |
8 | hsa6530 ( solute carrier family 6 member 2 ) | 0.529872 | 0 | 0 | 0 | 0 |
9 | hsa1080 ( cystic fibrosis transmembrane conductance regulator ) | 0.504922 | 0 | 0 | 0 | 0 |
10 | hsa6331 ( sodium voltage-gated channel alpha subunit 5 ) | 0.494948 | 0 | 0 | 0 | 0 |
Rank | Target | Score | Validated | KEGG | DrugBank | Matador |
---|---|---|---|---|---|---|
1 | hsa1080 ( cystic fibrosis transmembrane conductance regulator ) | 0.899529 | 0 | 0 | 0 | 0 |
2 | hsa3783 ( potassium calcium-activated channel subfamily N member 4 ) | 0.87403 | 0 | 0 | 0 | 0 |
3 | hsa3359 ( 5-hydroxytryptamine receptor 3A ) | 0.711154 | 0 | 0 | 0 | 0 |
4 | hsa8913 ( calcium voltage-gated channel subunit alpha1 G ) | 0.699723 | 0 | 0 | 0 | 0 |
5 | hsa775 ( calcium voltage-gated channel subunit alpha1 C ) | 0.69907 | 0 | 0 | 0 | 0 |
6 | hsa2554 ( gamma-aminobutyric acid type A receptor alpha1 subunit ) | 0.688411 | 0 | 0 | 0 | 0 |
7 | hsa5026 ( purinergic receptor P2X 5 ) | 0.6855 | 0 | 0 | 0 | 0 |
8 | hsa6331 ( sodium voltage-gated channel alpha subunit 5 ) | 0.685284 | 0 | 0 | 0 | 0 |
9 | hsa3758 ( potassium voltage-gated channel subfamily J member 1 ) | 0.68273 | 0 | 0 | 0 | 0 |
10 | hsa1141 ( cholinergic receptor nicotinic beta 2 subunit ) | 0.652523 | 0 | 0 | 0 | 0 |
Rank | Target | Score | Validated | KEGG | DrugBank | Matador |
---|---|---|---|---|---|---|
1 | hsa3782 ( potassium calcium-activated channel subfamily N member 3 ) | 0.983056 | 0 | 0 | 0 | 0 |
2 | hsa3780 ( potassium calcium-activated channel subfamily N member 1 ) | 0.95455 | 0 | 0 | 0 | 0 |
3 | hsa3763 ( potassium voltage-gated channel subfamily J member 6 ) | 0.897478 | 0 | 0 | 0 | 0 |
4 | hsa3783 ( potassium calcium-activated channel subfamily N member 4 ) | 0.866864 | 0 | 0 | 0 | 0 |
5 | hsa3758 ( potassium voltage-gated channel subfamily J member 1 ) | 0.772547 | 0 | 0 | 0 | 0 |
6 | hsa3757 ( potassium voltage-gated channel subfamily H member 2 ) | 0.756528 | 0 | 0 | 0 | 0 |
7 | hsa3767 ( potassium voltage-gated channel subfamily J member 11 ) | 0.735162 | 0 | 0 | 0 | 0 |
8 | hsa2554 ( gamma-aminobutyric acid type A receptor alpha1 subunit ) | 0.716196 | 0 | 0 | 0 | 0 |
9 | hsa3784 ( potassium voltage-gated channel subfamily Q member 1 ) | 0.70892 | 0 | 0 | 0 | 0 |
10 | hsa9132 ( potassium voltage-gated channel subfamily Q member 4 ) | 0.705391 | 0 | 0 | 0 | 0 |
Rank | Target | Score | Validated | KEGG | DrugBank | Matador |
---|---|---|---|---|---|---|
1 | hsa3743 ( potassium voltage-gated channel subfamily A member 7 ) | 0.767412 | 0 | 0 | 0 | 0 |
2 | hsa3758 ( potassium voltage-gated channel subfamily J member 1 ) | 0.720418 | 0 | 0 | 0 | 0 |
3 | hsa6332 ( sodium voltage-gated channel alpha subunit 7 ) | 0.715948 | 0 | 0 | 0 | 0 |
4 | hsa54207 ( potassium two pore domain channel subfamily K member 10 ) | 0.649784 | 0 | 0 | 0 | 0 |
5 | hsa3767 ( potassium voltage-gated channel subfamily J member 11 ) | 0.646798 | 0 | 0 | 0 | 0 |
6 | hsa3782 ( potassium calcium-activated channel subfamily N member 3 ) | 0.64301 | 0 | 0 | 0 | 0 |
7 | hsa83795 ( potassium two pore domain channel subfamily K member 16 ) | 0.630563 | 0 | 0 | 0 | 0 |
8 | hsa9424 ( potassium two pore domain channel subfamily K member 6 ) | 0.624529 | 0 | 0 | 0 | 0 |
9 | hsa3738 ( potassium voltage-gated channel subfamily A member 3 ) | 0.624405 | 0 | 0 | 0 | 0 |
10 | hsa3784 ( potassium voltage-gated channel subfamily Q member 1 ) | 0.623561 | 0 | 0 | 0 | 0 |
Rank | Target | Score | Validated | KEGG | DrugBank | Matador |
---|---|---|---|---|---|---|
1 | hsa3782 ( potassium calcium-activated channel subfamily N member 3 ) | 0.782775 | 0 | 0 | 0 | 0 |
2 | hsa5026 ( purinergic receptor P2X 5 ) | 0.780182 | 1 | 0 | 0 | 1 |
3 | hsa6833 ( ATP binding cassette subfamily C member 8 ) | 0.773265 | 0 | 0 | 0 | 0 |
4 | hsa3758 ( potassium voltage-gated channel subfamily J member 1 ) | 0.769888 | 0 | 0 | 0 | 0 |
5 | hsa3781 ( potassium calcium-activated channel subfamily N member 2 ) | 0.757015 | 0 | 0 | 0 | 0 |
6 | hsa5024 ( purinergic receptor P2X 3 ) | 0.731373 | 1 | 0 | 0 | 1 |
7 | hsa5027 ( purinergic receptor P2X 7 ) | 0.725032 | 1 | 0 | 0 | 1 |
8 | hsa5025 ( purinergic receptor P2X 4 ) | 0.722815 | 1 | 0 | 0 | 1 |
9 | hsa3757 ( potassium voltage-gated channel subfamily H member 2 ) | 0.720695 | 0 | 0 | 0 | 0 |
10 | hsa9127 ( purinergic receptor P2X 6 ) | 0.718232 | 1 | 0 | 0 | 1 |
Rank | Target | Score | Validated | KEGG | DrugBank | Matador |
---|---|---|---|---|---|---|
1 | hsa3782 ( potassium calcium-activated channel subfamily N member 3 ) | 0.980274 | 0 | 0 | 0 | 0 |
2 | hsa3781 ( potassium calcium-activated channel subfamily N member 2 ) | 0.978644 | 0 | 0 | 0 | 0 |
3 | hsa3763 ( potassium voltage-gated channel subfamily J member 6 ) | 0.898903 | 0 | 0 | 0 | 0 |
4 | hsa3783 ( potassium calcium-activated channel subfamily N member 4 ) | 0.88228 | 0 | 0 | 0 | 0 |
5 | hsa2554 ( gamma-aminobutyric acid type A receptor alpha1 subunit ) | 0.781868 | 0 | 0 | 0 | 0 |
6 | hsa3758 ( potassium voltage-gated channel subfamily J member 1 ) | 0.742346 | 0 | 0 | 0 | 0 |
7 | hsa3757 ( potassium voltage-gated channel subfamily H member 2 ) | 0.741578 | 0 | 0 | 0 | 0 |
8 | hsa3767 ( potassium voltage-gated channel subfamily J member 11 ) | 0.72279 | 0 | 0 | 0 | 0 |
9 | hsa1135 ( cholinergic receptor nicotinic alpha 2 subunit ) | 0.699997 | 0 | 0 | 0 | 0 |
10 | hsa3784 ( potassium voltage-gated channel subfamily Q member 1 ) | 0.671344 | 0 | 0 | 0 | 0 |
Rank | Target | Score | Validated | KEGG | DrugBank | Matador |
---|---|---|---|---|---|---|
1 | hsa3758 ( potassium voltage-gated channel subfamily J member 1 ) | 0.966725 | 0 | 0 | 0 | 0 |
2 | hsa6833 ( ATP binding cassette subfamily C member 8 ) | 0.861409 | 1 | 1 | 1 | 1 |
3 | hsa3757 ( potassium voltage-gated channel subfamily H member 2 ) | 0.761716 | 0 | 0 | 0 | 0 |
4 | hsa3763 ( potassium voltage-gated channel subfamily J member 6 ) | 0.748058 | 0 | 0 | 0 | 0 |
5 | hsa3782 ( potassium calcium-activated channel subfamily N member 3 ) | 0.706161 | 0 | 0 | 0 | 0 |
6 | hsa1135 ( cholinergic receptor nicotinic alpha 2 subunit ) | 0.687614 | 0 | 0 | 0 | 0 |
7 | hsa1080 ( cystic fibrosis transmembrane conductance regulator ) | 0.682071 | 0 | 0 | 0 | 0 |
8 | hsa3781 ( potassium calcium-activated channel subfamily N member 2 ) | 0.669898 | 0 | 0 | 0 | 0 |
9 | hsa6331 ( sodium voltage-gated channel alpha subunit 5 ) | 0.66377 | 0 | 0 | 0 | 0 |
10 | hsa2554 ( gamma-aminobutyric acid type A receptor alpha1 subunit ) | 0.65649 | 0 | 0 | 0 | 0 |
Rank | Target | Score | Validated | KEGG | DrugBank | Matador |
---|---|---|---|---|---|---|
1 | hsa6532 ( solute carrier family 6 member 4 ) | 0.963767 | 0 | 0 | 0 | 0 |
2 | hsa6531 ( solute carrier family 6 member 3 ) | 0.950157 | 0 | 0 | 0 | 0 |
3 | hsa11254 ( solute carrier family 6 member 14 ) | 0.837355 | 0 | 0 | 0 | 0 |
4 | hsa6534 ( solute carrier family 6 member 7 ) | 0.815399 | 0 | 0 | 0 | 0 |
5 | hsa6529 ( solute carrier family 6 member 1 ) | 0.790653 | 0 | 0 | 0 | 0 |
6 | hsa6331 ( sodium voltage-gated channel alpha subunit 5 ) | 0.721485 | 0 | 0 | 0 | 0 |
7 | hsa3359 ( 5-hydroxytryptamine receptor 3A ) | 0.708761 | 0 | 0 | 0 | 0 |
8 | hsa3782 ( potassium calcium-activated channel subfamily N member 3 ) | 0.702945 | 0 | 0 | 0 | 0 |
9 | hsa3757 ( potassium voltage-gated channel subfamily H member 2 ) | 0.687125 | 0 | 0 | 0 | 0 |
10 | hsa3758 ( potassium voltage-gated channel subfamily J member 1 ) | 0.68669 | 1 | 0 | 1 | 0 |
Rank | Target | Score | Validated | KEGG | DrugBank | Matador |
---|---|---|---|---|---|---|
1 | hsa6833 ( ATP binding cassette subfamily C member 8 ) | 0.81049 | 0 | 0 | 0 | 0 |
2 | hsa3758 ( potassium voltage-gated channel subfamily J member 1 ) | 0.791007 | 0 | 0 | 0 | 0 |
3 | hsa3782 ( potassium calcium-activated channel subfamily N member 3 ) | 0.790655 | 0 | 0 | 0 | 0 |
4 | hsa3781 ( potassium calcium-activated channel subfamily N member 2 ) | 0.764411 | 0 | 0 | 0 | 0 |
5 | hsa5026 ( purinergic receptor P2X 5 ) | 0.763999 | 0 | 0 | 0 | 0 |
6 | hsa3757 ( potassium voltage-gated channel subfamily H member 2 ) | 0.721566 | 0 | 0 | 0 | 0 |
7 | hsa5024 ( purinergic receptor P2X 3 ) | 0.713421 | 0 | 0 | 0 | 0 |
8 | hsa5027 ( purinergic receptor P2X 7 ) | 0.709172 | 0 | 0 | 0 | 0 |
9 | hsa5025 ( purinergic receptor P2X 4 ) | 0.706957 | 0 | 0 | 0 | 0 |
10 | hsa9127 ( purinergic receptor P2X 6 ) | 0.700773 | 0 | 0 | 0 | 0 |
Rank | Target | Score | Validated | KEGG | DrugBank | Matador |
---|---|---|---|---|---|---|
1 | hsa6331 ( sodium voltage-gated channel alpha subunit 5 ) | 0.989475 | 0 | 0 | 0 | 0 |
2 | hsa6323 ( sodium voltage-gated channel alpha subunit 1 ) | 0.972947 | 0 | 0 | 0 | 0 |
3 | hsa6328 ( sodium voltage-gated channel alpha subunit 3 ) | 0.972755 | 0 | 0 | 0 | 0 |
4 | hsa6329 ( sodium voltage-gated channel alpha subunit 4 ) | 0.96982 | 0 | 0 | 0 | 0 |
5 | hsa6326 ( sodium voltage-gated channel alpha subunit 2 ) | 0.956403 | 0 | 0 | 0 | 0 |
6 | hsa6334 ( sodium voltage-gated channel alpha subunit 8 ) | 0.954471 | 0 | 0 | 0 | 0 |
7 | hsa6335 ( sodium voltage-gated channel alpha subunit 9 ) | 0.94541 | 0 | 0 | 0 | 0 |
8 | hsa8645 ( potassium two pore domain channel subfamily K member 5 ) | 0.915608 | 0 | 0 | 0 | 0 |
9 | hsa6332 ( sodium voltage-gated channel alpha subunit 7 ) | 0.819262 | 0 | 0 | 0 | 0 |
10 | hsa11280 ( sodium voltage-gated channel alpha subunit 11 ) | 0.755298 | 0 | 0 | 0 | 0 |
Rank | Target | Score | Validated | KEGG | DrugBank | Matador |
---|---|---|---|---|---|---|
1 | hsa3758 ( potassium voltage-gated channel subfamily J member 1 ) | 0.968931 | 0 | 0 | 0 | 0 |
2 | hsa6833 ( ATP binding cassette subfamily C member 8 ) | 0.86585 | 1 | 1 | 0 | 0 |
3 | hsa3757 ( potassium voltage-gated channel subfamily H member 2 ) | 0.769687 | 0 | 0 | 0 | 0 |
4 | hsa3763 ( potassium voltage-gated channel subfamily J member 6 ) | 0.749699 | 0 | 0 | 0 | 0 |
5 | hsa3782 ( potassium calcium-activated channel subfamily N member 3 ) | 0.702786 | 0 | 0 | 0 | 0 |
6 | hsa1135 ( cholinergic receptor nicotinic alpha 2 subunit ) | 0.686515 | 0 | 0 | 0 | 0 |
7 | hsa1080 ( cystic fibrosis transmembrane conductance regulator ) | 0.68442 | 0 | 0 | 0 | 0 |
8 | hsa3781 ( potassium calcium-activated channel subfamily N member 2 ) | 0.666781 | 0 | 0 | 0 | 0 |
9 | hsa3784 ( potassium voltage-gated channel subfamily Q member 1 ) | 0.655624 | 0 | 0 | 0 | 0 |
10 | hsa1141 ( cholinergic receptor nicotinic beta 2 subunit ) | 0.648475 | 0 | 0 | 0 | 0 |
Rank | Target | Score | Validated | KEGG | DrugBank | Matador |
---|---|---|---|---|---|---|
1 | hsa3758 ( potassium voltage-gated channel subfamily J member 1 ) | 0.942238 | 0 | 0 | 0 | 0 |
2 | hsa1080 ( cystic fibrosis transmembrane conductance regulator ) | 0.895954 | 0 | 0 | 0 | 0 |
3 | hsa3767 ( potassium voltage-gated channel subfamily J member 11 ) | 0.842069 | 0 | 0 | 0 | 0 |
4 | hsa2554 ( gamma-aminobutyric acid type A receptor alpha1 subunit ) | 0.772094 | 0 | 0 | 0 | 0 |
5 | hsa3783 ( potassium calcium-activated channel subfamily N member 4 ) | 0.747203 | 0 | 0 | 0 | 0 |
6 | hsa3782 ( potassium calcium-activated channel subfamily N member 3 ) | 0.690611 | 0 | 0 | 0 | 0 |
7 | hsa3778 ( potassium calcium-activated channel subfamily M alpha 1 ) | 0.683928 | 0 | 0 | 0 | 0 |
8 | hsa3757 ( potassium voltage-gated channel subfamily H member 2 ) | 0.677819 | 0 | 0 | 0 | 0 |
9 | hsa6530 ( solute carrier family 6 member 2 ) | 0.669366 | 0 | 0 | 0 | 0 |
10 | hsa6261 ( ryanodine receptor 1 ) | 0.66215 | 0 | 0 | 0 | 0 |
Rank | Target | Score | Validated | KEGG | DrugBank | Matador |
---|---|---|---|---|---|---|
1 | hsa3758 ( potassium voltage-gated channel subfamily J member 1 ) | 0.95012 | 0 | 0 | 0 | 0 |
2 | hsa6833 ( ATP binding cassette subfamily C member 8 ) | 0.802316 | 1 | 1 | 1 | 0 |
3 | hsa3757 ( potassium voltage-gated channel subfamily H member 2 ) | 0.789619 | 0 | 0 | 0 | 0 |
4 | hsa3763 ( potassium voltage-gated channel subfamily J member 6 ) | 0.784346 | 0 | 0 | 0 | 0 |
5 | hsa3782 ( potassium calcium-activated channel subfamily N member 3 ) | 0.752028 | 0 | 0 | 0 | 0 |
6 | hsa3781 ( potassium calcium-activated channel subfamily N member 2 ) | 0.72375 | 0 | 0 | 0 | 0 |
7 | hsa9132 ( potassium voltage-gated channel subfamily Q member 4 ) | 0.692174 | 0 | 0 | 0 | 0 |
8 | hsa3784 ( potassium voltage-gated channel subfamily Q member 1 ) | 0.691132 | 0 | 0 | 0 | 0 |
9 | hsa2554 ( gamma-aminobutyric acid type A receptor alpha1 subunit ) | 0.667667 | 0 | 0 | 0 | 0 |
10 | hsa1135 ( cholinergic receptor nicotinic alpha 2 subunit ) | 0.660042 | 0 | 0 | 0 | 0 |
Rank | Target | Score | Validated | KEGG | DrugBank | Matador |
---|---|---|---|---|---|---|
1 | hsa778 ( calcium voltage-gated channel subunit alpha1 F ) | 0.980737 | 1 | 1 | 0 | 1 |
2 | hsa776 ( calcium voltage-gated channel subunit alpha1 D ) | 0.96897 | 1 | 1 | 0 | 1 |
3 | hsa773 ( calcium voltage-gated channel subunit alpha1 A ) | 0.961056 | 1 | 0 | 0 | 1 |
4 | hsa786 ( calcium voltage-gated channel auxiliary subunit gamma 1 ) | 0.900811 | 1 | 0 | 0 | 1 |
5 | hsa777 ( calcium voltage-gated channel subunit alpha1 E ) | 0.881568 | 1 | 0 | 0 | 1 |
6 | hsa3738 ( potassium voltage-gated channel subfamily A member 3 ) | 0.873132 | 0 | 0 | 0 | 0 |
7 | hsa781 ( calcium voltage-gated channel auxiliary subunit alpha2delta 1 ) | 0.871483 | 1 | 0 | 0 | 1 |
8 | hsa783 ( calcium voltage-gated channel auxiliary subunit beta 2 ) | 0.857075 | 1 | 0 | 0 | 1 |
9 | hsa93589 ( calcium voltage-gated channel auxiliary subunit alpha2delta 4 ) | 0.855118 | 0 | 0 | 0 | 0 |
10 | hsa3739 ( potassium voltage-gated channel subfamily A member 4 ) | 0.848788 | 0 | 0 | 0 | 0 |
Rank | Target | Score | Validated | KEGG | DrugBank | Matador |
---|---|---|---|---|---|---|
1 | hsa2743 ( glycine receptor beta ) | 0.830159 | 0 | 0 | 0 | 0 |
2 | hsa6530 ( solute carrier family 6 member 2 ) | 0.808539 | 0 | 0 | 0 | 0 |
3 | hsa2554 ( gamma-aminobutyric acid type A receptor alpha1 subunit ) | 0.796537 | 0 | 0 | 0 | 0 |
4 | hsa6532 ( solute carrier family 6 member 4 ) | 0.762482 | 0 | 0 | 0 | 0 |
5 | hsa116443 ( glutamate ionotropic receptor NMDA type subunit 3A ) | 0.750934 | 0 | 0 | 0 | 0 |
6 | hsa2890 ( glutamate ionotropic receptor AMPA type subunit 1 ) | 0.729667 | 0 | 0 | 0 | 0 |
7 | hsa6531 ( solute carrier family 6 member 3 ) | 0.71108 | 0 | 0 | 0 | 0 |
8 | hsa6331 ( sodium voltage-gated channel alpha subunit 5 ) | 0.686064 | 0 | 0 | 0 | 0 |
9 | hsa3758 ( potassium voltage-gated channel subfamily J member 1 ) | 0.682252 | 0 | 0 | 0 | 0 |
10 | hsa3736 ( potassium voltage-gated channel subfamily A member 1 ) | 0.680243 | 0 | 0 | 0 | 0 |
Rank | Target | Score | Validated | KEGG | DrugBank | Matador |
---|---|---|---|---|---|---|
1 | hsa3741 ( potassium voltage-gated channel subfamily A member 5 ) | 0.804087 | 0 | 0 | 0 | 0 |
2 | hsa6332 ( sodium voltage-gated channel alpha subunit 7 ) | 0.796199 | 1 | 0 | 0 | 1 |
3 | hsa8913 ( calcium voltage-gated channel subunit alpha1 G ) | 0.733318 | 0 | 0 | 0 | 0 |
4 | hsa3763 ( potassium voltage-gated channel subfamily J member 6 ) | 0.713143 | 0 | 0 | 0 | 0 |
5 | hsa11280 ( sodium voltage-gated channel alpha subunit 11 ) | 0.710913 | 0 | 0 | 0 | 0 |
6 | hsa3758 ( potassium voltage-gated channel subfamily J member 1 ) | 0.656645 | 0 | 0 | 0 | 0 |
7 | hsa3743 ( potassium voltage-gated channel subfamily A member 7 ) | 0.629203 | 0 | 0 | 0 | 0 |
8 | hsa3359 ( 5-hydroxytryptamine receptor 3A ) | 0.605101 | 0 | 0 | 0 | 0 |
9 | hsa54207 ( potassium two pore domain channel subfamily K member 10 ) | 0.597854 | 0 | 0 | 0 | 0 |
10 | hsa8911 ( calcium voltage-gated channel subunit alpha1 I ) | 0.597375 | 0 | 0 | 0 | 0 |
Rank | Target | Score | Validated | KEGG | DrugBank | Matador |
---|---|---|---|---|---|---|
1 | hsa6336 ( sodium voltage-gated channel alpha subunit 10 ) | 0.962502 | 0 | 0 | 0 | 0 |
2 | hsa8645 ( potassium two pore domain channel subfamily K member 5 ) | 0.934381 | 0 | 0 | 0 | 0 |
3 | hsa3763 ( potassium voltage-gated channel subfamily J member 6 ) | 0.841845 | 0 | 0 | 0 | 0 |
4 | hsa3741 ( potassium voltage-gated channel subfamily A member 5 ) | 0.801278 | 0 | 0 | 0 | 0 |
5 | hsa3782 ( potassium calcium-activated channel subfamily N member 3 ) | 0.723752 | 0 | 0 | 0 | 0 |
6 | hsa6332 ( sodium voltage-gated channel alpha subunit 7 ) | 0.720255 | 0 | 0 | 0 | 0 |
7 | hsa3758 ( potassium voltage-gated channel subfamily J member 1 ) | 0.712393 | 0 | 0 | 0 | 0 |
8 | hsa3781 ( potassium calcium-activated channel subfamily N member 2 ) | 0.701924 | 0 | 0 | 0 | 0 |
9 | hsa8913 ( calcium voltage-gated channel subunit alpha1 G ) | 0.681543 | 0 | 0 | 0 | 0 |
10 | hsa3743 ( potassium voltage-gated channel subfamily A member 7 ) | 0.662814 | 0 | 0 | 0 | 0 |
Rank | Target | Score | Validated | KEGG | DrugBank | Matador |
---|---|---|---|---|---|---|
1 | hsa6336 ( sodium voltage-gated channel alpha subunit 10 ) | 0.976725 | 0 | 0 | 0 | 0 |
2 | hsa8645 ( potassium two pore domain channel subfamily K member 5 ) | 0.952255 | 0 | 0 | 0 | 0 |
3 | hsa3741 ( potassium voltage-gated channel subfamily A member 5 ) | 0.819595 | 0 | 0 | 0 | 0 |
4 | hsa6332 ( sodium voltage-gated channel alpha subunit 7 ) | 0.77906 | 0 | 0 | 0 | 0 |
5 | hsa8913 ( calcium voltage-gated channel subunit alpha1 G ) | 0.737144 | 0 | 0 | 0 | 0 |
6 | hsa3763 ( potassium voltage-gated channel subfamily J member 6 ) | 0.734838 | 0 | 0 | 0 | 0 |
7 | hsa11280 ( sodium voltage-gated channel alpha subunit 11 ) | 0.69082 | 0 | 0 | 0 | 0 |
8 | hsa3743 ( potassium voltage-gated channel subfamily A member 7 ) | 0.66784 | 0 | 0 | 0 | 0 |
9 | hsa3758 ( potassium voltage-gated channel subfamily J member 1 ) | 0.658988 | 0 | 0 | 0 | 0 |
10 | hsa54207 ( potassium two pore domain channel subfamily K member 10 ) | 0.610291 | 0 | 0 | 0 | 0 |
Rank | Target | Score | Validated | KEGG | DrugBank | Matador |
---|---|---|---|---|---|---|
1 | hsa27133 ( potassium voltage-gated channel subfamily H member 5 ) | 0.821594 | 0 | 0 | 0 | 0 |
2 | hsa3758 ( potassium voltage-gated channel subfamily J member 1 ) | 0.783067 | 0 | 0 | 0 | 0 |
3 | hsa3783 ( potassium calcium-activated channel subfamily N member 4 ) | 0.764562 | 0 | 0 | 0 | 0 |
4 | hsa3776 ( potassium two pore domain channel subfamily K member 2 ) | 0.751978 | 0 | 0 | 0 | 0 |
5 | hsa3767 ( potassium voltage-gated channel subfamily J member 11 ) | 0.746167 | 0 | 0 | 0 | 0 |
6 | hsa3744 ( potassium voltage-gated channel subfamily A member 10 ) | 0.716619 | 0 | 0 | 0 | 0 |
7 | hsa3782 ( potassium calcium-activated channel subfamily N member 3 ) | 0.712277 | 0 | 0 | 0 | 0 |
8 | hsa90134 ( potassium voltage-gated channel subfamily H member 7 ) | 0.70633 | 0 | 0 | 0 | 0 |
9 | hsa81033 ( potassium voltage-gated channel subfamily H member 6 ) | 0.702034 | 0 | 0 | 0 | 0 |
10 | hsa3781 ( potassium calcium-activated channel subfamily N member 2 ) | 0.701642 | 0 | 0 | 0 | 0 |
Rank | Target | Score | Validated | KEGG | DrugBank | Matador |
---|---|---|---|---|---|---|
1 | hsa8645 ( potassium two pore domain channel subfamily K member 5 ) | 0.940591 | 0 | 0 | 0 | 0 |
2 | hsa6332 ( sodium voltage-gated channel alpha subunit 7 ) | 0.79964 | 0 | 0 | 0 | 0 |
3 | hsa8913 ( calcium voltage-gated channel subunit alpha1 G ) | 0.760404 | 0 | 0 | 0 | 0 |
4 | hsa3741 ( potassium voltage-gated channel subfamily A member 5 ) | 0.749662 | 0 | 0 | 0 | 0 |
5 | hsa11280 ( sodium voltage-gated channel alpha subunit 11 ) | 0.716523 | 0 | 0 | 0 | 0 |
6 | hsa3359 ( 5-hydroxytryptamine receptor 3A ) | 0.6548 | 0 | 0 | 0 | 0 |
7 | hsa3763 ( potassium voltage-gated channel subfamily J member 6 ) | 0.653768 | 0 | 0 | 0 | 0 |
8 | hsa3758 ( potassium voltage-gated channel subfamily J member 1 ) | 0.649043 | 0 | 0 | 0 | 0 |
9 | hsa6261 ( ryanodine receptor 1 ) | 0.624095 | 0 | 0 | 0 | 0 |
10 | hsa8911 ( calcium voltage-gated channel subunit alpha1 I ) | 0.622894 | 0 | 0 | 0 | 0 |
Rank | Target | Score | Validated | KEGG | DrugBank | Matador |
---|---|---|---|---|---|---|
1 | hsa1141 ( cholinergic receptor nicotinic beta 2 subunit ) | 0.973667 | 0 | 0 | 0 | 0 |
2 | hsa1145 ( cholinergic receptor nicotinic epsilon subunit ) | 0.896246 | 0 | 0 | 0 | 0 |
3 | hsa3359 ( 5-hydroxytryptamine receptor 3A ) | 0.861632 | 0 | 0 | 0 | 0 |
4 | hsa2554 ( gamma-aminobutyric acid type A receptor alpha1 subunit ) | 0.795272 | 0 | 0 | 0 | 0 |
5 | hsa1144 ( cholinergic receptor nicotinic delta subunit ) | 0.78884 | 0 | 0 | 0 | 0 |
6 | hsa9312 ( potassium voltage-gated channel subfamily B member 2 ) | 0.776207 | 0 | 0 | 0 | 0 |
7 | hsa1140 ( cholinergic receptor nicotinic beta 1 subunit ) | 0.723109 | 0 | 0 | 0 | 0 |
8 | hsa3752 ( potassium voltage-gated channel subfamily D member 3 ) | 0.720567 | 0 | 0 | 0 | 0 |
9 | hsa9177 ( 5-hydroxytryptamine receptor 3B ) | 0.683434 | 0 | 0 | 0 | 0 |
10 | hsa285242 ( 5-hydroxytryptamine receptor 3E ) | 0.669454 | 0 | 0 | 0 | 0 |
Rank | Target | Score | Validated | KEGG | DrugBank | Matador |
---|---|---|---|---|---|---|
1 | hsa3781 ( potassium calcium-activated channel subfamily N member 2 ) | 0.979872 | 0 | 0 | 0 | 0 |
2 | hsa3780 ( potassium calcium-activated channel subfamily N member 1 ) | 0.954155 | 0 | 0 | 0 | 0 |
3 | hsa3763 ( potassium voltage-gated channel subfamily J member 6 ) | 0.905376 | 0 | 0 | 0 | 0 |
4 | hsa3783 ( potassium calcium-activated channel subfamily N member 4 ) | 0.861858 | 0 | 0 | 0 | 0 |
5 | hsa3758 ( potassium voltage-gated channel subfamily J member 1 ) | 0.781542 | 0 | 0 | 0 | 0 |
6 | hsa3767 ( potassium voltage-gated channel subfamily J member 11 ) | 0.729873 | 0 | 0 | 0 | 0 |
7 | hsa3757 ( potassium voltage-gated channel subfamily H member 2 ) | 0.727423 | 0 | 0 | 0 | 0 |
8 | hsa3784 ( potassium voltage-gated channel subfamily Q member 1 ) | 0.711847 | 0 | 0 | 0 | 0 |
9 | hsa6530 ( solute carrier family 6 member 2 ) | 0.71123 | 0 | 0 | 0 | 0 |
10 | hsa2554 ( gamma-aminobutyric acid type A receptor alpha1 subunit ) | 0.700337 | 0 | 0 | 0 | 0 |
Rank | Target | Score | Validated | KEGG | DrugBank | Matador |
---|---|---|---|---|---|---|
1 | hsa1141 ( cholinergic receptor nicotinic beta 2 subunit ) | 0.967225 | 1 | 0 | 1 | 0 |
2 | hsa3359 ( 5-hydroxytryptamine receptor 3A ) | 0.902692 | 0 | 0 | 0 | 0 |
3 | hsa1145 ( cholinergic receptor nicotinic epsilon subunit ) | 0.887257 | 1 | 0 | 1 | 0 |
4 | hsa2554 ( gamma-aminobutyric acid type A receptor alpha1 subunit ) | 0.793064 | 0 | 0 | 0 | 0 |
5 | hsa1144 ( cholinergic receptor nicotinic delta subunit ) | 0.783157 | 1 | 0 | 1 | 0 |
6 | hsa9177 ( 5-hydroxytryptamine receptor 3B ) | 0.761592 | 0 | 0 | 0 | 0 |
7 | hsa285242 ( 5-hydroxytryptamine receptor 3E ) | 0.75922 | 0 | 0 | 0 | 0 |
8 | hsa1140 ( cholinergic receptor nicotinic beta 1 subunit ) | 0.717255 | 1 | 0 | 1 | 0 |
9 | hsa9312 ( potassium voltage-gated channel subfamily B member 2 ) | 0.701887 | 0 | 0 | 0 | 0 |
10 | hsa3752 ( potassium voltage-gated channel subfamily D member 3 ) | 0.68649 | 0 | 0 | 0 | 0 |
Rank | Target | Score | Validated | KEGG | DrugBank | Matador |
---|---|---|---|---|---|---|
1 | hsa1141 ( cholinergic receptor nicotinic beta 2 subunit ) | 0.964985 | 1 | 1 | 0 | 0 |
2 | hsa1145 ( cholinergic receptor nicotinic epsilon subunit ) | 0.86814 | 0 | 0 | 0 | 0 |
3 | hsa3359 ( 5-hydroxytryptamine receptor 3A ) | 0.826631 | 0 | 0 | 0 | 0 |
4 | hsa9312 ( potassium voltage-gated channel subfamily B member 2 ) | 0.764839 | 0 | 0 | 0 | 0 |
5 | hsa1144 ( cholinergic receptor nicotinic delta subunit ) | 0.748947 | 0 | 0 | 0 | 0 |
6 | hsa2554 ( gamma-aminobutyric acid type A receptor alpha1 subunit ) | 0.739323 | 0 | 0 | 0 | 0 |
7 | hsa3752 ( potassium voltage-gated channel subfamily D member 3 ) | 0.731913 | 0 | 0 | 0 | 0 |
8 | hsa1140 ( cholinergic receptor nicotinic beta 1 subunit ) | 0.683893 | 0 | 0 | 0 | 0 |
9 | hsa3781 ( potassium calcium-activated channel subfamily N member 2 ) | 0.664328 | 0 | 0 | 0 | 0 |
10 | hsa3758 ( potassium voltage-gated channel subfamily J member 1 ) | 0.646818 | 0 | 0 | 0 | 0 |
Rank | Target | Score | Validated | KEGG | DrugBank | Matador |
---|---|---|---|---|---|---|
1 | hsa1141 ( cholinergic receptor nicotinic beta 2 subunit ) | 0.933062 | 0 | 0 | 0 | 0 |
2 | hsa3782 ( potassium calcium-activated channel subfamily N member 3 ) | 0.861009 | 0 | 0 | 0 | 0 |
3 | hsa1145 ( cholinergic receptor nicotinic epsilon subunit ) | 0.799004 | 1 | 1 | 0 | 0 |
4 | hsa9312 ( potassium voltage-gated channel subfamily B member 2 ) | 0.759068 | 0 | 0 | 0 | 0 |
5 | hsa2566 ( gamma-aminobutyric acid type A receptor gamma2 subunit ) | 0.755539 | 0 | 0 | 0 | 0 |
6 | hsa3359 ( 5-hydroxytryptamine receptor 3A ) | 0.749879 | 1 | 0 | 1 | 0 |
7 | hsa2567 ( gamma-aminobutyric acid type A receptor gamma3 subunit ) | 0.74847 | 0 | 0 | 0 | 0 |
8 | hsa2564 ( gamma-aminobutyric acid type A receptor epsilon subunit ) | 0.730978 | 0 | 0 | 0 | 0 |
9 | hsa3783 ( potassium calcium-activated channel subfamily N member 4 ) | 0.673781 | 0 | 0 | 0 | 0 |
10 | hsa1144 ( cholinergic receptor nicotinic delta subunit ) | 0.671301 | 1 | 1 | 0 | 0 |
Rank | Target | Score | Validated | KEGG | DrugBank | Matador |
---|---|---|---|---|---|---|
1 | hsa3782 ( potassium calcium-activated channel subfamily N member 3 ) | 0.978851 | 0 | 0 | 0 | 0 |
2 | hsa3780 ( potassium calcium-activated channel subfamily N member 1 ) | 0.943485 | 0 | 0 | 0 | 0 |
3 | hsa3783 ( potassium calcium-activated channel subfamily N member 4 ) | 0.863447 | 0 | 0 | 0 | 0 |
4 | hsa3763 ( potassium voltage-gated channel subfamily J member 6 ) | 0.851549 | 0 | 0 | 0 | 0 |
5 | hsa3757 ( potassium voltage-gated channel subfamily H member 2 ) | 0.795508 | 0 | 0 | 0 | 0 |
6 | hsa3758 ( potassium voltage-gated channel subfamily J member 1 ) | 0.775744 | 0 | 0 | 0 | 0 |
7 | hsa2554 ( gamma-aminobutyric acid type A receptor alpha1 subunit ) | 0.74614 | 0 | 0 | 0 | 0 |
8 | hsa3767 ( potassium voltage-gated channel subfamily J member 11 ) | 0.732934 | 0 | 0 | 0 | 0 |
9 | hsa3784 ( potassium voltage-gated channel subfamily Q member 1 ) | 0.711512 | 0 | 0 | 0 | 0 |
10 | hsa3359 ( 5-hydroxytryptamine receptor 3A ) | 0.708689 | 1 | 0 | 0 | 1 |
Rank | Target | Score | Validated | KEGG | DrugBank | Matador |
---|---|---|---|---|---|---|
1 | hsa6532 ( solute carrier family 6 member 4 ) | 0.966065 | 0 | 0 | 0 | 0 |
2 | hsa6531 ( solute carrier family 6 member 3 ) | 0.956277 | 0 | 0 | 0 | 0 |
3 | hsa11254 ( solute carrier family 6 member 14 ) | 0.839532 | 0 | 0 | 0 | 0 |
4 | hsa6534 ( solute carrier family 6 member 7 ) | 0.816616 | 0 | 0 | 0 | 0 |
5 | hsa6529 ( solute carrier family 6 member 1 ) | 0.796066 | 0 | 0 | 0 | 0 |
6 | hsa3758 ( potassium voltage-gated channel subfamily J member 1 ) | 0.724076 | 0 | 0 | 0 | 0 |
7 | hsa3782 ( potassium calcium-activated channel subfamily N member 3 ) | 0.720203 | 0 | 0 | 0 | 0 |
8 | hsa1135 ( cholinergic receptor nicotinic alpha 2 subunit ) | 0.715486 | 1 | 0 | 0 | 1 |
9 | hsa3359 ( 5-hydroxytryptamine receptor 3A ) | 0.711712 | 0 | 0 | 0 | 0 |
10 | hsa1141 ( cholinergic receptor nicotinic beta 2 subunit ) | 0.709177 | 1 | 0 | 0 | 1 |
Rank | Target | Score | Validated | KEGG | DrugBank | Matador |
---|---|---|---|---|---|---|
1 | hsa2564 ( gamma-aminobutyric acid type A receptor epsilon subunit ) | 0.912837 | 1 | 1 | 1 | 1 |
2 | hsa2566 ( gamma-aminobutyric acid type A receptor gamma2 subunit ) | 0.912577 | 1 | 1 | 1 | 1 |
3 | hsa2567 ( gamma-aminobutyric acid type A receptor gamma3 subunit ) | 0.910957 | 1 | 1 | 1 | 1 |
4 | hsa55879 ( gamma-aminobutyric acid type A receptor theta subunit ) | 0.880356 | 1 | 1 | 1 | 1 |
5 | hsa2561 ( gamma-aminobutyric acid type A receptor beta2 subunit ) | 0.877095 | 1 | 1 | 1 | 1 |
6 | hsa2569 ( gamma-aminobutyric acid type A receptor rho1 subunit ) | 0.875712 | 1 | 0 | 0 | 1 |
7 | hsa2563 ( gamma-aminobutyric acid type A receptor delta subunit ) | 0.875237 | 1 | 1 | 1 | 1 |
8 | hsa2562 ( gamma-aminobutyric acid type A receptor beta3 subunit ) | 0.871086 | 1 | 1 | 1 | 1 |
9 | hsa2560 ( gamma-aminobutyric acid type A receptor beta1 subunit ) | 0.862823 | 1 | 1 | 1 | 1 |
10 | hsa2741 ( glycine receptor alpha 1 ) | 0.813644 | 0 | 0 | 0 | 0 |
Rank | Target | Score | Validated | KEGG | DrugBank | Matador |
---|---|---|---|---|---|---|
1 | hsa3741 ( potassium voltage-gated channel subfamily A member 5 ) | 0.939029 | 0 | 0 | 0 | 0 |
2 | hsa3743 ( potassium voltage-gated channel subfamily A member 7 ) | 0.913462 | 0 | 0 | 0 | 0 |
3 | hsa3736 ( potassium voltage-gated channel subfamily A member 1 ) | 0.858608 | 0 | 0 | 0 | 0 |
4 | hsa3739 ( potassium voltage-gated channel subfamily A member 4 ) | 0.852635 | 0 | 0 | 0 | 0 |
5 | hsa3737 ( potassium voltage-gated channel subfamily A member 2 ) | 0.835225 | 0 | 0 | 0 | 0 |
6 | hsa3744 ( potassium voltage-gated channel subfamily A member 10 ) | 0.826376 | 0 | 0 | 0 | 0 |
7 | hsa3746 ( potassium voltage-gated channel subfamily C member 1 ) | 0.825745 | 0 | 0 | 0 | 0 |
8 | hsa3763 ( potassium voltage-gated channel subfamily J member 6 ) | 0.799971 | 0 | 0 | 0 | 0 |
9 | hsa6331 ( sodium voltage-gated channel alpha subunit 5 ) | 0.79029 | 0 | 0 | 0 | 0 |
10 | hsa6323 ( sodium voltage-gated channel alpha subunit 1 ) | 0.763733 | 0 | 0 | 0 | 0 |
Rank | Target | Score | Validated | KEGG | DrugBank | Matador |
---|---|---|---|---|---|---|
1 | hsa3741 ( potassium voltage-gated channel subfamily A member 5 ) | 0.930478 | 0 | 0 | 0 | 0 |
2 | hsa3743 ( potassium voltage-gated channel subfamily A member 7 ) | 0.899897 | 0 | 0 | 0 | 0 |
3 | hsa3736 ( potassium voltage-gated channel subfamily A member 1 ) | 0.855096 | 0 | 0 | 0 | 0 |
4 | hsa3739 ( potassium voltage-gated channel subfamily A member 4 ) | 0.848163 | 0 | 0 | 0 | 0 |
5 | hsa3737 ( potassium voltage-gated channel subfamily A member 2 ) | 0.823375 | 0 | 0 | 0 | 0 |
6 | hsa3744 ( potassium voltage-gated channel subfamily A member 10 ) | 0.815469 | 0 | 0 | 0 | 0 |
7 | hsa3746 ( potassium voltage-gated channel subfamily C member 1 ) | 0.812527 | 0 | 0 | 0 | 0 |
8 | hsa1135 ( cholinergic receptor nicotinic alpha 2 subunit ) | 0.790274 | 0 | 0 | 0 | 0 |
9 | hsa3763 ( potassium voltage-gated channel subfamily J member 6 ) | 0.761406 | 0 | 0 | 0 | 0 |
10 | hsa3757 ( potassium voltage-gated channel subfamily H member 2 ) | 0.759552 | 0 | 0 | 0 | 0 |
Rank | Target | Score | Validated | KEGG | DrugBank | Matador |
---|---|---|---|---|---|---|
1 | hsa3738 ( potassium voltage-gated channel subfamily A member 3 ) | 0.898009 | 0 | 0 | 0 | 0 |
2 | hsa6336 ( sodium voltage-gated channel alpha subunit 10 ) | 0.895848 | 0 | 0 | 0 | 0 |
3 | hsa3757 ( potassium voltage-gated channel subfamily H member 2 ) | 0.88947 | 1 | 0 | 1 | 0 |
4 | hsa9312 ( potassium voltage-gated channel subfamily B member 2 ) | 0.828815 | 0 | 0 | 0 | 0 |
5 | hsa3737 ( potassium voltage-gated channel subfamily A member 2 ) | 0.787992 | 0 | 0 | 0 | 0 |
6 | hsa3736 ( potassium voltage-gated channel subfamily A member 1 ) | 0.783109 | 0 | 0 | 0 | 0 |
7 | hsa3744 ( potassium voltage-gated channel subfamily A member 10 ) | 0.747179 | 0 | 0 | 0 | 0 |
8 | hsa3746 ( potassium voltage-gated channel subfamily C member 1 ) | 0.739358 | 0 | 0 | 0 | 0 |
9 | hsa3763 ( potassium voltage-gated channel subfamily J member 6 ) | 0.732783 | 0 | 0 | 0 | 0 |
10 | hsa3758 ( potassium voltage-gated channel subfamily J member 1 ) | 0.69611 | 0 | 0 | 0 | 0 |
Rank | Target | Score | Validated | KEGG | DrugBank | Matador |
---|---|---|---|---|---|---|
1 | hsa6263 ( ryanodine receptor 3 ) | 0.970142 | 1 | 1 | 0 | 0 |
2 | hsa6262 ( ryanodine receptor 2 ) | 0.966156 | 1 | 1 | 0 | 0 |
3 | hsa1080 ( cystic fibrosis transmembrane conductance regulator ) | 0.84462 | 0 | 0 | 0 | 0 |
4 | hsa3783 ( potassium calcium-activated channel subfamily N member 4 ) | 0.823606 | 0 | 0 | 0 | 0 |
5 | hsa2554 ( gamma-aminobutyric acid type A receptor alpha1 subunit ) | 0.802144 | 0 | 0 | 0 | 0 |
6 | hsa775 ( calcium voltage-gated channel subunit alpha1 C ) | 0.699873 | 0 | 0 | 0 | 0 |
7 | hsa6331 ( sodium voltage-gated channel alpha subunit 5 ) | 0.697864 | 0 | 0 | 0 | 0 |
8 | hsa8913 ( calcium voltage-gated channel subunit alpha1 G ) | 0.680453 | 0 | 0 | 0 | 0 |
9 | hsa3359 ( 5-hydroxytryptamine receptor 3A ) | 0.666607 | 0 | 0 | 0 | 0 |
10 | hsa3758 ( potassium voltage-gated channel subfamily J member 1 ) | 0.664413 | 0 | 0 | 0 | 0 |
Rank | Target | Score | Validated | KEGG | DrugBank | Matador |
---|---|---|---|---|---|---|
1 | hsa3767 ( potassium voltage-gated channel subfamily J member 11 ) | 0.75149 | 1 | 0 | 1 | 0 |
2 | hsa6833 ( ATP binding cassette subfamily C member 8 ) | 0.539372 | 0 | 0 | 0 | 0 |
3 | hsa6323 ( sodium voltage-gated channel alpha subunit 1 ) | 0.432318 | 0 | 0 | 0 | 0 |
4 | hsa2890 ( glutamate ionotropic receptor AMPA type subunit 1 ) | 0.403761 | 0 | 0 | 0 | 0 |
5 | hsa2891 ( glutamate ionotropic receptor AMPA type subunit 2 ) | 0.376561 | 0 | 0 | 0 | 0 |
6 | hsa3776 ( potassium two pore domain channel subfamily K member 2 ) | 0.363173 | 0 | 0 | 0 | 0 |
7 | hsa6334 ( sodium voltage-gated channel alpha subunit 8 ) | 0.359564 | 0 | 0 | 0 | 0 |
8 | hsa6335 ( sodium voltage-gated channel alpha subunit 9 ) | 0.353044 | 0 | 0 | 0 | 0 |
9 | hsa6326 ( sodium voltage-gated channel alpha subunit 2 ) | 0.332447 | 0 | 0 | 0 | 0 |
10 | hsa1080 ( cystic fibrosis transmembrane conductance regulator ) | 0.324746 | 0 | 0 | 0 | 0 |
Rank | Target | Score | Validated | KEGG | DrugBank | Matador |
---|---|---|---|---|---|---|
1 | hsa6530 ( solute carrier family 6 member 2 ) | 0.976258 | 0 | 0 | 0 | 0 |
2 | hsa6531 ( solute carrier family 6 member 3 ) | 0.93186 | 1 | 0 | 1 | 0 |
3 | hsa11254 ( solute carrier family 6 member 14 ) | 0.840278 | 0 | 0 | 0 | 0 |
4 | hsa3782 ( potassium calcium-activated channel subfamily N member 3 ) | 0.820671 | 0 | 0 | 0 | 0 |
5 | hsa6534 ( solute carrier family 6 member 7 ) | 0.816478 | 0 | 0 | 0 | 0 |
6 | hsa3359 ( 5-hydroxytryptamine receptor 3A ) | 0.801074 | 0 | 0 | 0 | 0 |
7 | hsa116443 ( glutamate ionotropic receptor NMDA type subunit 3A ) | 0.793629 | 0 | 0 | 0 | 0 |
8 | hsa6529 ( solute carrier family 6 member 1 ) | 0.787438 | 0 | 0 | 0 | 0 |
9 | hsa3758 ( potassium voltage-gated channel subfamily J member 1 ) | 0.731077 | 0 | 0 | 0 | 0 |
10 | hsa1135 ( cholinergic receptor nicotinic alpha 2 subunit ) | 0.723385 | 0 | 0 | 0 | 0 |
Rank | Target | Score | Validated | KEGG | DrugBank | Matador |
---|---|---|---|---|---|---|
1 | hsa6530 ( solute carrier family 6 member 2 ) | 0.975019 | 1 | 0 | 1 | 0 |
2 | hsa6531 ( solute carrier family 6 member 3 ) | 0.933407 | 0 | 0 | 0 | 0 |
3 | hsa11254 ( solute carrier family 6 member 14 ) | 0.841437 | 0 | 0 | 0 | 0 |
4 | hsa6534 ( solute carrier family 6 member 7 ) | 0.816929 | 0 | 0 | 0 | 0 |
5 | hsa116443 ( glutamate ionotropic receptor NMDA type subunit 3A ) | 0.811746 | 0 | 0 | 0 | 0 |
6 | hsa6529 ( solute carrier family 6 member 1 ) | 0.794954 | 0 | 0 | 0 | 0 |
7 | hsa6331 ( sodium voltage-gated channel alpha subunit 5 ) | 0.74071 | 0 | 0 | 0 | 0 |
8 | hsa3758 ( potassium voltage-gated channel subfamily J member 1 ) | 0.73808 | 0 | 0 | 0 | 0 |
9 | hsa3782 ( potassium calcium-activated channel subfamily N member 3 ) | 0.737271 | 0 | 0 | 0 | 0 |
10 | hsa3359 ( 5-hydroxytryptamine receptor 3A ) | 0.724032 | 0 | 0 | 0 | 0 |
Rank | Target | Score | Validated | KEGG | DrugBank | Matador |
---|---|---|---|---|---|---|
1 | hsa3782 ( potassium calcium-activated channel subfamily N member 3 ) | 0.800948 | 0 | 0 | 0 | 0 |
2 | hsa3781 ( potassium calcium-activated channel subfamily N member 2 ) | 0.7775 | 0 | 0 | 0 | 0 |
3 | hsa3758 ( potassium voltage-gated channel subfamily J member 1 ) | 0.765553 | 0 | 0 | 0 | 0 |
4 | hsa6833 ( ATP binding cassette subfamily C member 8 ) | 0.761103 | 0 | 0 | 0 | 0 |
5 | hsa5026 ( purinergic receptor P2X 5 ) | 0.75045 | 1 | 0 | 0 | 1 |
6 | hsa3359 ( 5-hydroxytryptamine receptor 3A ) | 0.720051 | 0 | 0 | 0 | 0 |
7 | hsa3757 ( potassium voltage-gated channel subfamily H member 2 ) | 0.711 | 0 | 0 | 0 | 0 |
8 | hsa5024 ( purinergic receptor P2X 3 ) | 0.699703 | 1 | 0 | 0 | 1 |
9 | hsa5025 ( purinergic receptor P2X 4 ) | 0.694343 | 1 | 0 | 0 | 1 |
10 | hsa5027 ( purinergic receptor P2X 7 ) | 0.694293 | 1 | 0 | 0 | 1 |
Rank | Target | Score | Validated | KEGG | DrugBank | Matador |
---|---|---|---|---|---|---|
1 | hsa2567 ( gamma-aminobutyric acid type A receptor gamma3 subunit ) | 0.875665 | 0 | 0 | 0 | 0 |
2 | hsa2564 ( gamma-aminobutyric acid type A receptor epsilon subunit ) | 0.874401 | 0 | 0 | 0 | 0 |
3 | hsa2566 ( gamma-aminobutyric acid type A receptor gamma2 subunit ) | 0.873988 | 0 | 0 | 0 | 0 |
4 | hsa55879 ( gamma-aminobutyric acid type A receptor theta subunit ) | 0.830158 | 0 | 0 | 0 | 0 |
5 | hsa2561 ( gamma-aminobutyric acid type A receptor beta2 subunit ) | 0.825192 | 0 | 0 | 0 | 0 |
6 | hsa2569 ( gamma-aminobutyric acid type A receptor rho1 subunit ) | 0.824099 | 0 | 0 | 0 | 0 |
7 | hsa2563 ( gamma-aminobutyric acid type A receptor delta subunit ) | 0.822649 | 0 | 0 | 0 | 0 |
8 | hsa2562 ( gamma-aminobutyric acid type A receptor beta3 subunit ) | 0.815959 | 0 | 0 | 0 | 0 |
9 | hsa2560 ( gamma-aminobutyric acid type A receptor beta1 subunit ) | 0.806097 | 0 | 0 | 0 | 0 |
10 | hsa3736 ( potassium voltage-gated channel subfamily A member 1 ) | 0.781326 | 0 | 0 | 0 | 0 |
Rank | Target | Score | Validated | KEGG | DrugBank | Matador |
---|---|---|---|---|---|---|
1 | hsa3782 ( potassium calcium-activated channel subfamily N member 3 ) | 0.822651 | 0 | 0 | 0 | 0 |
2 | hsa3781 ( potassium calcium-activated channel subfamily N member 2 ) | 0.817902 | 0 | 0 | 0 | 0 |
3 | hsa27133 ( potassium voltage-gated channel subfamily H member 5 ) | 0.81497 | 0 | 0 | 0 | 0 |
4 | hsa3783 ( potassium calcium-activated channel subfamily N member 4 ) | 0.798274 | 0 | 0 | 0 | 0 |
5 | hsa3744 ( potassium voltage-gated channel subfamily A member 10 ) | 0.764879 | 0 | 0 | 0 | 0 |
6 | hsa3758 ( potassium voltage-gated channel subfamily J member 1 ) | 0.760597 | 0 | 0 | 0 | 0 |
7 | hsa3763 ( potassium voltage-gated channel subfamily J member 6 ) | 0.741214 | 0 | 0 | 0 | 0 |
8 | hsa3743 ( potassium voltage-gated channel subfamily A member 7 ) | 0.721844 | 0 | 0 | 0 | 0 |
9 | hsa3767 ( potassium voltage-gated channel subfamily J member 11 ) | 0.719366 | 0 | 0 | 0 | 0 |
10 | hsa3776 ( potassium two pore domain channel subfamily K member 2 ) | 0.717417 | 0 | 0 | 0 | 0 |
Rank | Target | Score | Validated | KEGG | DrugBank | Matador |
---|---|---|---|---|---|---|
1 | hsa2891 ( glutamate ionotropic receptor AMPA type subunit 2 ) | 0.891716 | 0 | 0 | 0 | 0 |
2 | hsa2890 ( glutamate ionotropic receptor AMPA type subunit 1 ) | 0.886708 | 0 | 0 | 0 | 0 |
3 | hsa116443 ( glutamate ionotropic receptor NMDA type subunit 3A ) | 0.797313 | 0 | 0 | 0 | 0 |
4 | hsa2554 ( gamma-aminobutyric acid type A receptor alpha1 subunit ) | 0.794021 | 0 | 0 | 0 | 0 |
5 | hsa2892 ( glutamate ionotropic receptor AMPA type subunit 3 ) | 0.792478 | 0 | 0 | 0 | 0 |
6 | hsa1135 ( cholinergic receptor nicotinic alpha 2 subunit ) | 0.777848 | 0 | 0 | 0 | 0 |
7 | hsa2893 ( glutamate ionotropic receptor AMPA type subunit 4 ) | 0.760024 | 0 | 0 | 0 | 0 |
8 | hsa2895 ( glutamate ionotropic receptor delta type subunit 2 ) | 0.752219 | 0 | 0 | 0 | 0 |
9 | hsa3359 ( 5-hydroxytryptamine receptor 3A ) | 0.741266 | 0 | 0 | 0 | 0 |
10 | hsa6331 ( sodium voltage-gated channel alpha subunit 5 ) | 0.740116 | 0 | 0 | 0 | 0 |
Rank | Target | Score | Validated | KEGG | DrugBank | Matador |
---|---|---|---|---|---|---|
1 | hsa6532 ( solute carrier family 6 member 4 ) | 0.97204 | 0 | 0 | 0 | 0 |
2 | hsa6531 ( solute carrier family 6 member 3 ) | 0.948695 | 0 | 0 | 0 | 0 |
3 | hsa3782 ( potassium calcium-activated channel subfamily N member 3 ) | 0.873826 | 0 | 0 | 0 | 0 |
4 | hsa11254 ( solute carrier family 6 member 14 ) | 0.843816 | 0 | 0 | 0 | 0 |
5 | hsa6534 ( solute carrier family 6 member 7 ) | 0.822314 | 0 | 0 | 0 | 0 |
6 | hsa3781 ( potassium calcium-activated channel subfamily N member 2 ) | 0.800316 | 0 | 0 | 0 | 0 |
7 | hsa6529 ( solute carrier family 6 member 1 ) | 0.793504 | 0 | 0 | 0 | 0 |
8 | hsa3758 ( potassium voltage-gated channel subfamily J member 1 ) | 0.722784 | 0 | 0 | 0 | 0 |
9 | hsa3359 ( 5-hydroxytryptamine receptor 3A ) | 0.720986 | 0 | 0 | 0 | 0 |
10 | hsa116443 ( glutamate ionotropic receptor NMDA type subunit 3A ) | 0.713335 | 0 | 0 | 0 | 0 |
Rank | Target | Score | Validated | KEGG | DrugBank | Matador |
---|---|---|---|---|---|---|
1 | hsa775 ( calcium voltage-gated channel subunit alpha1 C ) | 0.861231 | 0 | 0 | 0 | 0 |
2 | hsa777 ( calcium voltage-gated channel subunit alpha1 E ) | 0.848778 | 0 | 0 | 0 | 0 |
3 | hsa773 ( calcium voltage-gated channel subunit alpha1 A ) | 0.828596 | 0 | 0 | 0 | 0 |
4 | hsa779 ( calcium voltage-gated channel subunit alpha1 S ) | 0.828593 | 0 | 0 | 0 | 0 |
5 | hsa786 ( calcium voltage-gated channel auxiliary subunit gamma 1 ) | 0.828249 | 0 | 0 | 0 | 0 |
6 | hsa778 ( calcium voltage-gated channel subunit alpha1 F ) | 0.825135 | 0 | 0 | 0 | 0 |
7 | hsa776 ( calcium voltage-gated channel subunit alpha1 D ) | 0.814836 | 0 | 0 | 0 | 0 |
8 | hsa781 ( calcium voltage-gated channel auxiliary subunit alpha2delta 1 ) | 0.811302 | 0 | 0 | 0 | 0 |
9 | hsa783 ( calcium voltage-gated channel auxiliary subunit beta 2 ) | 0.798379 | 0 | 0 | 0 | 0 |
10 | hsa3757 ( potassium voltage-gated channel subfamily H member 2 ) | 0.791662 | 0 | 0 | 0 | 0 |
Rank | Target | Score | Validated | KEGG | DrugBank | Matador |
---|---|---|---|---|---|---|
1 | hsa786 ( calcium voltage-gated channel auxiliary subunit gamma 1 ) | 0.939844 | 1 | 0 | 0 | 1 |
2 | hsa777 ( calcium voltage-gated channel subunit alpha1 E ) | 0.931716 | 0 | 0 | 0 | 0 |
3 | hsa93589 ( calcium voltage-gated channel auxiliary subunit alpha2delta 4 ) | 0.931626 | 0 | 0 | 0 | 0 |
4 | hsa783 ( calcium voltage-gated channel auxiliary subunit beta 2 ) | 0.926616 | 1 | 0 | 1 | 1 |
5 | hsa781 ( calcium voltage-gated channel auxiliary subunit alpha2delta 1 ) | 0.903972 | 1 | 0 | 1 | 0 |
6 | hsa8912 ( calcium voltage-gated channel subunit alpha1 H ) | 0.901485 | 0 | 0 | 0 | 0 |
7 | hsa8911 ( calcium voltage-gated channel subunit alpha1 I ) | 0.894562 | 0 | 0 | 0 | 0 |
8 | hsa8913 ( calcium voltage-gated channel subunit alpha1 G ) | 0.88934 | 0 | 0 | 0 | 0 |
9 | hsa774 ( calcium voltage-gated channel subunit alpha1 B ) | 0.884253 | 1 | 0 | 1 | 0 |
10 | hsa55799 ( calcium voltage-gated channel auxiliary subunit alpha2delta 3 ) | 0.865196 | 1 | 0 | 1 | 0 |
Rank | Target | Score | Validated | KEGG | DrugBank | Matador |
---|---|---|---|---|---|---|
1 | hsa3753 ( potassium voltage-gated channel subfamily E regulatory subunit 1 ) | 0.890028 | 0 | 0 | 0 | 0 |
2 | hsa3763 ( potassium voltage-gated channel subfamily J member 6 ) | 0.788641 | 0 | 0 | 0 | 0 |
3 | hsa3782 ( potassium calcium-activated channel subfamily N member 3 ) | 0.771313 | 0 | 0 | 0 | 0 |
4 | hsa9132 ( potassium voltage-gated channel subfamily Q member 4 ) | 0.764018 | 0 | 0 | 0 | 0 |
5 | hsa3758 ( potassium voltage-gated channel subfamily J member 1 ) | 0.751877 | 0 | 0 | 0 | 0 |
6 | hsa3781 ( potassium calcium-activated channel subfamily N member 2 ) | 0.751169 | 0 | 0 | 0 | 0 |
7 | hsa3757 ( potassium voltage-gated channel subfamily H member 2 ) | 0.742552 | 1 | 1 | 0 | 0 |
8 | hsa3767 ( potassium voltage-gated channel subfamily J member 11 ) | 0.72869 | 0 | 0 | 0 | 0 |
9 | hsa3778 ( potassium calcium-activated channel subfamily M alpha 1 ) | 0.699004 | 0 | 0 | 0 | 0 |
10 | hsa2554 ( gamma-aminobutyric acid type A receptor alpha1 subunit ) | 0.683636 | 0 | 0 | 0 | 0 |
Rank | Target | Score | Validated | KEGG | DrugBank | Matador |
---|---|---|---|---|---|---|
1 | hsa2555 ( gamma-aminobutyric acid type A receptor alpha2 subunit ) | 0.949676 | 1 | 0 | 1 | 0 |
2 | hsa2556 ( gamma-aminobutyric acid type A receptor alpha3 subunit ) | 0.945553 | 1 | 0 | 1 | 0 |
3 | hsa2558 ( gamma-aminobutyric acid type A receptor alpha5 subunit ) | 0.945505 | 1 | 0 | 1 | 0 |
4 | hsa2559 ( gamma-aminobutyric acid type A receptor alpha6 subunit ) | 0.943273 | 1 | 0 | 1 | 0 |
5 | hsa2557 ( gamma-aminobutyric acid type A receptor alpha4 subunit ) | 0.943023 | 1 | 0 | 1 | 0 |
6 | hsa2564 ( gamma-aminobutyric acid type A receptor epsilon subunit ) | 0.849248 | 1 | 0 | 1 | 0 |
7 | hsa2566 ( gamma-aminobutyric acid type A receptor gamma2 subunit ) | 0.848019 | 1 | 0 | 1 | 0 |
8 | hsa2567 ( gamma-aminobutyric acid type A receptor gamma3 subunit ) | 0.84781 | 1 | 0 | 1 | 0 |
9 | hsa55879 ( gamma-aminobutyric acid type A receptor theta subunit ) | 0.823154 | 1 | 0 | 1 | 0 |
10 | hsa2561 ( gamma-aminobutyric acid type A receptor beta2 subunit ) | 0.81872 | 1 | 0 | 1 | 0 |
Rank | Target | Score | Validated | KEGG | DrugBank | Matador |
---|---|---|---|---|---|---|
1 | hsa3780 ( potassium calcium-activated channel subfamily N member 1 ) | 0.946937 | 0 | 0 | 0 | 0 |
2 | hsa3783 ( potassium calcium-activated channel subfamily N member 4 ) | 0.878562 | 0 | 0 | 0 | 0 |
3 | hsa3763 ( potassium voltage-gated channel subfamily J member 6 ) | 0.871285 | 0 | 0 | 0 | 0 |
4 | hsa3757 ( potassium voltage-gated channel subfamily H member 2 ) | 0.795827 | 1 | 0 | 1 | 0 |
5 | hsa3758 ( potassium voltage-gated channel subfamily J member 1 ) | 0.784552 | 0 | 0 | 0 | 0 |
6 | hsa6530 ( solute carrier family 6 member 2 ) | 0.748401 | 0 | 0 | 0 | 0 |
7 | hsa3767 ( potassium voltage-gated channel subfamily J member 11 ) | 0.72507 | 0 | 0 | 0 | 0 |
8 | hsa6532 ( solute carrier family 6 member 4 ) | 0.709512 | 0 | 0 | 0 | 0 |
9 | hsa2554 ( gamma-aminobutyric acid type A receptor alpha1 subunit ) | 0.709336 | 0 | 0 | 0 | 0 |
10 | hsa3784 ( potassium voltage-gated channel subfamily Q member 1 ) | 0.705087 | 0 | 0 | 0 | 0 |
Rank | Target | Score | Validated | KEGG | DrugBank | Matador |
---|---|---|---|---|---|---|
1 | hsa1137 ( cholinergic receptor nicotinic alpha 4 subunit ) | 0.965774 | 1 | 0 | 1 | 0 |
2 | hsa1138 ( cholinergic receptor nicotinic alpha 5 subunit ) | 0.959932 | 1 | 0 | 1 | 0 |
3 | hsa1139 ( cholinergic receptor nicotinic alpha 7 subunit ) | 0.959924 | 1 | 0 | 1 | 0 |
4 | hsa1134 ( cholinergic receptor nicotinic alpha 1 subunit ) | 0.95599 | 0 | 0 | 0 | 0 |
5 | hsa285242 ( 5-hydroxytryptamine receptor 3E ) | 0.834253 | 0 | 0 | 0 | 0 |
6 | hsa9177 ( 5-hydroxytryptamine receptor 3B ) | 0.830583 | 0 | 0 | 0 | 0 |
7 | hsa1144 ( cholinergic receptor nicotinic delta subunit ) | 0.824231 | 0 | 0 | 0 | 0 |
8 | hsa2554 ( gamma-aminobutyric acid type A receptor alpha1 subunit ) | 0.785364 | 0 | 0 | 0 | 0 |
9 | hsa1140 ( cholinergic receptor nicotinic beta 1 subunit ) | 0.756282 | 0 | 0 | 0 | 0 |
10 | hsa6530 ( solute carrier family 6 member 2 ) | 0.723605 | 0 | 0 | 0 | 0 |
Rank | Target | Score | Validated | KEGG | DrugBank | Matador |
---|---|---|---|---|---|---|
1 | hsa3782 ( potassium calcium-activated channel subfamily N member 3 ) | 0.91924 | 0 | 0 | 0 | 0 |
2 | hsa3781 ( potassium calcium-activated channel subfamily N member 2 ) | 0.9088 | 0 | 0 | 0 | 0 |
3 | hsa1080 ( cystic fibrosis transmembrane conductance regulator ) | 0.900792 | 0 | 0 | 0 | 0 |
4 | hsa6261 ( ryanodine receptor 1 ) | 0.885705 | 0 | 0 | 0 | 0 |
5 | hsa6262 ( ryanodine receptor 2 ) | 0.874858 | 0 | 0 | 0 | 0 |
6 | hsa6263 ( ryanodine receptor 3 ) | 0.874648 | 0 | 0 | 0 | 0 |
7 | hsa3780 ( potassium calcium-activated channel subfamily N member 1 ) | 0.850581 | 0 | 0 | 0 | 0 |
8 | hsa3757 ( potassium voltage-gated channel subfamily H member 2 ) | 0.807472 | 0 | 0 | 0 | 0 |
9 | hsa3744 ( potassium voltage-gated channel subfamily A member 10 ) | 0.785195 | 0 | 0 | 0 | 0 |
10 | hsa3758 ( potassium voltage-gated channel subfamily J member 1 ) | 0.743173 | 0 | 0 | 0 | 0 |
Rank | Target | Score | Validated | KEGG | DrugBank | Matador |
---|---|---|---|---|---|---|
1 | hsa1141 ( cholinergic receptor nicotinic beta 2 subunit ) | 0.965854 | 0 | 0 | 0 | 0 |
2 | hsa1145 ( cholinergic receptor nicotinic epsilon subunit ) | 0.878152 | 0 | 0 | 0 | 0 |
3 | hsa3359 ( 5-hydroxytryptamine receptor 3A ) | 0.836421 | 0 | 0 | 0 | 0 |
4 | hsa9312 ( potassium voltage-gated channel subfamily B member 2 ) | 0.798229 | 0 | 0 | 0 | 0 |
5 | hsa2554 ( gamma-aminobutyric acid type A receptor alpha1 subunit ) | 0.794638 | 0 | 0 | 0 | 0 |
6 | hsa1144 ( cholinergic receptor nicotinic delta subunit ) | 0.761244 | 0 | 0 | 0 | 0 |
7 | hsa3752 ( potassium voltage-gated channel subfamily D member 3 ) | 0.7284 | 0 | 0 | 0 | 0 |
8 | hsa1140 ( cholinergic receptor nicotinic beta 1 subunit ) | 0.696509 | 0 | 0 | 0 | 0 |
9 | hsa3781 ( potassium calcium-activated channel subfamily N member 2 ) | 0.663496 | 0 | 0 | 0 | 0 |
10 | hsa3757 ( potassium voltage-gated channel subfamily H member 2 ) | 0.661896 | 0 | 0 | 0 | 0 |
Rank | Target | Score | Validated | KEGG | DrugBank | Matador |
---|---|---|---|---|---|---|
1 | hsa6530 ( solute carrier family 6 member 2 ) | 0.920092 | 1 | 0 | 1 | 0 |
2 | hsa1141 ( cholinergic receptor nicotinic beta 2 subunit ) | 0.883195 | 1 | 0 | 1 | 0 |
3 | hsa8973 ( cholinergic receptor nicotinic alpha 6 subunit ) | 0.877707 | 0 | 0 | 0 | 0 |
4 | hsa1136 ( cholinergic receptor nicotinic alpha 3 subunit ) | 0.85246 | 1 | 0 | 1 | 0 |
5 | hsa57053 ( cholinergic receptor nicotinic alpha 10 subunit ) | 0.842489 | 0 | 0 | 0 | 0 |
6 | hsa55584 ( cholinergic receptor nicotinic alpha 9 subunit ) | 0.839067 | 0 | 0 | 0 | 0 |
7 | hsa1137 ( cholinergic receptor nicotinic alpha 4 subunit ) | 0.829764 | 1 | 0 | 1 | 0 |
8 | hsa6531 ( solute carrier family 6 member 3 ) | 0.818666 | 0 | 0 | 0 | 0 |
9 | hsa3359 ( 5-hydroxytryptamine receptor 3A ) | 0.817819 | 0 | 0 | 0 | 0 |
10 | hsa1138 ( cholinergic receptor nicotinic alpha 5 subunit ) | 0.812881 | 0 | 0 | 0 | 0 |
Rank | Target | Score | Validated | KEGG | DrugBank | Matador |
---|---|---|---|---|---|---|
1 | hsa1141 ( cholinergic receptor nicotinic beta 2 subunit ) | 0.95576 | 0 | 0 | 0 | 0 |
2 | hsa1145 ( cholinergic receptor nicotinic epsilon subunit ) | 0.867027 | 0 | 0 | 0 | 0 |
3 | hsa3359 ( 5-hydroxytryptamine receptor 3A ) | 0.831524 | 0 | 0 | 0 | 0 |
4 | hsa9312 ( potassium voltage-gated channel subfamily B member 2 ) | 0.812422 | 0 | 0 | 0 | 0 |
5 | hsa2554 ( gamma-aminobutyric acid type A receptor alpha1 subunit ) | 0.795726 | 0 | 0 | 0 | 0 |
6 | hsa1144 ( cholinergic receptor nicotinic delta subunit ) | 0.74706 | 0 | 0 | 0 | 0 |
7 | hsa3752 ( potassium voltage-gated channel subfamily D member 3 ) | 0.731739 | 0 | 0 | 0 | 0 |
8 | hsa1140 ( cholinergic receptor nicotinic beta 1 subunit ) | 0.682467 | 0 | 0 | 0 | 0 |
9 | hsa3757 ( potassium voltage-gated channel subfamily H member 2 ) | 0.674415 | 0 | 0 | 0 | 0 |
10 | hsa3758 ( potassium voltage-gated channel subfamily J member 1 ) | 0.673544 | 0 | 0 | 0 | 0 |
Rank | Target | Score | Validated | KEGG | DrugBank | Matador |
---|---|---|---|---|---|---|
1 | hsa3743 ( potassium voltage-gated channel subfamily A member 7 ) | 0.939403 | 0 | 0 | 0 | 0 |
2 | hsa3739 ( potassium voltage-gated channel subfamily A member 4 ) | 0.905772 | 0 | 0 | 0 | 0 |
3 | hsa776 ( calcium voltage-gated channel subunit alpha1 D ) | 0.903247 | 1 | 1 | 0 | 0 |
4 | hsa773 ( calcium voltage-gated channel subunit alpha1 A ) | 0.894649 | 0 | 0 | 0 | 0 |
5 | hsa3744 ( potassium voltage-gated channel subfamily A member 10 ) | 0.868293 | 0 | 0 | 0 | 0 |
6 | hsa3747 ( potassium voltage-gated channel subfamily C member 2 ) | 0.839862 | 0 | 0 | 0 | 0 |
7 | hsa9312 ( potassium voltage-gated channel subfamily B member 2 ) | 0.801023 | 0 | 0 | 0 | 0 |
8 | hsa3763 ( potassium voltage-gated channel subfamily J member 6 ) | 0.797138 | 0 | 0 | 0 | 0 |
9 | hsa2554 ( gamma-aminobutyric acid type A receptor alpha1 subunit ) | 0.790667 | 0 | 0 | 0 | 0 |
10 | hsa2890 ( glutamate ionotropic receptor AMPA type subunit 1 ) | 0.712744 | 0 | 0 | 0 | 0 |
Rank | Target | Score | Validated | KEGG | DrugBank | Matador |
---|---|---|---|---|---|---|
1 | hsa3782 ( potassium calcium-activated channel subfamily N member 3 ) | 0.791873 | 0 | 0 | 0 | 0 |
2 | hsa3767 ( potassium voltage-gated channel subfamily J member 11 ) | 0.788585 | 0 | 0 | 0 | 0 |
3 | hsa2554 ( gamma-aminobutyric acid type A receptor alpha1 subunit ) | 0.782504 | 0 | 0 | 0 | 0 |
4 | hsa6331 ( sodium voltage-gated channel alpha subunit 5 ) | 0.77592 | 0 | 0 | 0 | 0 |
5 | hsa3781 ( potassium calcium-activated channel subfamily N member 2 ) | 0.74582 | 0 | 0 | 0 | 0 |
6 | hsa3757 ( potassium voltage-gated channel subfamily H member 2 ) | 0.733026 | 0 | 0 | 0 | 0 |
7 | hsa6323 ( sodium voltage-gated channel alpha subunit 1 ) | 0.726698 | 0 | 0 | 0 | 0 |
8 | hsa6532 ( solute carrier family 6 member 4 ) | 0.706267 | 0 | 0 | 0 | 0 |
9 | hsa3758 ( potassium voltage-gated channel subfamily J member 1 ) | 0.68819 | 0 | 0 | 0 | 0 |
10 | hsa1135 ( cholinergic receptor nicotinic alpha 2 subunit ) | 0.679275 | 0 | 0 | 0 | 0 |
Rank | Target | Score | Validated | KEGG | DrugBank | Matador |
---|---|---|---|---|---|---|
1 | hsa6336 ( sodium voltage-gated channel alpha subunit 10 ) | 0.967333 | 1 | 0 | 0 | 1 |
2 | hsa8645 ( potassium two pore domain channel subfamily K member 5 ) | 0.939202 | 0 | 0 | 0 | 0 |
3 | hsa3741 ( potassium voltage-gated channel subfamily A member 5 ) | 0.82242 | 0 | 0 | 0 | 0 |
4 | hsa3763 ( potassium voltage-gated channel subfamily J member 6 ) | 0.817959 | 0 | 0 | 0 | 0 |
5 | hsa6332 ( sodium voltage-gated channel alpha subunit 7 ) | 0.736718 | 1 | 0 | 0 | 1 |
6 | hsa8913 ( calcium voltage-gated channel subunit alpha1 G ) | 0.715228 | 0 | 0 | 0 | 0 |
7 | hsa3758 ( potassium voltage-gated channel subfamily J member 1 ) | 0.676301 | 0 | 0 | 0 | 0 |
8 | hsa3743 ( potassium voltage-gated channel subfamily A member 7 ) | 0.674164 | 0 | 0 | 0 | 0 |
9 | hsa3767 ( potassium voltage-gated channel subfamily J member 11 ) | 0.637679 | 0 | 0 | 0 | 0 |
10 | hsa11280 ( sodium voltage-gated channel alpha subunit 11 ) | 0.633898 | 0 | 0 | 0 | 0 |
Rank | Target | Score | Validated | KEGG | DrugBank | Matador |
---|---|---|---|---|---|---|
1 | hsa3780 ( potassium calcium-activated channel subfamily N member 1 ) | 0.943099 | 0 | 0 | 0 | 0 |
2 | hsa3783 ( potassium calcium-activated channel subfamily N member 4 ) | 0.878738 | 0 | 0 | 0 | 0 |
3 | hsa3763 ( potassium voltage-gated channel subfamily J member 6 ) | 0.866495 | 0 | 0 | 0 | 0 |
4 | hsa3757 ( potassium voltage-gated channel subfamily H member 2 ) | 0.799578 | 1 | 0 | 1 | 0 |
5 | hsa3758 ( potassium voltage-gated channel subfamily J member 1 ) | 0.774782 | 0 | 0 | 0 | 0 |
6 | hsa3767 ( potassium voltage-gated channel subfamily J member 11 ) | 0.719115 | 0 | 0 | 0 | 0 |
7 | hsa3784 ( potassium voltage-gated channel subfamily Q member 1 ) | 0.704091 | 0 | 0 | 0 | 0 |
8 | hsa6530 ( solute carrier family 6 member 2 ) | 0.70321 | 0 | 0 | 0 | 0 |
9 | hsa2554 ( gamma-aminobutyric acid type A receptor alpha1 subunit ) | 0.702828 | 0 | 0 | 0 | 0 |
10 | hsa9132 ( potassium voltage-gated channel subfamily Q member 4 ) | 0.681519 | 0 | 0 | 0 | 0 |
Rank | Target | Score | Validated | KEGG | DrugBank | Matador |
---|---|---|---|---|---|---|
1 | hsa3741 ( potassium voltage-gated channel subfamily A member 5 ) | 0.83716 | 0 | 0 | 0 | 0 |
2 | hsa6332 ( sodium voltage-gated channel alpha subunit 7 ) | 0.785035 | 0 | 0 | 0 | 0 |
3 | hsa3763 ( potassium voltage-gated channel subfamily J member 6 ) | 0.744544 | 0 | 0 | 0 | 0 |
4 | hsa8913 ( calcium voltage-gated channel subunit alpha1 G ) | 0.707172 | 0 | 0 | 0 | 0 |
5 | hsa11280 ( sodium voltage-gated channel alpha subunit 11 ) | 0.690174 | 0 | 0 | 0 | 0 |
6 | hsa3758 ( potassium voltage-gated channel subfamily J member 1 ) | 0.676231 | 0 | 0 | 0 | 0 |
7 | hsa3743 ( potassium voltage-gated channel subfamily A member 7 ) | 0.658867 | 0 | 0 | 0 | 0 |
8 | hsa3752 ( potassium voltage-gated channel subfamily D member 3 ) | 0.625175 | 0 | 0 | 0 | 0 |
9 | hsa54207 ( potassium two pore domain channel subfamily K member 10 ) | 0.616226 | 0 | 0 | 0 | 0 |
10 | hsa3359 ( 5-hydroxytryptamine receptor 3A ) | 0.595702 | 0 | 0 | 0 | 0 |
Rank | Target | Score | Validated | KEGG | DrugBank | Matador |
---|---|---|---|---|---|---|
1 | hsa285242 ( 5-hydroxytryptamine receptor 3E ) | 0.965323 | 1 | 1 | 0 | 0 |
2 | hsa9177 ( 5-hydroxytryptamine receptor 3B ) | 0.957084 | 1 | 1 | 0 | 0 |
3 | hsa170572 ( 5-hydroxytryptamine receptor 3C ) | 0.917119 | 1 | 1 | 0 | 0 |
4 | hsa200909 ( 5-hydroxytryptamine receptor 3D ) | 0.913835 | 1 | 1 | 0 | 0 |
5 | hsa1135 ( cholinergic receptor nicotinic alpha 2 subunit ) | 0.79325 | 0 | 0 | 0 | 0 |
6 | hsa1141 ( cholinergic receptor nicotinic beta 2 subunit ) | 0.74293 | 0 | 0 | 0 | 0 |
7 | hsa3758 ( potassium voltage-gated channel subfamily J member 1 ) | 0.728869 | 0 | 0 | 0 | 0 |
8 | hsa2554 ( gamma-aminobutyric acid type A receptor alpha1 subunit ) | 0.717164 | 0 | 0 | 0 | 0 |
9 | hsa6331 ( sodium voltage-gated channel alpha subunit 5 ) | 0.71322 | 0 | 0 | 0 | 0 |
10 | hsa6530 ( solute carrier family 6 member 2 ) | 0.713121 | 0 | 0 | 0 | 0 |
Rank | Target | Score | Validated | KEGG | DrugBank | Matador |
---|---|---|---|---|---|---|
1 | hsa6530 ( solute carrier family 6 member 2 ) | 0.824492 | 0 | 0 | 0 | 0 |
2 | hsa6532 ( solute carrier family 6 member 4 ) | 0.754065 | 0 | 0 | 0 | 0 |
3 | hsa3757 ( potassium voltage-gated channel subfamily H member 2 ) | 0.749136 | 0 | 0 | 0 | 0 |
4 | hsa1135 ( cholinergic receptor nicotinic alpha 2 subunit ) | 0.744668 | 0 | 0 | 0 | 0 |
5 | hsa3782 ( potassium calcium-activated channel subfamily N member 3 ) | 0.741967 | 0 | 0 | 0 | 0 |
6 | hsa3767 ( potassium voltage-gated channel subfamily J member 11 ) | 0.729284 | 0 | 0 | 0 | 0 |
7 | hsa2554 ( gamma-aminobutyric acid type A receptor alpha1 subunit ) | 0.719379 | 0 | 0 | 0 | 0 |
8 | hsa6531 ( solute carrier family 6 member 3 ) | 0.705042 | 0 | 0 | 0 | 0 |
9 | hsa6331 ( sodium voltage-gated channel alpha subunit 5 ) | 0.701347 | 0 | 0 | 0 | 0 |
10 | hsa1141 ( cholinergic receptor nicotinic beta 2 subunit ) | 0.698783 | 0 | 0 | 0 | 0 |
Rank | Target | Score | Validated | KEGG | DrugBank | Matador |
---|---|---|---|---|---|---|
1 | hsa2555 ( gamma-aminobutyric acid type A receptor alpha2 subunit ) | 0.950428 | 1 | 0 | 0 | 1 |
2 | hsa2558 ( gamma-aminobutyric acid type A receptor alpha5 subunit ) | 0.946423 | 1 | 0 | 0 | 1 |
3 | hsa2556 ( gamma-aminobutyric acid type A receptor alpha3 subunit ) | 0.946388 | 1 | 0 | 0 | 1 |
4 | hsa2559 ( gamma-aminobutyric acid type A receptor alpha6 subunit ) | 0.943944 | 1 | 0 | 0 | 1 |
5 | hsa2557 ( gamma-aminobutyric acid type A receptor alpha4 subunit ) | 0.943768 | 1 | 0 | 0 | 1 |
6 | hsa2564 ( gamma-aminobutyric acid type A receptor epsilon subunit ) | 0.846415 | 1 | 0 | 0 | 1 |
7 | hsa2566 ( gamma-aminobutyric acid type A receptor gamma2 subunit ) | 0.846075 | 1 | 0 | 0 | 1 |
8 | hsa2567 ( gamma-aminobutyric acid type A receptor gamma3 subunit ) | 0.845683 | 1 | 0 | 0 | 1 |
9 | hsa55879 ( gamma-aminobutyric acid type A receptor theta subunit ) | 0.819182 | 1 | 0 | 0 | 1 |
10 | hsa2561 ( gamma-aminobutyric acid type A receptor beta2 subunit ) | 0.814265 | 1 | 0 | 0 | 1 |
Rank | Target | Score | Validated | KEGG | DrugBank | Matador |
---|---|---|---|---|---|---|
1 | hsa6532 ( solute carrier family 6 member 4 ) | 0.967676 | 1 | 0 | 1 | 0 |
2 | hsa11254 ( solute carrier family 6 member 14 ) | 0.856566 | 0 | 0 | 0 | 0 |
3 | hsa6529 ( solute carrier family 6 member 1 ) | 0.834828 | 0 | 0 | 0 | 0 |
4 | hsa6534 ( solute carrier family 6 member 7 ) | 0.832994 | 0 | 0 | 0 | 0 |
5 | hsa3359 ( 5-hydroxytryptamine receptor 3A ) | 0.756164 | 0 | 0 | 0 | 0 |
6 | hsa1141 ( cholinergic receptor nicotinic beta 2 subunit ) | 0.745239 | 0 | 0 | 0 | 0 |
7 | hsa2554 ( gamma-aminobutyric acid type A receptor alpha1 subunit ) | 0.734074 | 0 | 0 | 0 | 0 |
8 | hsa3758 ( potassium voltage-gated channel subfamily J member 1 ) | 0.715147 | 0 | 0 | 0 | 0 |
9 | hsa1135 ( cholinergic receptor nicotinic alpha 2 subunit ) | 0.702249 | 0 | 0 | 0 | 0 |
10 | hsa6331 ( sodium voltage-gated channel alpha subunit 5 ) | 0.698421 | 0 | 0 | 0 | 0 |
Rank | Target | Score | Validated | KEGG | DrugBank | Matador |
---|---|---|---|---|---|---|
1 | hsa775 ( calcium voltage-gated channel subunit alpha1 C ) | 0.978078 | 1 | 0 | 0 | 1 |
2 | hsa779 ( calcium voltage-gated channel subunit alpha1 S ) | 0.975366 | 0 | 0 | 0 | 0 |
3 | hsa778 ( calcium voltage-gated channel subunit alpha1 F ) | 0.973281 | 1 | 0 | 0 | 1 |
4 | hsa776 ( calcium voltage-gated channel subunit alpha1 D ) | 0.963014 | 1 | 0 | 0 | 1 |
5 | hsa786 ( calcium voltage-gated channel auxiliary subunit gamma 1 ) | 0.89641 | 1 | 0 | 0 | 1 |
6 | hsa783 ( calcium voltage-gated channel auxiliary subunit beta 2 ) | 0.888283 | 1 | 0 | 0 | 1 |
7 | hsa93589 ( calcium voltage-gated channel auxiliary subunit alpha2delta 4 ) | 0.879274 | 0 | 0 | 0 | 0 |
8 | hsa781 ( calcium voltage-gated channel auxiliary subunit alpha2delta 1 ) | 0.872008 | 0 | 0 | 0 | 0 |
9 | hsa774 ( calcium voltage-gated channel subunit alpha1 B ) | 0.849906 | 0 | 0 | 0 | 0 |
10 | hsa55799 ( calcium voltage-gated channel auxiliary subunit alpha2delta 3 ) | 0.834176 | 0 | 0 | 0 | 0 |
Rank | Target | Score | Validated | KEGG | DrugBank | Matador |
---|---|---|---|---|---|---|
1 | hsa6323 ( sodium voltage-gated channel alpha subunit 1 ) | 0.959354 | 1 | 1 | 0 | 0 |
2 | hsa6328 ( sodium voltage-gated channel alpha subunit 3 ) | 0.953147 | 1 | 1 | 0 | 0 |
3 | hsa6336 ( sodium voltage-gated channel alpha subunit 10 ) | 0.952746 | 0 | 0 | 0 | 0 |
4 | hsa6329 ( sodium voltage-gated channel alpha subunit 4 ) | 0.948798 | 1 | 1 | 0 | 0 |
5 | hsa6326 ( sodium voltage-gated channel alpha subunit 2 ) | 0.935734 | 1 | 1 | 0 | 0 |
6 | hsa6334 ( sodium voltage-gated channel alpha subunit 8 ) | 0.93443 | 1 | 1 | 0 | 0 |
7 | hsa6335 ( sodium voltage-gated channel alpha subunit 9 ) | 0.925776 | 1 | 1 | 0 | 0 |
8 | hsa8645 ( potassium two pore domain channel subfamily K member 5 ) | 0.898714 | 0 | 0 | 0 | 0 |
9 | hsa3763 ( potassium voltage-gated channel subfamily J member 6 ) | 0.837143 | 0 | 0 | 0 | 0 |
10 | hsa3782 ( potassium calcium-activated channel subfamily N member 3 ) | 0.757647 | 0 | 0 | 0 | 0 |
Rank | Target | Score | Validated | KEGG | DrugBank | Matador |
---|---|---|---|---|---|---|
1 | hsa1141 ( cholinergic receptor nicotinic beta 2 subunit ) | 0.960879 | 1 | 0 | 1 | 0 |
2 | hsa1145 ( cholinergic receptor nicotinic epsilon subunit ) | 0.862174 | 0 | 0 | 0 | 0 |
3 | hsa3359 ( 5-hydroxytryptamine receptor 3A ) | 0.806747 | 0 | 0 | 0 | 0 |
4 | hsa9312 ( potassium voltage-gated channel subfamily B member 2 ) | 0.802623 | 0 | 0 | 0 | 0 |
5 | hsa3781 ( potassium calcium-activated channel subfamily N member 2 ) | 0.76532 | 0 | 0 | 0 | 0 |
6 | hsa3782 ( potassium calcium-activated channel subfamily N member 3 ) | 0.747027 | 0 | 0 | 0 | 0 |
7 | hsa3763 ( potassium voltage-gated channel subfamily J member 6 ) | 0.735243 | 0 | 0 | 0 | 0 |
8 | hsa3780 ( potassium calcium-activated channel subfamily N member 1 ) | 0.72164 | 0 | 0 | 0 | 0 |
9 | hsa1144 ( cholinergic receptor nicotinic delta subunit ) | 0.719069 | 0 | 0 | 0 | 0 |
10 | hsa2554 ( gamma-aminobutyric acid type A receptor alpha1 subunit ) | 0.689571 | 0 | 0 | 0 | 0 |
Rank | Target | Score | Validated | KEGG | DrugBank | Matador |
---|---|---|---|---|---|---|
1 | hsa1141 ( cholinergic receptor nicotinic beta 2 subunit ) | 0.966131 | 0 | 0 | 0 | 0 |
2 | hsa1145 ( cholinergic receptor nicotinic epsilon subunit ) | 0.877543 | 0 | 0 | 0 | 0 |
3 | hsa3359 ( 5-hydroxytryptamine receptor 3A ) | 0.833529 | 0 | 0 | 0 | 0 |
4 | hsa2554 ( gamma-aminobutyric acid type A receptor alpha1 subunit ) | 0.784018 | 0 | 0 | 0 | 0 |
5 | hsa1144 ( cholinergic receptor nicotinic delta subunit ) | 0.75624 | 0 | 0 | 0 | 0 |
6 | hsa3752 ( potassium voltage-gated channel subfamily D member 3 ) | 0.705178 | 0 | 0 | 0 | 0 |
7 | hsa3738 ( potassium voltage-gated channel subfamily A member 3 ) | 0.69362 | 0 | 0 | 0 | 0 |
8 | hsa1140 ( cholinergic receptor nicotinic beta 1 subunit ) | 0.688659 | 0 | 0 | 0 | 0 |
9 | hsa3767 ( potassium voltage-gated channel subfamily J member 11 ) | 0.663062 | 0 | 0 | 0 | 0 |
10 | hsa3758 ( potassium voltage-gated channel subfamily J member 1 ) | 0.642581 | 0 | 0 | 0 | 0 |
Rank | Target | Score | Validated | KEGG | DrugBank | Matador |
---|---|---|---|---|---|---|
1 | hsa6532 ( solute carrier family 6 member 4 ) | 0.968459 | 1 | 0 | 1 | 0 |
2 | hsa11254 ( solute carrier family 6 member 14 ) | 0.853287 | 0 | 0 | 0 | 0 |
3 | hsa6331 ( sodium voltage-gated channel alpha subunit 5 ) | 0.837978 | 0 | 0 | 0 | 0 |
4 | hsa6529 ( solute carrier family 6 member 1 ) | 0.829425 | 0 | 0 | 0 | 0 |
5 | hsa6534 ( solute carrier family 6 member 7 ) | 0.828043 | 0 | 0 | 0 | 0 |
6 | hsa6336 ( sodium voltage-gated channel alpha subunit 10 ) | 0.776309 | 0 | 0 | 0 | 0 |
7 | hsa6323 ( sodium voltage-gated channel alpha subunit 1 ) | 0.728076 | 0 | 0 | 0 | 0 |
8 | hsa11280 ( sodium voltage-gated channel alpha subunit 11 ) | 0.687278 | 0 | 0 | 0 | 0 |
9 | hsa3758 ( potassium voltage-gated channel subfamily J member 1 ) | 0.682253 | 0 | 0 | 0 | 0 |
10 | hsa3359 ( 5-hydroxytryptamine receptor 3A ) | 0.678775 | 0 | 0 | 0 | 0 |
Rank | Target | Score | Validated | KEGG | DrugBank | Matador |
---|---|---|---|---|---|---|
1 | hsa2564 ( gamma-aminobutyric acid type A receptor epsilon subunit ) | 0.889263 | 0 | 0 | 0 | 0 |
2 | hsa2567 ( gamma-aminobutyric acid type A receptor gamma3 subunit ) | 0.889129 | 0 | 0 | 0 | 0 |
3 | hsa2566 ( gamma-aminobutyric acid type A receptor gamma2 subunit ) | 0.888595 | 0 | 0 | 0 | 0 |
4 | hsa55879 ( gamma-aminobutyric acid type A receptor theta subunit ) | 0.846614 | 0 | 0 | 0 | 0 |
5 | hsa2561 ( gamma-aminobutyric acid type A receptor beta2 subunit ) | 0.843287 | 0 | 0 | 0 | 0 |
6 | hsa2569 ( gamma-aminobutyric acid type A receptor rho1 subunit ) | 0.841513 | 0 | 0 | 0 | 0 |
7 | hsa2563 ( gamma-aminobutyric acid type A receptor delta subunit ) | 0.84054 | 0 | 0 | 0 | 0 |
8 | hsa2562 ( gamma-aminobutyric acid type A receptor beta3 subunit ) | 0.839383 | 0 | 0 | 0 | 0 |
9 | hsa2560 ( gamma-aminobutyric acid type A receptor beta1 subunit ) | 0.827727 | 0 | 0 | 0 | 0 |
10 | hsa3781 ( potassium calcium-activated channel subfamily N member 2 ) | 0.786767 | 0 | 0 | 0 | 0 |
Rank | Target | Score | Validated | KEGG | DrugBank | Matador |
---|---|---|---|---|---|---|
1 | hsa2555 ( gamma-aminobutyric acid type A receptor alpha2 subunit ) | 0.952547 | 1 | 1 | 0 | 0 |
2 | hsa2556 ( gamma-aminobutyric acid type A receptor alpha3 subunit ) | 0.948647 | 1 | 1 | 0 | 0 |
3 | hsa2558 ( gamma-aminobutyric acid type A receptor alpha5 subunit ) | 0.94857 | 1 | 1 | 0 | 0 |
4 | hsa2559 ( gamma-aminobutyric acid type A receptor alpha6 subunit ) | 0.946448 | 1 | 1 | 0 | 0 |
5 | hsa2557 ( gamma-aminobutyric acid type A receptor alpha4 subunit ) | 0.946156 | 1 | 1 | 0 | 0 |
6 | hsa2564 ( gamma-aminobutyric acid type A receptor epsilon subunit ) | 0.853138 | 1 | 1 | 0 | 0 |
7 | hsa2566 ( gamma-aminobutyric acid type A receptor gamma2 subunit ) | 0.852193 | 1 | 1 | 0 | 0 |
8 | hsa2567 ( gamma-aminobutyric acid type A receptor gamma3 subunit ) | 0.85171 | 1 | 1 | 0 | 0 |
9 | hsa55879 ( gamma-aminobutyric acid type A receptor theta subunit ) | 0.825799 | 1 | 1 | 0 | 0 |
10 | hsa2561 ( gamma-aminobutyric acid type A receptor beta2 subunit ) | 0.821269 | 1 | 1 | 0 | 0 |
Rank | Target | Score | Validated | KEGG | DrugBank | Matador |
---|---|---|---|---|---|---|
1 | hsa6323 ( sodium voltage-gated channel alpha subunit 1 ) | 0.976669 | 1 | 1 | 0 | 0 |
2 | hsa6328 ( sodium voltage-gated channel alpha subunit 3 ) | 0.97252 | 1 | 1 | 0 | 0 |
3 | hsa6336 ( sodium voltage-gated channel alpha subunit 10 ) | 0.971519 | 0 | 0 | 0 | 0 |
4 | hsa6329 ( sodium voltage-gated channel alpha subunit 4 ) | 0.970004 | 1 | 1 | 0 | 0 |
5 | hsa6326 ( sodium voltage-gated channel alpha subunit 2 ) | 0.961816 | 1 | 1 | 0 | 0 |
6 | hsa6334 ( sodium voltage-gated channel alpha subunit 8 ) | 0.960249 | 1 | 1 | 0 | 0 |
7 | hsa6335 ( sodium voltage-gated channel alpha subunit 9 ) | 0.954249 | 1 | 1 | 0 | 0 |
8 | hsa8645 ( potassium two pore domain channel subfamily K member 5 ) | 0.929685 | 0 | 0 | 0 | 0 |
9 | hsa6332 ( sodium voltage-gated channel alpha subunit 7 ) | 0.747751 | 0 | 0 | 0 | 0 |
10 | hsa3741 ( potassium voltage-gated channel subfamily A member 5 ) | 0.747021 | 0 | 0 | 0 | 0 |